Processing 00000000.tx.1: The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor Ruth C. von Rotz1, Bernhard M. 

Phrase: "The APP intracellular domain"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   853   C0162808:Protein Domain [Spatial Concept]
   853   C1514562:Protein Domain [Amino Acid Sequence]
   804   C0175996:intracellular [Cell Component]
   804   C0178719:Intracellular [Spatial Concept]
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "nuclear multiprotein complexes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0751283:Multiprotein Complexes [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704241:Complexes [Chemical Viewed Structurally]
   793 E C0439855:Complex [Qualitative Concept]

Phrase: "and"

Phrase: "regulates"

Phrase: "the transcription of its own precursor Ruth C. von Rotz1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0040649:Transcription [Genetic Function]

Phrase: "Bernhard M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.2: Kohli1, Jrme Bosset1, Michelle Meier1, Toshiharu Suzuki2, Roger M. 

Phrase: "Kohli1,"

Phrase: "Jrme Bosset1,"

Phrase: "Michelle Meier1,"

Phrase: "Toshiharu Suzuki2,"

Phrase: "Roger M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.3: Nitsch1 and Uwe Konietzko1,* 1 Division of Psychiatry Research, University of Zurich, August Forel-Str. 

Phrase: "Nitsch1"

Phrase: "and"

Phrase: "Uwe Konietzko1,"

Phrase: "* 1 Division of Psychiatry Research,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1293097:Division [Therapeutic or Preventive Procedure]
   760   C2919030:Division [Organization]
   760   C2919031:Division [Activity]

Phrase: "University of Zurich,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "August Forel-Str."
Processing 00000000.tx.4: 1, 8008 Zurich, Switzerland 2 Laboratory of Neuroscience, Graduate School of Pharmaceutical Sciences, Hokkaido University, Kita-ku, Kita 12, Nishi-6, Sapporo, 060-0812, Japan * Author for correspondence (e-mail: uwe.konietzko{at}bli.unizh.ch ) Accepted 24 May 2004  Summary Top Summary Introduction Materials and Methods Results Discussion References  The physiological functions of the beta-amyloid precursor protein (APP) may include nuclear signaling. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "8008 Zurich,"

Phrase: "Switzerland 2 Laboratory of Neuroscience,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0022877:Laboratory [Manufactured Object,Organization]
   760   C3244292:laboratory [Functional Concept]

Phrase: "Graduate School of Pharmaceutical Sciences,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0870614:graduate school [Manufactured Object,Organization]
   760   C0036375:School [Manufactured Object,Organization]
   760   C0588053:Graduate [Population Group]
   760   C1547183:Graduate [Idea or Concept]

Phrase: "Hokkaido University,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041740:University [Manufactured Object,Organization]
   861   C0454745:Hokkaido [Geographic Area]

Phrase: "Kita-ku,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1532717:ku [Quantitative Concept]
   861   C1881335:kU [Quantitative Concept]

Phrase: "Kita 12,"

Phrase: "Nishi-6,"

Phrase: "Sapporo,"

Phrase: "060-0812,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "* Author for correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0221193:Author [Professional or Occupational Group]

Phrase: "(e-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "uwe.konietzko{at}bli.unizh.ch )"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0558269:Ch. [Professional or Occupational Group]
   799   C1552984:[Ch] [Quantitative Concept]

Phrase: "Accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "24 May 2004  Summary Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The physiological functions of the beta-amyloid precursor protein (APP)"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C1750295:beta protein function [Genetic Function]
   745   C0815043:function protein [Amino Acid, Peptide, or Protein]
   745   C1527118:Protein Function [Molecular Function]
   742   C0542341:Functions [Functional Concept]
   708 E C0031843:function [Physiologic Function]
   708 E C0700205:FUNCTION [Classification]
   708 E C1705273:Function [Intellectual Product]

Phrase: "may"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "nuclear signaling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]
Processing 00000000.tx.5: To characterize the role of the APP adaptor proteins Fe65, Jip1b, X11 (MINT1) and the chromatin-associated protein Tip60, we analyzed their interactions by confocal microscopy and co-immunoprecipitations. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "characterize"

Phrase: "the role of the APP adaptor proteins Fe65,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]

Phrase: "Jip1b,"

Phrase: "X11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412456:X11 [Gene or Genome]
  1000   C3538726:X11 [Gene or Genome]

Phrase: "(MINT1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412456:MINT1 [Gene or Genome]
  1000   C3538726:MINT1 [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "the chromatin-associated protein Tip60,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1333931:TIP60 [Gene or Genome]
   812   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1705504:TIP60 [Gene or Genome]
   708   C0598996:chromatin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "their interactions by confocal microscopy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "co-immunoprecipitations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1449705:Co-Immunoprecipitations [Laboratory Procedure]
   827   C0021069:Immunoprecipitation [Laboratory Procedure]
Processing 00000000.tx.6: AICD corresponding to S3-cleaved APP bound to Fe65 that transported it to nuclei and docked it to Tip60. 

Phrase: "AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "corresponding to S3-cleaved APP"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205242:Cleaved [Spatial Concept]
   748   C0333853:Cleaved [Cell]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1179706:S3 [Body Location or Region]
   748   C1335643:S3 [Gene or Genome]
   748   C1419033:S3 [Gene or Genome]
   748   C1709634:Precursor [Idea or Concept]

Phrase: "bound to Fe65"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0332297:bound [Spatial Concept]
   790   C1145667:Bound [Activity]
   790   C1167622:Bound [Molecular Function]
   790   C1412459:FE65 [Gene or Genome]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]

Phrase: "that transported"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005528:Transport, NOS [Cell Function]
   966   C1317949:Transport [Manufactured Object]
   966   C3495449:transport [Medical Device]

Phrase: "it to nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0007610:Nucleus [Cell Component]

Phrase: "and"

Phrase: "docked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0330386:Dock [Plant]
   966   C0442632:Dock [Manufactured Object]

Phrase: "it to Tip60."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1333931:TIP60 [Gene or Genome]
   790   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1705504:TIP60 [Gene or Genome]
Processing 00000000.tx.7: These proteins formed AICD-Fe65-Tip60 (AFT) complexes that were concentrated in spherical nuclear spots. 

Phrase: "These proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "AICD-Fe65-Tip60 (AFT) complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1704241:Complexes [Chemical Viewed Structurally]
   779 E C0439855:Complex [Qualitative Concept]

Phrase: "that"

Phrase: "were"

Phrase: "concentrated in spherical nuclear spots."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   760   C0015230:spots [Disease or Syndrome]
   760   C0329155:Spot [Fish]
   760   C0332501:Spherical [Spatial Concept]
   760   C0521447:Nuclear [Spatial Concept]
   760   C0848332:Spots [Sign or Symptom]
   760   C1427618:SPOT [Gene or Genome]
   760   C1705203:Spot [Conceptual Entity]
   760   C1880165:Concentrated [Biomedical or Dental Material]
   726 E C1880310:Concentrate [Manufactured Object]
   726 E C2003864:Concentrate [Substance]
Processing 00000000.tx.8: -Secretase inhibitors prevented AFT-complex formation with AICD derived from full-length APP. 

Phrase: "-Secretase inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "AFT-complex formation with AICD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]

Phrase: "derived from full-length APP."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0443225:Full [Qualitative Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1441547:Derived [Qualitative Concept]
   748   C1444754:Length [Quantitative Concept]
   748   C1706316:LENGTH [Research Activity]
   748   C1709634:Precursor [Idea or Concept]
   748   C3245521:derived [Idea or Concept]
Processing 00000000.tx.9: The APP adaptor protein Jip1b also transported AICD to nuclei and docked it to Tip60, but AICD-Jip1b-Tip60 (AJT) complexes had different, speckle-like morphology. 

Phrase: "The APP adaptor protein Jip1b also transported AICD to nuclei"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   736   C0972395:aicd [Medical Device]
   736   C2611803:AICD [Cell Function]
   736   C3156099:AICD [Cell Function]
   736   C3537205:AICD [Cell Function]

Phrase: "and"

Phrase: "docked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0330386:Dock [Plant]
   966   C0442632:Dock [Manufactured Object]

Phrase: "it to Tip60,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1333931:TIP60 [Gene or Genome]
   790   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1705504:TIP60 [Gene or Genome]

Phrase: "but"

Phrase: "AICD-Jip1b-Tip60 (AJT) complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1704241:Complexes [Chemical Viewed Structurally]
   779 E C0439855:Complex [Qualitative Concept]

Phrase: "had"

Phrase: "different, speckle-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0439691:Speckled [Qualitative Concept]

Phrase: "like morphology."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0332437:Morphology [Qualitative Concept]
  1000   C0543482:morphology [Spatial Concept]
  1000   C0700329:Morphology, NOS [Finding]
  1000   C0700619:Morphology [Biomedical Occupation or Discipline]
Processing 00000000.tx.10: By contrast, X11 trapped AICD in the cytosol. 

Phrase: "By contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "X11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412456:X11 [Gene or Genome]
  1000   C3538726:X11 [Gene or Genome]

Phrase: "trapped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184047:Trapped [Medical Device]

Phrase: "AICD in the cytosol."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0972395:aicd [Medical Device]
   770   C2611803:AICD [Cell Function]
   770   C3156099:AICD [Cell Function]
   770   C3537205:AICD [Cell Function]
Processing 00000000.tx.11: Induced AICD expression identified the APP-effector genes APP, BACE, Tip60, GSK3 and KAI1, but not the Notch-effector gene Hes1 as transcriptional targets. 

Phrase: "Induced AICD expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "the APP-effector genes APP,"

Phrase: "BACE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412727:BACE [Gene or Genome]

Phrase: "Tip60,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "KAI1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0286983:KAI1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812444:KAI1 [Gene or Genome]
  1000   C1705784:KAI1 [Gene or Genome]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the Notch-effector gene Hes1 as transcriptional targets."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1415725:HES1 gene [Gene or Genome]
           HES1
   744   C1412958:HES1 [Gene or Genome]
Processing 00000000.tx.12: These data establish a role for APP in nuclear signaling, and they suggest that therapeutic strategies designed to modulate the cleavage of APP affect AICD-dependent signaling. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "a role for APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in nuclear signaling,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "and"

Phrase: "they"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that therapeutic strategies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679199:strategies [Mental Process]

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the cleavage of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0597304:Protein Cleavage [Molecular Function]
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "AICD-dependent signaling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037083:Signaling [Cell Function]
   827   C3537152:signaling [Biologic Function]
Processing 00000000.tx.13: Key words: AICD, Alzheimer's disease, Tip60, Fe65, -Secretase, Transcriptional regulation  Introduction Top Summary Introduction Materials and Methods Results Discussion References  The amyloid precursor protein (APP) is a single-pass transmembrane protein that is involved in the pathophysiology of Alzheimer's disease (AD) (Selkoe, 1999). 

Phrase: "Key words"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705313:Word [Idea or Concept]
   789 E C0439824:Verbal [Qualitative Concept]
   761 E C0871946:verb [Intellectual Product]

Phrase: ":"

Phrase: "AICD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "Alzheimer's disease,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "Tip60,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "Fe65, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "Secretase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Transcriptional regulation  Introduction Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "(APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "is"

Phrase: "a single-pass transmembrane protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2329187:Single-pass transmembrane protein [Amino Acid, Peptide, or Protein]
   861   C0021699:Transmembrane protein [Amino Acid, Peptide, or Protein]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1167322:transmembrane [Cell Component]
   812   C2752508:transmembrane [Cell Component]

Phrase: "that"

Phrase: "is"

Phrase: "involved in the pathophysiology of Alzheimer's disease"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0031847:pathophysiology [Functional Concept]
   748   C0277785:Pathophysiology [Qualitative Concept]
   748   C1314939:Involved [Functional Concept]

Phrase: "(AD) (Selkoe,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.14: Successive proteolytic processing, with ectodomain shedding followed by intramembraneous cleavage (De Strooper, 2003; Sisodia and St George-Hyslop, 2002; Walter et al., 2001), generates beta-amyloid (A) peptides; 

Phrase: "Successive proteolytic processing,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1514570:Proteolytic Processing [Molecular Function]
   827   C1709694:Processing [Activity]

Phrase: "with ectodomain shedding"

Phrase: "followed by intramembraneous cleavage"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "(De Strooper,"

Phrase: "2003"

Phrase: "; Sisodia"

Phrase: "and"

Phrase: "St George-Hyslop,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1553316:St. George [Population Group]

Phrase: "2002"

Phrase: "; Walter et al.,"

Phrase: "2001"

Phrase: ")"

Phrase: ","

Phrase: "generates"

Phrase: "beta-amyloid (A) peptides"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C2825879:Amyloid, Beta [Laboratory Procedure]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2004068:Beta [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.15: these aggregate to form -amyloid plaques in the brains of patients with AD. 

Phrase: "these aggregate to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:Aggregate [Qualitative Concept]

Phrase: "form -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "amyloid plaques in the brains of patients"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   778   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   778   C2936349:Plaques, Amyloid [Acquired Abnormality]
   714 E C0011389:Plaque [Disease or Syndrome]
   714 E C0332461:Plaque [Finding]

Phrase: "with AD."
Processing 00000000.tx.16: A large body of genetic and cell biological evidence strongly argues for pathogenic activities of A, including a role in the formation of neurofibrillary tangles (Gotz et al., 2001; Lewis et al., 2001). 

Phrase: "A large body of genetic"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0242821:body [Human]
   760   C0460148:Body [Anatomical Structure]
   760   C1268086:Body [Anatomical Structure]
   756   C3533118:Amyloid bodies [Finding]

Phrase: "and"

Phrase: "cell biological evidence strongly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0332120:Evidence [Functional Concept]

Phrase: "argues for pathogenic activities of A,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0441655:Activities [Activity]
   753   C0450254:Pathogenic [Organism]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   719 E C0205177:Activity [Functional Concept]
   719 E C0439167:% activity [Quantitative Concept]
   719 E C1561536:*Activity [Idea or Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "a role in the formation of neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "(Gotz et al.,"

Phrase: "2001"

Phrase: "; Lewis et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.17: Initial clinical evidence in support of a pathogenic role of A in humans was recently provided by the observation that antibodies against A generated in response to vaccination slowed the rate of cognitive decline in patients with AD (Hock et al., 2002; Hock et al., 2003). 

Phrase: "Initial clinical evidence in support of a pathogenic role of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "was"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "provided by the observation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0302523:Observation [Research Activity]
   770   C0700325:observation [Health Care Activity]
   770   C1964257:Observation [Diagnostic Procedure]
   770   C1999230:Provided [Activity]

Phrase: "that antibodies against A"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "generated in response"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]
   790   C3146294:Generated [Activity]

Phrase: "to vaccination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042196:Vaccination [Therapeutic or Preventive Procedure]

Phrase: "slowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439834:Slow [Qualitative Concept]

Phrase: "the rate of cognitive decline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with AD (Hock et al.,"

Phrase: "2002"

Phrase: "; Hock et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.18: Together, these findings led to the development of a large variety of different pharmacological and immunological approaches aiming at lowering brain levels of A. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "led to the development of a large variety of different pharmacological"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   738   C0031330:Pharmacological [Biomedical Occupation or Discipline]
   738   C0205464:pharmacological [Functional Concept]
   738   C0243107:development [Physiologic Function]
   738   C0549177:Large [Quantitative Concept]
   738   C0678723:Development [Organism Function]
   738   C1527148:Development [Functional Concept]
   738   C1705242:Different [Qualitative Concept]
   738   C1708698:LED [Manufactured Object]
   738   C1883525:Variety [Conceptual Entity]
   738   C2346866:Variety [Conceptual Entity]
   704 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   704 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   704 E C1522538:Lead [Functional Concept]
   704 E C2348269:Lead [Element, Ion, or Isotope]
   704 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "immunological approaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449445:Approaches [Spatial Concept]
   861   C1292724:Approaches [Functional Concept]

Phrase: "aiming at lowering brain levels of A."
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0441889:Levels [Qualitative Concept]
   748   C0441994:lowering [Spatial Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C2003888:Lowering [Activity]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C1548802:Lower [Body Location or Region]
   714   C1947946:Aim [Idea or Concept]
   714 E C2946261:Level [Pharmacologic Substance]
   714   C2948600:Aim [Pharmacologic Substance]
   714   C3540471:AIM [Gene or Genome]
   714   C3540472:AIM [Functional Concept]
Processing 00000000.tx.19: Along with A generation, intramembraneous proteolysis of APP also liberates the APP intracellular C-terminus (AICD) from the membrane. 

Phrase: "Along with A generation,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0079411:Generation [Temporal Concept]
   861   C3146294:Generation [Activity]
   768 E C1414672:Genesis [Gene or Genome]
   768 E C2984892:Genesis [Gene or Genome]

Phrase: "intramembraneous proteolysis of APP also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0597304:Proteolysis [Molecular Function]

Phrase: "liberates"

Phrase: "the APP intracellular C-terminus"

Phrase: "(AICD) from the membrane."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0972395:aicd [Medical Device]
   770   C2611803:AICD [Cell Function]
   770   C3156099:AICD [Cell Function]
   770   C3537205:AICD [Cell Function]
Processing 00000000.tx.20: AICD was described long after the initial identification of APP (Passer et al., 2000), probably because of its rapid degradation after release from the membrane into the cytoplasm (Cupers et al., 2001a; Kimberly et al., 2001), in part by insulin degrading enzyme (Edbauer et al., 2002; Farris et al., 2003). 

Phrase: "AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "was"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "long after the initial identification of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205166:Long [Qualitative Concept]
   742   C1706317:Long [Qualitative Concept]

Phrase: "(Passer et al.,"

Phrase: "2000"

Phrase: ")"

Phrase: ","

Phrase: "probably because of its rapid degradation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0243125:degradation [Functional Concept]
   753   C0439831:Rapid [Qualitative Concept]
   753   C0699900:Degradation [Organism Function]
   753   C0750492:Probably [Idea or Concept]

Phrase: "after release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "from the membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "into the cytoplasm"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010834:Cytoplasm [Cell Component]
   928 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "(Cupers et al.,"

Phrase: "2001a"

Phrase: "; Kimberly et al.,"

Phrase: "2001"

Phrase: ")"

Phrase: ","

Phrase: "in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "by insulin degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Edbauer et al.,"

Phrase: "2002"

Phrase: "; Farris et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.21: The analogy of APP processing to Notch receptor signaling suggested a possible function for AICD in nuclear signaling (De Strooper et al., 1999; Schroeter et al., 1998). 

Phrase: "The analogy of APP processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0679213:analogy [Idea or Concept]

Phrase: "to Notch receptor signaling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1514762:Receptor Signaling [Molecular Function]
   827   C0037083:Signaling [Cell Function]
   827   C3537152:signaling [Biologic Function]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a possible function for AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "in nuclear signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "(De Strooper et al.,"

Phrase: "1999"

Phrase: "; Schroeter et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.22: In a seminal experiment, Cao and Sdhof (Cao and Sdhof, 2001) have used APP- and AICD-fusions with the yeast Gal4 transcription factor DNA-binding domain and observed transactivation activity for AICD. 

Phrase: "In a seminal experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "Cao"

Phrase: "and"

Phrase: "Sdhof"

Phrase: "(Cao"

Phrase: "and"

Phrase: "Sdhof,"

Phrase: "2001"

Phrase: ")"

Phrase: "have"

Phrase: "used APP-"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "AICD-fusions with the yeast Gal4 transcription factor DNA-binding domain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0332466:fusions [Functional Concept]
   738   C1293131:fusions [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "observed transactivation activity for AICD."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.23: This was dependent on the APP-adaptor protein Fe65 (Duilio et al., 1991; Minopoli et al., 2001) and the Fe65-binding nuclear histone acetylase Tip60 (Sterner and Berger, 2000). 

Phrase: "This"

Phrase: "was"

Phrase: "dependent on the APP-adaptor protein Fe65"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0851827:Dependent [Qualitative Concept]
   742   C1701901:Dependent [Qualitative Concept]
   742   C3244310:dependent [Functional Concept]

Phrase: "(Duilio et al.,"

Phrase: "1991"

Phrase: "; Minopoli et al.,"

Phrase: "2001"

Phrase: ")"

Phrase: "and"

Phrase: "the Fe65-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "nuclear histone acetylase Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1333931:TIP60 [Gene or Genome]
   812   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1705504:TIP60 [Gene or Genome]

Phrase: "(Sterner"

Phrase: "and"

Phrase: "Berger,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.24: However, the possibility remains that, in transient transfection assays, the transcription from reporter constructs could also occur in the cytosol. 

Phrase: "However,"

Phrase: "the possibility"

Phrase: "remains"

Phrase: "that,"

Phrase: "in transient transfection assays,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   827   C0040704:Transient [Population Group]
   827   C0205374:Transient [Temporal Concept]
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "the transcription from reporter constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0040649:Transcription [Genetic Function]

Phrase: "could"

Phrase: "also"

Phrase: "occur in the cytosol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1383501:Cytosol [Cell Component]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.25: Fe65 has been shown to stabilize the intracellular domains of -secretase cleaved APP, APLP1 and APLP2, which together with Fe65, localized to the nuclear compartment (Kimberly et al., 2001; Walsh et al., 2003). 

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stabilize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184512:stabilize [Qualitative Concept]

Phrase: "the intracellular domains of -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "cleaved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "APLP1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412466:APLP1 [Gene or Genome]

Phrase: "and"

Phrase: "APLP2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412467:APLP2 [Gene or Genome]

Phrase: "which together with Fe65,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1412459:FE65 [Gene or Genome]
   770   C1883357:Together [Qualitative Concept]

Phrase: "localized to the nuclear compartment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0392752:Localized [Spatial Concept]
   760   C0521447:Nuclear [Spatial Concept]
   760   C1185625:Compartment [Body Space or Junction]
   760   C2986730:Compartment [Spatial Concept]

Phrase: "(Kimberly et al.,"

Phrase: "2001"

Phrase: "; Walsh et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.26: These experiments suggested a role in nuclear signaling for the AICD. 

Phrase: "These experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a role in nuclear signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "for the AICD."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]
Processing 00000000.tx.27: To characterize the molecular requirements for the nuclear localization of AICD, we used inducible expression of fluorescently tagged AICD and cotransfection of AICD-adaptor proteins, followed by analysis via confocal microscopy and co-immunoprecipitation.  

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "characterize"

Phrase: "the molecular requirements for the nuclear localization of AICD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C1514873:Requirement [Functional Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "inducible expression of fluorescently tagged AICD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "cotransfection of AICD-adaptor proteins,"

Phrase: "followed by analysis"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "via confocal microscopy"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0242842:Microscopy, Confocal [Laboratory Procedure]
   861   C0026018:Microscopy [Laboratory Procedure]
   789 E C0205288:Microscopic [Qualitative Concept]

Phrase: "and"

Phrase: "co-immunoprecipitation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   861   C0021069:Immunoprecipitation [Laboratory Procedure]
Processing 00000000.tx.28: Materials and Methods Top Summary Introduction Materials and Methods Results Discussion References  Cell culture HEK293 cells were grown in DMEM supplemented with 10% fetal bovine serum (Gibco, Basel, Switzerland). 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cell culture HEK293 cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C2936239:HEK293 Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]

Phrase: "were"

Phrase: "grown in DMEM"

Phrase: "supplemented with 10% fetal bovine serum"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0007452:Bovine [Mammal]
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0521457:Fetal [Functional Concept]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "(Gibco,"

Phrase: "Basel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331779:Basel [Health Care Related Organization]

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")."
Processing 00000000.tx.29: Transfections were done with Lipofectamin 2000 (Invitrogen, Basel, Switzerland) either on plastic culture dishes or on glass slide chambers (Falcon, Mettmenstetten, Switzerland) coated with polyornithine (10 g/ml, Sigma, Buchs, Switzerland) and laminin (5 g/ml, Invitrogen, Basel, Switzerland). 

Phrase: "Transfections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]

Phrase: "were"

Phrase: "done with Lipofectamin 2000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1272695:Done [Qualitative Concept]
   770   C2746065:Done [Temporal Concept]

Phrase: "(Invitrogen,"

Phrase: "Basel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331779:Basel [Health Care Related Organization]

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: "either on plastic culture dishes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0010453:Culture [Idea or Concept]
   760   C0032167:Plastic [Substance]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C2242979:Culture [Laboratory Procedure]
   726   C0020498:DISH [Disease or Syndrome]

Phrase: "or on glass slide chambers"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0017596:Glass [Manufactured Object]
   760   C0179874:chambers [Medical Device]
   760   C0444330:Slide [Research Device]
   760   C1705201:Slide [Manufactured Object]
   760   C1947936:Glass [Medical Device]
   726 E C0935616:Chamber [Body Part, Organ, or Organ Component]

Phrase: "(Falcon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325579:Falcon, NOS [Bird]

Phrase: "Mettmenstetten,"

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: "coated with polyornithine"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0071632:polyornithine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C1522408:Coated [Qualitative Concept]
   756 E C0453946:Coat [Manufactured Object]
   756 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "(10 g/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1300565:g/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "Buchs,"

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "laminin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(5 g/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1300565:g/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "Invitrogen,"

Phrase: "Basel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331779:Basel [Health Care Related Organization]

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")."
Processing 00000000.tx.30: For all experiments involving confocal microscopy cells were fixed with 4% paraformaldehyde in PBS 16 to 20 hours after transfection. 

Phrase: "For all experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "confocal microscopy cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C0242842:Microscopy, Confocal [Laboratory Procedure]

Phrase: "were"

Phrase: "fixed with 4% paraformaldehyde"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "in PBS 16"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720830:PBS [Disease or Syndrome]
   861   C1823521:PBS [Gene or Genome]

Phrase: "to 20 hours"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "after transfection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
Processing 00000000.tx.31: At this time expression levels of transfected Fe65 were threefold higher than endogenous levels and transfected Tip60 led to a fivefold increase over expression in naive HEK293 cells as determined by western blotting. 

Phrase: "At this time expression levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   867   C3244092:expression level [Idea or Concept]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "of transfected Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412459:FE65 [Gene or Genome]

Phrase: "were"

Phrase: "threefold higher than endogenous levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "transfected Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1333931:TIP60 [Gene or Genome]
   861   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1705504:TIP60 [Gene or Genome]

Phrase: "led to a fivefold increase over expression"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0442805:Increase [Functional Concept]
   748   C1708698:LED [Manufactured Object]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C1522538:Lead [Functional Concept]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in naive HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C2936239:HEK293 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "determined by western blotting."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]
Processing 00000000.tx.32: In experiments involving stable lines with inducible expression of citrine-AICD, the expression was induced the day before transfection, resulting in expression for 40 to 44 hours. 

Phrase: "In experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "stable lines with inducible expression of citrine-AICD,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0205132:lines [Spatial Concept]
   711 E C1550648:Line [Substance]
   711 E C1552960:Line [Quantitative Concept]

Phrase: "the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "the day before transfection,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332173:/day [Temporal Concept]
   770   C0439228:day [Temporal Concept]
   770   C0439505:/day [Temporal Concept]

Phrase: "resulting in expression"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C0332294:Resulting in [Functional Concept]
   790   C0185117:Expression [Therapeutic or Preventive Procedure]
   790   C0678226:resulting [Functional Concept]
   756 E C1274040:Result [Functional Concept]
   756 E C1546471:Result [Idea or Concept]
   756 E C2825142:Result [Finding]

Phrase: "for 40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "to 44 hours."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]
Processing 00000000.tx.33: In long-term experiments we observed no evidence of toxicity or apoptosis, as determined by TUNEL staining (Kit 1 684 817, Roche, Rotkreuz, Switzerland), for up to 5 days of induced expression of citrine-AICD. 

Phrase: "In long-term experiments"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C0443252:Long-term [Temporal Concept]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "no evidence of toxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "or"

Phrase: "apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "as"

Phrase: "determined by TUNEL staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0487602:Staining [Laboratory Procedure]
   770   C0600528:TUNEL [Molecular Biology Research Technique]
   770   C1704680:Staining [Finding]

Phrase: "(Kit 1 684 817,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0812225:KIT [Medical Device]
   812   C1150635:KIT [Molecular Function]
   812   C1705212:Kit [Medical Device]
   812   C1705213:KIT [Medical Device]
   812   C3273202:Kit [Manufactured Object]

Phrase: "Roche,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331965:Roche [Health Care Related Organization]

Phrase: "Rotkreuz,"

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "for"

Phrase: "up to 5 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442466:5 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "of induced expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of citrine-AICD."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0972395:aicd [Medical Device]
   861   C2611803:AICD [Cell Function]
   861   C3156099:AICD [Cell Function]
   861   C3537205:AICD [Cell Function]
Processing 00000000.tx.34: To inhibit -secretase either 1 M DAPT or 10 M L685,458 (Calbiochem, Lucerne, Switzerland) were added after transfection. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit -"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "secretase either 1 M DAPT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0634829:dapt [Lipid]

Phrase: "or"

Phrase: "10 M L685,"

Phrase: "458"

Phrase: "(Calbiochem,"

Phrase: "Lucerne,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002022:Lucerne [Plant]
  1000   C2349204:Lucerne [Food]

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: "were"

Phrase: "added after transfection."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   790   C1524062:Added [Functional Concept]
   756 E C1883712:Add [Functional Concept]
Processing 00000000.tx.35: SH-SY5Y neuroblastoma cells were grown in DMEM/F12 supplemented with 20% fetal bovine serum. 

Phrase: "SH-SY5Y neuroblastoma cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   844   C0815000:neuroblastoma cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown in DMEM/F12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1414499:F12 [Gene or Genome]

Phrase: "supplemented with 20% fetal bovine serum."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0007452:Bovine [Mammal]
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0521457:Fetal [Functional Concept]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.36: For differentiation, cells were sequentially treated for 5 days with 5 M retinoic acid (Sigma, Buchs, Switzerland) and for 5 days with 20 ng/ml BDNF (Peprotech, London, UK), with serum reduced to 2%, after which they were transfected identically to HEK293 cells. 

Phrase: "For differentiation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "sequentially"

Phrase: "treated for 5 days"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0332293:treated [Therapeutic or Preventive Procedure]
   770   C0439228:days [Temporal Concept]
   770   C1522326:Treated [Functional Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "with 5 M retinoic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "(Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "Buchs,"

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: "and for 5 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0439228:days [Temporal Concept]
   770   C1515981:And [Idea or Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: "with 20 ng/ml BDNF"

Phrase: "(Peprotech,"

Phrase: "London,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023973:London [Geographic Area]

Phrase: "UK"

Phrase: ")"

Phrase: ","

Phrase: "with serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0229671:Serum [Body Substance]
  1000   C1546774:Serum [Intellectual Product]
  1000   C1550100:Serum [Body Substance]

Phrase: "reduced to 2%,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392756:Reduced [Qualitative Concept]

Phrase: "after"

Phrase: "which they"

Phrase: "were"

Phrase: "transfected"

Phrase: "identically to HEK293 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C2936239:HEK293 Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.37: Expression constructs To construct an inducible expression vector we excised the Bombyx mori ecdyson receptor-VP16 fusion transactivator and response elements from a retroviral backbone (Suhr et al., 1998) and cloned them into plasmids with inverted repeats recognized by the sleeping beauty transposase (Ivics et al., 1997). 

Phrase: "Expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "an inducible expression vector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]

Phrase: "we"

Phrase: "excised"

Phrase: "the Bombyx mori ecdyson receptor-VP16 fusion transactivator"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0040627:Trans-Activator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "response elements from a retroviral backbone"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0600508:Response Elements [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0013879:Elements [Element, Ion, or Isotope]
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]
   719 E C1705248:Element [Conceptual Entity]

Phrase: "(Suhr et al.,"

Phrase: "1998"

Phrase: ")"

Phrase: "and"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "them into plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "with inverted repeats"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0205341:repeats [Functional Concept]
   861   C1705914:Repeats [Conceptual Entity]
   827 E C1547730:Repeat [Temporal Concept]

Phrase: "recognized by the sleeping beauty transposase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004898:Beauty [Qualitative Concept]
   753   C0037313:Sleeping [Organism Function]
   753   C0076934:Transposase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0424522:Sleeping [Finding]

Phrase: "(Ivics et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.38: Expression of the Bombyx transactivator was driven by a glyceraldehyde-3-phosphate dehydrogenase promotor excised HindIII/XbaI from a plasmid provided by Maria Alexander (Harvard Medical School, Cambridge, MA) (Alexander et al., 1988). 

Phrase: "Expression of the Bombyx transactivator"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "driven by a glyceraldehyde-3-phosphate dehydrogenase promotor excised HindIII/XbaI"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   797   C1414968:GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE [Gene or Genome]
   797   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   775   C0017855:Glyceraldehyde 3-Phosphate [Biologically Active Substance,Carbohydrate]
           glyceraldehyde phosphate
   772   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]
   738   C0017854:Glyceraldehyde [Carbohydrate]
   738   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   738   C0031701:phosphate [Organophosphorus Compound]
   738   C0086860:promotor [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   704   C0013126:Drive [Mental Process]

Phrase: "from a plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "provided by Maria Alexander"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1551702:Alexander [Population Group]
   770   C1999230:Provided [Activity]
   737   C0019944:Mare [Mammal]
   737   C1422420:MARE [Gene or Genome]

Phrase: "(Harvard Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]

Phrase: "Cambridge,"

Phrase: "MA) (Alexander et al.,"

Phrase: "1988"

Phrase: ")."
Processing 00000000.tx.39: The ecdyson response element was followed by a polylinker for the insertion of citrine-AICD and APP-citrine fusion proteins. 

Phrase: "The ecdyson response element"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0013879:Element [Element, Ion, or Isotope]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1705248:Element [Conceptual Entity]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "was"

Phrase: "followed by a polylinker"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0332283:Followed by [Temporal Concept]
           followed
   737 E C1719822:Follow [Intellectual Product]

Phrase: "for the insertion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021107:Insertion [Therapeutic or Preventive Procedure]
  1000   C0441587:Insertion [Health Care Activity]
  1000   C1512796:Insertion [Genetic Function]
  1000   C1883719:Insertion [Functional Concept]

Phrase: "of citrine-AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0972395:aicd [Medical Device]
   861   C2611803:AICD [Cell Function]
   861   C3156099:AICD [Cell Function]
   861   C3537205:AICD [Cell Function]

Phrase: "and"

Phrase: "APP-citrine fusion proteins."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   895   C1456454:Amyloid Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   799   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0332466:Fusion [Functional Concept]
   799   C1293131:Fusion [Therapeutic or Preventive Procedure]
   793   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
Processing 00000000.tx.40: The improved YFP citrine (Griesbeck et al., 2001) was a gift from R. 

Phrase: "The improved YFP citrine"

Phrase: "(Griesbeck et al.,"

Phrase: "2001"

Phrase: ")"

Phrase: "was"

Phrase: "a gift from R."
Processing 00000000.tx.41: Y. 

Phrase: "Y."
Processing 00000000.tx.42: Tsien (University of California at San Diego, CA). 

Phrase: "Tsien"

Phrase: "(University of California at San Diego,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0006754:California [Geographic Area]
   753   C0041740:University [Manufactured Object,Organization]
   753   C3146274:California [Plant]

Phrase: "CA)."
Processing 00000000.tx.43: For the citrine-AICD fusion protein, the C-terminal lysine of citrine was followed by a GPGAL spacer fused to valine50 (A sequence) of the S3-cleaved APP C-terminal domain. 

Phrase: "For the citrine-AICD fusion protein,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332466:Fusion [Functional Concept]
   812   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "the C-terminal lysine of citrine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0024337:Lysine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "followed by a GPGAL spacer"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0221874:Spacer [Medical Device]
   760   C1704737:Spacer [Medical Device]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "fused to valine50"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0699952:Fused [Functional Concept]
   756 E C1414861:FUSE [Gene or Genome]
   756 E C1708111:Fuse [Manufactured Object]

Phrase: "(A sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: ")"

Phrase: "of the S3-cleaved APP C-terminal domain."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   836   C0162808:Protein Domain [Spatial Concept]
   836   C1514562:Protein Domain [Amino Acid Sequence]
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.44: For full-length APP, citrine was fused to the C-terminus of APP695, either via a short spacer (APP-PGPRASLPVAT-citrine), or via a dual tandem HA tag (APP-PGPRSGYPYDVPDYATGYPYDVPDYATGDP-citrine). 

Phrase: "For full-length APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "citrine"

Phrase: "was"

Phrase: "fused to the C-terminus of APP695,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0699952:Fused [Functional Concept]
   714 E C1414861:FUSE [Gene or Genome]
   714 E C1708111:Fuse [Manufactured Object]

Phrase: "either via a short spacer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0221874:Spacer [Medical Device]
   760   C1282927:short [Qualitative Concept]
   760   C1704737:Spacer [Medical Device]
   760   C1806781:Short [Quantitative Concept]
   760   C2350002:Short [Quantitative Concept]

Phrase: "(APP-PGPRASLPVAT-citrine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "via a dual tandem HA tag (APP-PGPRSGYPYDVPDYATGYPYDVPDYATGDP-citrine"

Phrase: ")."
Processing 00000000.tx.45: Mouse Jip1b and human X11 with an N-terminal HA tag in pcDNA3.1 have been described previously (Taru et al., 2002a; Taru and Suzuki, 2004). 

Phrase: "Mouse Jip1b"

Phrase: "and"

Phrase: "human X11 with an N-terminal HA tag"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1412456:X11 [Gene or Genome]
   744   C3538726:X11 [Gene or Genome]

Phrase: "in pcDNA3.1"

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(Taru et al.,"

Phrase: "2002a"

Phrase: "; Taru"

Phrase: "and"

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "2004"

Phrase: ")."
Processing 00000000.tx.46: Human Fe65 with an N-terminal HA tag in pcDNA3.1 was a gift from Konrad Beyreuther (ZMBH, Heidelberg, Germany). 

Phrase: "Human Fe65 with an N-terminal HA tag"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1412459:FE65 [Gene or Genome]

Phrase: "in pcDNA3.1"

Phrase: "was"

Phrase: "a gift from Konrad Beyreuther"

Phrase: "(ZMBH,"

Phrase: "Heidelberg,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.47: We exchanged the HA tag for myc or FLAG tags in Fe65 and Jip1b for some experiments. 

Phrase: "We"

Phrase: "exchanged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0678640:exchange [Social Behavior]

Phrase: "the HA tag for myc"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0037293:Tag [Neoplastic Process]
   760   C0181496:Tag [Manufactured Object]
   760   C1710492:TAG [Gene or Genome]

Phrase: "or"

Phrase: "FLAG tags in Fe65"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1139855:tags [Medical Device]
   737 E C0037293:Tag [Neoplastic Process]
   737 E C0181496:Tag [Manufactured Object]
   737 E C1710492:TAG [Gene or Genome]

Phrase: "and"

Phrase: "Jip1b for some experiments."
Processing 00000000.tx.48: A CFP-Tip60 (human Tip60) fusion protein in pEGFP-C2 (Clontech, Basel, Switzerland) was provided by Craig Robson (Northern Institute for Cancer Research, Newcastle, UK) (Gaughan et al., 2001) and the GFP was substituted by CFP via NheI and BsrGI sites. 

Phrase: "A CFP-Tip60"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C1333931:TIP60 [Gene or Genome]
   804   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1705504:TIP60 [Gene or Genome]
   717   C1121779:Cyan Fluorescent Protein [Amino Acid, Peptide, or Protein]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(human Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1333931:TIP60 [Gene or Genome]
   861   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1705504:TIP60 [Gene or Genome]

Phrase: ")"

Phrase: "fusion protein in pEGFP-C2 (Clontech,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332466:Fusion [Functional Concept]
   753   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "Basel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331779:Basel [Health Care Related Organization]

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: "was"

Phrase: "provided by Craig Robson"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1551776:Craig [Population Group]
   770   C1999230:Provided [Activity]

Phrase: "(Northern Institute for Cancer Research,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0035172:Research Institute [Organization]
   760   C0021622:institute [Organization]
   760   C1272753:Institute [Idea or Concept]

Phrase: "Newcastle,"

Phrase: "UK"

Phrase: ")"

Phrase: "(Gaughan et al.,"

Phrase: "2001"

Phrase: ")"

Phrase: "and"

Phrase: "the GFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "substituted by CFP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   862   C1121779:Cyan Fluorescent Protein [Amino Acid, Peptide, or Protein]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "via NheI"

Phrase: "and"

Phrase: "BsrGI sites."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.49: Site-directed mutagenesis (Quick Change Mutagenesis Kit, Stratagene, Amsterdam, The Netherlands) was performed to mutate the NKSY of Tip60 to NASA. 

Phrase: "Site-directed mutagenesis"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
  1000   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   827   C0079866:Mutagenesis [Molecular Function]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
   827   C3146302:Mutagenesis [Laboratory Procedure]
   793   C0439851:Direct [Qualitative Concept]
   793   C1947931:Direct [Qualitative Concept]
   755 E C0439755:Directions [Spatial Concept]
   755 E C0449738:Direction [Spatial Concept]
   711 E C1707761:Directionality [Functional Concept]
   711 E C3274524:Directionality [Functional Concept]

Phrase: "(Quick Change Mutagenesis Kit,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0812225:KIT [Medical Device]
   812   C1150635:KIT [Molecular Function]
   812   C1705212:Kit [Medical Device]
   812   C1705213:KIT [Medical Device]
   812   C3273202:Kit [Manufactured Object]

Phrase: "Stratagene,"

Phrase: "Amsterdam,"

Phrase: "The Netherlands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027778:The Netherlands [Geographic Area]
           Netherlands

Phrase: ")"

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mutate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1513776:Mutate [Genetic Function]

Phrase: "the NKSY of Tip60"

Phrase: "to NASA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1254183:Nasa [Plant]
Processing 00000000.tx.50: All cloned and mutagenised constructs were verified by sequencing (ABI Prism 310, Perkin Elmer, Hhnenberg, Switzerland). 

Phrase: "All"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "and"

Phrase: "mutagenised constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "were"

Phrase: "verified by sequencing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1553778:Sequencing [Intellectual Product]
   790   C1561491:Sequencing [Functional Concept]
   790   C1711411:Verified [Functional Concept]

Phrase: "(ABI Prism 310,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0814195:PRISM [Intellectual Product]
   827   C1328319:ABI [Clinical Attribute]
   771 E C0138404:prisma [Organic Chemical,Pharmacologic Substance]

Phrase: "Perkin Elmer,"

Phrase: "Hhnenberg,"

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")."
Processing 00000000.tx.51: Staining and antibodies Primary antibodies were anti-HA tag, high affinity (Roche, Rotkreuz, Switzerland), anti-APP C-terminus (8717, Sigma, Buchs, Switzerland), 6E10 (Signet, Dedham, MA), 22C11 (MAB348, Chemicon, Lucerne, Switzerland), anti-Fe65 (sc-19751, Santa Cruz, Nunningen, Switzerland), anti-Jip1, 2 (34-5300, Zymed, Basel, Switzerland), anti-GAPDH (A6457, Molecular Probes, Lucerne, Switzerland), anti-Tip60 (Upstate, Lucerne, Switzerland), anti-myc tag (Upstate, Lucerne, Switzerland), anti-FLAG tag (Sigma, Buchs, Switzerland) and anti-GFP (Upstate, Lucerne, Switzerland). 

Phrase: "Staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "antibodies Primary antibodies"

Phrase: "were"

Phrase: "anti-HA tag,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037293:Tag [Neoplastic Process]
   827   C0181496:Tag [Manufactured Object]
   827   C1710492:TAG [Gene or Genome]

Phrase: "high affinity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205250:High [Qualitative Concept]
   861   C1299351:High [Qualitative Concept]
   861   C1510827:Affinity [Natural Phenomenon or Process]
   861   C2700149:HIGH [Intellectual Product]

Phrase: "(Roche,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331965:Roche [Health Care Related Organization]

Phrase: "Rotkreuz,"

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "anti-APP C-terminus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   709   C0432624:Anti C [Amino Acid, Peptide, or Protein,Immunologic Factor]
   709   C0432626:Anti c [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(8717,"

Phrase: "Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "Buchs,"

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "6E10"

Phrase: "(Signet,"

Phrase: "Dedham,"

Phrase: "MA"

Phrase: ")"

Phrase: ","

Phrase: "22C11"

Phrase: "(MAB348,"

Phrase: "Chemicon,"

Phrase: "Lucerne,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002022:Lucerne [Plant]
  1000   C2349204:Lucerne [Food]

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "anti-Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412459:FE65 [Gene or Genome]

Phrase: "(sc-19751,"

Phrase: "Santa Cruz,"

Phrase: "Nunningen,"

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "anti-Jip1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C3536909:JUN Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(34-5300,"

Phrase: "Zymed,"

Phrase: "Basel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331779:Basel [Health Care Related Organization]

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "anti-GAPDH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1414968:GAPDH [Gene or Genome]

Phrase: "(A6457,"

Phrase: "Molecular Probes,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "Lucerne,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002022:Lucerne [Plant]
  1000   C2349204:Lucerne [Food]

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "anti-Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1333931:TIP60 [Gene or Genome]
   861   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1705504:TIP60 [Gene or Genome]

Phrase: "(Upstate,"

Phrase: "Lucerne,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002022:Lucerne [Plant]
  1000   C2349204:Lucerne [Food]

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "anti-myc tag (Upstate,"

Phrase: "Lucerne,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002022:Lucerne [Plant]
  1000   C2349204:Lucerne [Food]

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "anti-FLAG tag (Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1719918:Sigma [Intellectual Product]

Phrase: "Buchs,"

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "anti-GFP (Upstate,"

Phrase: "Lucerne,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002022:Lucerne [Plant]
  1000   C2349204:Lucerne [Food]

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")."
Processing 00000000.tx.52: All washings were performed with TBS, 0.05% TritonX-100, for blocking and antibody incubation 5% normal horse and 5% normal goat serum were added. 

Phrase: "All washings"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0441648:Washing [Activity]

Phrase: "were"

Phrase: "performed with TBS,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0265246:TBS [Congenital Abnormality,Disease or Syndrome]
   790   C0884358:Performed [Functional Concept]
   790   C1532188:Tbsp [Quantitative Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "0.05% TritonX-100,"

Phrase: "for blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "and"

Phrase: "antibody incubation 5% normal horse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0019944:Horse [Mammal]
   804   C0242616:Horse [Mammal]
   804   C1265527:Horse [Mammal]

Phrase: "and"

Phrase: "5% normal goat serum"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   812   C0018019:goat [Mammal]
   812   C0205307:Normal [Qualitative Concept]
   812   C0229671:Serum [Body Substance]
   812   C0439166:% normal [Quantitative Concept]
   812   C1265549:goat [Mammal]
   812   C1510458:Goat [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   812   C2347086:% Normal [Quantitative Concept]

Phrase: "were"

Phrase: "added."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]
Processing 00000000.tx.53: All secondary antibodies were highly purified for species cross-reactivity (Jackson Labs, Bar Harbor, Maine) labeled with Cy3 or Cy5 dyes. 

Phrase: "All secondary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "purified for species cross-reactivity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0010357:Cross Reactivity [Molecular Function]
   806   C0872139:cross reactivity [Molecular Function]
   806   C1880190:CROSS REACTIVITY [Event]
   760   C1705920:Species [Conceptual Entity]
   760   C1998793:Purified [Functional Concept]
   760   C2828360:Cross [Conceptual Entity]

Phrase: "(Jackson Labs,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1515351:Jackson Labs [Health Care Related Organization]
   861   C0587081:Labs [Finding]
   827 E C0022877:Lab [Manufactured Object,Organization]
   789 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "Bar Harbor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0475311:Harbor [Manufactured Object]

Phrase: "Maine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024497:Maine [Geographic Area]

Phrase: ")"

Phrase: "labeled with Cy3"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "or"

Phrase: "Cy5 dyes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0013343:Dyes [Indicator, Reagent, or Diagnostic Aid]
   861   C2757062:Dyes [Molecular Function]
   861   C2911146:Dyes NOS [Finding]
Processing 00000000.tx.54: In control experiments, omitting the respective primary antibody showed no staining of antibodies from other species. 

Phrase: "In control experiments,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0009932:control experiments [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0681814:Experiments [Research Activity]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "omitting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750563:omitting [Idea or Concept]

Phrase: "the respective primary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no staining of antibodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]

Phrase: "from other species."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.55: For nuclear staining we used DRAQ5 (Biostatus, Leicestershire, UK), which is an anthraquinone that has a high affinity for DNA, can be excited by the 633 nm laser line, and emits in the far red spectrum. 

Phrase: "For nuclear staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "DRAQ5"

Phrase: "(Biostatus,"

Phrase: "Leicestershire,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454863:Leicestershire [Geographic Area]

Phrase: "UK"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "is"

Phrase: "an anthraquinone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003174:Anthraquinone [Organic Chemical,Pharmacologic Substance]
  1000   C0050133:Anthraquinone [Antibiotic,Organic Chemical]
  1000   C0303858:Anthraquinone [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "that"

Phrase: "has"

Phrase: "a high affinity for DNA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205250:High [Qualitative Concept]
   760   C1299351:High [Qualitative Concept]
   760   C1510827:Affinity [Natural Phenomenon or Process]
   760   C2700149:HIGH [Intellectual Product]

Phrase: "can"

Phrase: "be"

Phrase: "excited by the 633 nm laser line,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0023089:Laser [Manufactured Object]
   748   C0205132:Line [Spatial Concept]
   748   C0312860:NM [Cell Function]
   748   C0458142:Laser [Phenomenon or Process]
   748   C0549255:Excited [Activity]
   748   C1023865:Laser [Plant]
   748   C1550648:Line [Substance]
   748   C1552960:Line [Quantitative Concept]
   748   C1706315:Laser [Medical Device]

Phrase: "and"

Phrase: "emits in the far red spectrum."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0162676:EMIT [Laboratory Procedure]
   753   C1623049:EMIT [Laboratory Procedure]
Processing 00000000.tx.56: Confocal microscopy and fluorescence resonance energy transfer (FRET) analysis All images were acquired on a Leica TCS/SP2 confocal microscope (Leica, Wetzlar, Germany) with a 63x water immersion objective. 

Phrase: "Confocal microscopy"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0242842:Microscopy, Confocal [Laboratory Procedure]
   861   C0026018:Microscopy [Laboratory Procedure]
   789 E C0205288:Microscopic [Qualitative Concept]

Phrase: "and"

Phrase: "fluorescence resonance energy transfer (FRET) analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0002778:Analysis [Laboratory Procedure]
   804   C0936012:Analysis [Research Activity]
   804   C1524024:analysis [Functional Concept]
   771   C0597717:Fluorescence Resonance Energy Transfer [Laboratory Procedure]

Phrase: "All images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "acquired on a Leica TCS/SP2 confocal microscope"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C1626420:Confocal microscope [Medical Device]
   744   C0181839:Microscope [Medical Device]
   744   C0242387:TCS [Congenital Abnormality]
   744   C0439661:Acquired [Temporal Concept]
   744   C0450545:SP2 [Body Location or Region]
   744   C1420333:SP2 [Gene or Genome]
   744   C1706379:Microscope [Medical Device]
   744   C3245488:acquired [Intellectual Product]
   711 E C1706701:Acquire [Activity]

Phrase: "(Leica,"

Phrase: "Wetzlar,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")"

Phrase: "with a 63x water immersion objective."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0018017:Objective [Intellectual Product]
   812   C1571702:Objective [Qualitative Concept]
Processing 00000000.tx.57: The Argon Laser line of 458 nm was used to excite CFP (PMT window: 465-485 nm) and the 514 nm line to excite citrine. 

Phrase: "The Argon Laser line of 458 nm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205132:Line [Spatial Concept]
   748   C1550648:Line [Substance]
   748   C1552960:Line [Quantitative Concept]

Phrase: "was"

Phrase: "used to"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   833   C1273517:used [Finding]
   799 E C0042153:use [Functional Concept]
   799 E C0457083:Use [Functional Concept]
   799 E C1947944:Use [Intellectual Product]

Phrase: "excite"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549255:Excite [Activity]

Phrase: "CFP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1121779:Cyan Fluorescent Protein [Amino Acid, Peptide, or Protein]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(PMT window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: ":"

Phrase: "465-485 nm)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "and"

Phrase: "the 514 nm line to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205132:Line [Spatial Concept]
   760   C1550648:Line [Substance]
   760   C1552960:Line [Quantitative Concept]

Phrase: "excite"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549255:Excite [Activity]

Phrase: "citrine."
Processing 00000000.tx.58: The PMT window for detecting citrine was 525-580 nm when co-stained with Cy5, and 525-545 nm when co-stained with Cy3 to prevent the detection of Cy3 in the citrine channel. 

Phrase: "The PMT window for detecting citrine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0557702:Window [Manufactured Object]
   753   C1272706:Window [Temporal Concept]
   753   C1704674:Window [Manufactured Object]

Phrase: "was"

Phrase: "525-580 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "when"

Phrase: "co-stained with Cy5,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "525-545 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "when"

Phrase: "co-stained with Cy3 to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the detection of Cy3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "in the citrine channel."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439799:Channel [Spatial Concept]
   861   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.59: A 543 nm HeNe laser was used to excite Cy3 (PMT window: 553-600 nm). 

Phrase: "A 543 nm HeNe laser"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C1289846:HeNe laser [Medical Device]
   804   C0023089:Laser [Manufactured Object]
   804   C0458142:Laser [Phenomenon or Process]
   804   C1023865:Laser [Plant]
   804   C1706315:Laser [Medical Device]

Phrase: "was"

Phrase: "used to"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   833   C1273517:used [Finding]
   799 E C0042153:use [Functional Concept]
   799 E C0457083:Use [Functional Concept]
   799 E C1947944:Use [Intellectual Product]

Phrase: "excite"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549255:Excite [Activity]

Phrase: "Cy3"

Phrase: "(PMT window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: ":"

Phrase: "553-600 nm)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]
Processing 00000000.tx.60: A 633 nm HeNe laser was used to excite Cy5 (PMT window: 655-710 nm) or DRAQ5 (PMT window: 650-800 nm). 

Phrase: "A 633 nm HeNe laser"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C1289846:HeNe laser [Medical Device]
   804   C0023089:Laser [Manufactured Object]
   804   C0458142:Laser [Phenomenon or Process]
   804   C1023865:Laser [Plant]
   804   C1706315:Laser [Medical Device]

Phrase: "was"

Phrase: "used to"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   833   C1273517:used [Finding]
   799 E C0042153:use [Functional Concept]
   799 E C0457083:Use [Functional Concept]
   799 E C1947944:Use [Intellectual Product]

Phrase: "excite"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549255:Excite [Activity]

Phrase: "Cy5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(PMT window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: ":"

Phrase: "655-710 nm)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "or"

Phrase: "DRAQ5"

Phrase: "(PMT window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: ":"

Phrase: "650-800 nm)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]
Processing 00000000.tx.61: Between 5 and 15 sections in the z-axis (xy-mode) or y-axis (xz-mode) were acquired, and maximum projections of the sections encompassing the nucleus were performed. 

Phrase: "Between 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "15 sections in the z-axis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   719   C0205155:Section [Spatial Concept]
   719   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   719   C1522472:Section [Substance]
   719   C1552923:Section [Quantitative Concept]
   719   C1705191:Section [Physical Object]

Phrase: "(xy-mode"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1513371:Mode [Functional Concept]
   861   C1705738:Mode [Quantitative Concept]
   861   C2347637:Mode [Quantitative Concept]
   861   C2348146:Mode [Quantitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "y-axis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004457:Axis [Body Part, Organ, or Organ Component]
   861   C0999597:Axis [Mammal]
   861   C1522496:Axis [Spatial Concept]

Phrase: "(xz-mode"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1513371:Mode [Functional Concept]
   861   C1705738:Mode [Quantitative Concept]
   861   C2347637:Mode [Quantitative Concept]
   861   C2348146:Mode [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "acquired"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0439661:Acquired [Temporal Concept]
  1000   C3245488:acquired [Intellectual Product]
   966 E C1706701:Acquire [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "maximum projections of the sections"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0016538:projections [Intellectual Product]
   760   C0033363:projections [Mental Process]
   760   C0348018:projections [Spatial Concept]

Phrase: "encompassing"

Phrase: "the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "were"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.62: Raw FRET was measured by exciting CFP with the 458 nm laser line and measuring sensitized citrine emission at 525-555 nm in single sections. 

Phrase: "Raw FRET"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   937   C0597717:Fluorescence Resonance Energy Transfer [Laboratory Procedure]
   840   C0014274:Energy Transfer [Molecular Function]
   804   C0016315:Fluorescence [Natural Phenomenon or Process]
   804   C0040671:Transfer [Mental Process]
   804   C0231881:Resonance [Finding]
   804   C0424589:Energy [Finding]
   804   C0459800:resonance [Natural Phenomenon or Process]
   804   C0542479:Energy [Natural Phenomenon or Process]
   804   C0684213:Resonance [Qualitative Concept]
   804   C1442080:Energy [Quantitative Concept]
   804   C1705822:Transfer [Activity]
   733 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   733 E C0577554:Resonant [Qualitative Concept]

Phrase: "was"

Phrase: "measured by exciting CFP"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C1121779:Cyan Fluorescent Protein [Amino Acid, Peptide, or Protein]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0444706:Measured [Qualitative Concept]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "with the 458 nm laser line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205132:Line [Spatial Concept]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "measuring sensitized citrine emission at 525-555 nm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0233929:Emission [Body Substance]
   744   C2349995:Emission [Substance]

Phrase: "in single sections."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]
Processing 00000000.tx.63: Values for CFP bleach-through (0.24) and citrine cross-excitation (0.07) were determined in cells expressing either fluorophore alone. 

Phrase: "Values for CFP bleach-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0042295:Values [Qualitative Concept]
   719 E C1522609:Value [Quantitative Concept]

Phrase: "through"

Phrase: "(0.24"

Phrase: ")"

Phrase: "and"

Phrase: "citrine cross-excitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0549255:Excitation [Activity]

Phrase: "(0.07"

Phrase: ")"

Phrase: "were"

Phrase: "determined in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "either fluorophore"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0598447:fluorophore [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.64: No pixel shift was observed and background fluorescence was negligible. 

Phrase: "No pixel shift"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333051:Shift [Functional Concept]
   861   C2347509:Shift [Phenomenon or Process]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "background fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "negligible."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332269:Negligible [Qualitative Concept]
Processing 00000000.tx.65: After sequentially measuring raw FRET, CFP and citrine fluorescence NFRET calculations were performed as described previously (Xia and Liu, 2001). 

Phrase: "After"

Phrase: "sequentially"

Phrase: "measuring"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:measuring [Qualitative Concept]
  1000   C0449770:measuring [Quantitative Concept]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "raw FRET,"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   937   C0597717:Fluorescence Resonance Energy Transfer [Laboratory Procedure]
   840   C0014274:Energy Transfer [Molecular Function]
   804   C0016315:Fluorescence [Natural Phenomenon or Process]
   804   C0040671:Transfer [Mental Process]
   804   C0231881:Resonance [Finding]
   804   C0424589:Energy [Finding]
   804   C0459800:resonance [Natural Phenomenon or Process]
   804   C0542479:Energy [Natural Phenomenon or Process]
   804   C0684213:Resonance [Qualitative Concept]
   804   C1442080:Energy [Quantitative Concept]
   804   C1705822:Transfer [Activity]
   733 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   733 E C0577554:Resonant [Qualitative Concept]

Phrase: "CFP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1121779:Cyan Fluorescent Protein [Amino Acid, Peptide, or Protein]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "citrine fluorescence NFRET calculations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1441506:Calculation [Activity]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(Xia"

Phrase: "and"

Phrase: "Liu,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.66: For bleaching experiments the image was zoomed four- to sixfold and the citrine fluorescence in single nuclei was bleached with the 514 nm line at 100% laser intensity. 

Phrase: "For bleaching experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "the image"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1704254:Image [Intellectual Product]
  1000   C1704922:Image [Entity]
  1000   C3542466:Image [Intellectual Product]

Phrase: "was"

Phrase: "zoomed"

Phrase: "four-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205450:Four [Quantitative Concept]

Phrase: "to sixfold"

Phrase: "and"

Phrase: "the citrine fluorescence in single nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0016315:Fluorescence [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "bleached with the 514 nm line"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205132:Line [Spatial Concept]
   753   C0303749:bleached [Inorganic Chemical]
   753   C0312860:NM [Cell Function]
   753   C1550648:Line [Substance]
   753   C1552960:Line [Quantitative Concept]

Phrase: "at 100% laser intensity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0522510:Intensity [Qualitative Concept]
Processing 00000000.tx.67: Western blotting and immunoprecipitation Stably transfected HEK293 cells were induced to express citrine-AICD, and were cotransfected with Fe65 or Tip60 expression constructs. 

Phrase: "Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "immunoprecipitation Stably transfected HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   840   C2936239:HEK293 Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "citrine-AICD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0972395:aicd [Medical Device]
   861   C2611803:AICD [Cell Function]
   861   C3156099:AICD [Cell Function]
   861   C3537205:AICD [Cell Function]

Phrase: "and"

Phrase: "were"

Phrase: "cotransfected with Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1412459:FE65 [Gene or Genome]

Phrase: "or"

Phrase: "Tip60 expression constructs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2827421:Construct [Classification]
Processing 00000000.tx.68: For the preparation of nuclear protein extracts, cells were collected in hypotonic buffer 24 hours after cotransfection [10 mM Hepes, 10 mM KCl, 5 mM MgCl2, 1 mM DTT, 1 mM PMSF, 2.5x Roche Complete protease inhibitor mix without EDTA (Roche, Rotkreuz, Switzerland), 5 mM phenantroline (PNT) (Sigma, Buchs, Switzerland)], swollen on ice for 15 minutes and passed through a 22 G syringe. 

Phrase: "For the preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: "of nuclear protein extracts,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   896   C1518434:Nuclear Extract [Biomedical or Dental Material]
   793   C2828366:Extract [Substance]
   734   C0028589:Nuclear Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0949374:Nuclear Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "collected in hypotonic buffer 24 hours"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0439584:24 hours [Temporal Concept]
   790   C0456696:/24 hours [Temporal Concept]
   790   C1442770:24 Hours [Temporal Concept]
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0241938:Hypotonic [Pathologic Function]
   753   C0439227:hours [Temporal Concept]
   753   C1516695:Collected [Idea or Concept]
   753   C1516698:Collected [Functional Concept]
   719 E C0564385:/hour [Quantitative Concept]

Phrase: "after cotransfection"

Phrase: "[10 mM Hepes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "10 mM KCl,"

Phrase: "5 mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1 mM DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "1 mM PMSF,"

Phrase: "2.5x Roche Complete protease inhibitor mix without EDTA (Roche,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0205430:Mix [Functional Concept]
   739   C1421951:MIX [Gene or Genome]
   739   C1720722:Mix [Qualitative Concept]

Phrase: "Rotkreuz,"

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "5 mM phenantroline (PNT)"

Phrase: "(Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "Buchs,"

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: "],"

Phrase: "swollen on ice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0038999:Swollen [Finding]

Phrase: "for 15 minutes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1442447:15 Minutes [Temporal Concept]
   861   C0439232:minute [Temporal Concept]
   861   C0700321:minute [Quantitative Concept]
   861   C0702093:/minute [Temporal Concept]
   861   C1282918:Minute [Quantitative Concept]
   861   C2347166:Minute [Quantitative Concept]

Phrase: "and"

Phrase: "passed through a 22 G syringe."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0039142:Syringe [Medical Device]
   753   C0439267:g% [Quantitative Concept]
   753   C1706072:Syringe [Manufactured Object]
   753   C2828386:Passed [Finding]
Processing 00000000.tx.69: Sucrose was added to a final concentration of 0.25 M followed by centrifugation for 5 minutes at 500 g. 

Phrase: "Sucrose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
  1000   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "was"

Phrase: "added to a final concentration of 0.25 M"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   742   C0086045:Concentration [Mental Process]
   742   C0205088:Final [Temporal Concept]
   742   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0441923:M+ [Intellectual Product]
   742   C1446561:Concentration [Quantitative Concept]
   742   C1524062:Added [Functional Concept]
   742   C1546485:Final [Idea or Concept]
   708 E C1883712:Add [Functional Concept]

Phrase: "followed by centrifugation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0007703:Centrifugation [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "for 5 minutes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0886384:5 minute [Therapeutic or Preventive Procedure]
  1000   C1442468:5 Minutes [Temporal Concept]
   861   C0439232:minute [Temporal Concept]
   861   C0700321:minute [Quantitative Concept]
   861   C0702093:/minute [Temporal Concept]
   861   C1282918:Minute [Quantitative Concept]
   861   C2347166:Minute [Quantitative Concept]

Phrase: "at 500 g."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.70: Pellets were resuspended in wash buffer (25 mM sucrose pH 7.5, 6 mM MgCl2, 10 mM TrisHCl (pH 7.4), 0.1% TritonX-100, 1 mM PMSF, 5 mM PNT, 2.5x Roche Complete without EDTA) and centrifuged again at 500 g (repeated twice). 

Phrase: "Pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0993610:pellets [Biomedical or Dental Material]
   966 E C0441436:Pellet [Manufactured Object]
   966 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "resuspended in wash buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0441648:Wash [Activity]

Phrase: "(25 mM sucrose pH 7.5,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C1882074:pH 7 [Qualitative Concept]
   799   C0020283:[pH] [Quantitative Concept]
   799   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   799   C0450407:ph+ [Finding]
   799   C0450408:ph++ [Finding]
   799   C0450409:ph+++ [Finding]
   799   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "6 mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "10 mM TrisHCl"

Phrase: "(pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "0.1% TritonX-100,"

Phrase: "1 mM PMSF,"

Phrase: "5 mM PNT,"

Phrase: "2.5x Roche"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331965:Roche [Health Care Related Organization]

Phrase: "Complete without EDTA)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]
   790   C0205197:Complete [Qualitative Concept]

Phrase: "and"

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "again at 500 g ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439267:g% [Quantitative Concept]

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "twice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720725:Twice [Intellectual Product]
  1000   C1948050:Twice [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.71: Nuclei were solubilized for 1 hour in wash buffer supplemented with 1% TritonX-100 and mechanically disrupted by passing through a 26 G syringe. 

Phrase: "Nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007610:Nucleus [Cell Component]

Phrase: "were"

Phrase: "solubilized for 1 hour"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439227:Hour [Temporal Concept]
   770   C0564385:/hour [Quantitative Concept]

Phrase: "in wash buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "supplemented with 1% TritonX-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0242295:Supplement [Food]
   726   C1947943:Supplement [Intellectual Product]
   726   C2348609:Supplement [Functional Concept]

Phrase: "and"

Phrase: "mechanically"

Phrase: "disrupted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:Disrupted [Qualitative Concept]

Phrase: "by passing through a 26 G syringe."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0006539:BY [Geographic Area]
   748   C0039142:Syringe [Medical Device]
   748   C0439267:g% [Quantitative Concept]
   748   C1706072:Syringe [Manufactured Object]
   714   C2828386:Pass [Finding]
Processing 00000000.tx.72: Nuclear protein extracts were incubated over night at 4C with specific antibodies coupled to protein G sepharose (Amersham, Otelfingen, Switzerland) in the presence of 0.2% TritonX-100. 

Phrase: "Nuclear protein extracts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   896   C1518434:Nuclear Extract [Biomedical or Dental Material]
   793   C2828366:Extract [Substance]
   734   C0028589:Nuclear Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0949374:Nuclear Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "over night at 4C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0439583:Overnight [Temporal Concept]
   770   C0240526:Night [Temporal Concept]

Phrase: "with specific antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "coupled to protein G sepharose"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0060916:protein g [Amino Acid, Peptide, or Protein]
   797 E C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0036681:Sepharose [Carbohydrate]
   760   C0439267:g% [Quantitative Concept]
   760   C1948027:Coupled [Functional Concept]
   726 E C0010222:couple [Family Group]

Phrase: "(Amersham,"

Phrase: "Otelfingen,"

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 0.2% TritonX-100."
Processing 00000000.tx.73: Precipitated proteins were washed and boiled in LDS-containing loading buffer, separated by 4-12% Nupage Tris-PAGE (Invitrogen, Basel, Switzerland) with MOPS running buffer. 

Phrase: "Precipitated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "boiled in LDS-containing loading buffer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0242301:Boil [Disease or Syndrome]
   719   C1546559:Boil [Intellectual Product]

Phrase: "separated by 4-12% Nupage Tris-PAGE (Invitrogen,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   767   C1538569:PAGE-4 [Gene or Genome]
   744   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   744   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   744   C0086972:Separated [Finding]
   744   C0443299:separated [Spatial Concept]
   744   C0687118:Separated [Functional Concept]
   744   C0814229:TRI [Intellectual Product]
   744   C1704732:Page [Intellectual Product]

Phrase: "Basel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331779:Basel [Health Care Related Organization]

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: "with MOPS running buffer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.74: Blotting onto PVDF membranes (Invitrogen, Basel, Switzerland) was followed by enhanced chemiluminescense detection (Amersham, Otelfingen, Switzerland) or SuperSignal West Femto (Pierce, Lausanne, Switzerland). 

Phrase: "Blotting onto PVDF membranes"

Phrase: "(Invitrogen,"

Phrase: "Basel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331779:Basel [Health Care Related Organization]

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: "was"

Phrase: "followed by enhanced chemiluminescense detection"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C1511790:Detection [Therapeutic or Preventive Procedure]
   760   C2349975:Enhanced [Activity]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "(Amersham,"

Phrase: "Otelfingen,"

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: "or"

Phrase: "SuperSignal West Femto"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1553038:Femto [Quantitative Concept]

Phrase: "(Pierce,"

Phrase: "Lausanne,"

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")."
Processing 00000000.tx.75: Whole cell extracts from HEK293 were isolated in a PBS lysis buffer containing 1% Triton X-100, supplemented with 1 mM PMSF and Roche Complete Protease inhibitor mix with EDTA (Roche, Rotkreuz, Switzerland). 

Phrase: "Whole cell"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0007634:Cell [Cell]
   861   C0444667:Whole [Quantitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "extracts from HEK293"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "isolated in a PBS lysis buffer"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0024348:Lysis [Pathologic Function]
   753   C0205409:Isolated [Functional Concept]
   753   C1536403:lysis [Cell Function]
   753   C1548221:Isolated [Idea or Concept]
   753   C1720830:PBS [Disease or Syndrome]
   753   C1823521:PBS [Gene or Genome]
   719 E C0370215:Isolate [Substance]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]

Phrase: "supplemented with 1 mM PMSF"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1418486:MM-1 [Gene or Genome]
   726   C0242295:Supplement [Food]
   726   C1947943:Supplement [Intellectual Product]
   726   C2348609:Supplement [Functional Concept]

Phrase: "and"

Phrase: "Roche Complete Protease inhibitor mix with EDTA (Roche,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0205430:Mix [Functional Concept]
   744   C1421951:MIX [Gene or Genome]
   744   C1720722:Mix [Qualitative Concept]

Phrase: "Rotkreuz,"

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")."
Processing 00000000.tx.76: Extracts were separated on 10-20% Tricine gels (Invitrogen, Basel, Switzerland), blotted on nitrocellulose membranes (0.45 m; Biorad, Reinach, Switzerland) or Protran BA 79 Cellulosenitrate membranes (0.1 m; Schleicher & Schuell, Dassel, Germany) and detected by enhanced chemiluminescence as above. 

Phrase: "Extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "separated on 10-20% Tricine gels"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   783   C1630409:20/10 [Finding]
   753   C0017243:Gels [Biomedical or Dental Material]
   753   C0077068:tricine [Organic Chemical]
   753   C0086972:Separated [Finding]
   753   C0443299:separated [Spatial Concept]
   753   C0687118:Separated [Functional Concept]
   719 E C1382104:Gel [Substance]

Phrase: "(Invitrogen,"

Phrase: "Basel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331779:Basel [Health Care Related Organization]

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "blotted on nitrocellulose membranes"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0025255:Membranes [Tissue]
   770   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   737 E C0596901:Membrane [Cell Component]
   737 E C1706182:Membrane [Manufactured Object]

Phrase: "(0.45 m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "; Biorad,"

Phrase: "Reinach,"

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: "or"

Phrase: "Protran BA 79 Cellulosenitrate membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0025255:Membranes [Tissue]
   771 E C0596901:Membrane [Cell Component]
   771 E C1706182:Membrane [Manufactured Object]
   721 E C0205287:Membranous [Qualitative Concept]

Phrase: "(0.1 m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "; Schleicher & Schuell,"

Phrase: "Dassel,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "detected by enhanced chemiluminescence"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   770   C0442726:Detected [Finding]
   770   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C2349975:Enhanced [Activity]

Phrase: "as above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]
Processing 00000000.tx.77: Reverse transcription (RT) and quantitative real-time PCR Total RNA was isolated from clonal HEK293 lines with TRIzol (Invitrogen, Basel, Switzerland). 

Phrase: "Reverse transcription (RT)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035380:Reverse Transcription [Genetic Function]
   861   C0040649:Transcription [Genetic Function]
   861   C1555029:Reverse [Idea or Concept]

Phrase: "and"

Phrase: "quantitative real-time PCR Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "isolated from clonal HEK293 lines"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   760   C0205132:lines [Spatial Concept]
   760   C0205409:Isolated [Functional Concept]
   760   C1522642:Clonal [Tissue]
   760   C1548221:Isolated [Idea or Concept]
   760   C1704387:Clonal [Qualitative Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "with TRIzol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0916178:trizol [Organic Chemical]

Phrase: "(Invitrogen,"

Phrase: "Basel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331779:Basel [Health Care Related Organization]

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")."
Processing 00000000.tx.78: Cells were grown either with or without the induction of citrine-AICD expression for 48 hours. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown"

Phrase: "either with"

Phrase: "or without the induction of citrine-AICD expression"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0205263:Induction [Functional Concept]
   744   C0857127:induction [Therapeutic or Preventive Procedure]
   744   C0972395:aicd [Medical Device]
   744   C2611803:AICD [Cell Function]
   744   C3156099:AICD [Cell Function]
   744   C3537205:AICD [Cell Function]

Phrase: "for 48 hours."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0439586:48 hours [Temporal Concept]
  1000   C1442464:48 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]
Processing 00000000.tx.79: First-strand cDNA synthesis was performed using the SuperScript First-Strand Synthesis System for RT-PCR (Invitrogen, Basel, Switzerland) according to the manufacturer's protocol. 

Phrase: "First-strand cDNA synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0220781:synthesis [Biologic Function]
   812   C1883254:Synthesis [Activity]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the SuperScript First-Strand Synthesis System"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0449913:System [Functional Concept]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   733 E C0205373:Systemic [Functional Concept]

Phrase: "for RT-PCR (Invitrogen,"

Phrase: "Basel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331779:Basel [Health Care Related Organization]

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: "according to the manufacturer's protocol."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.80: Real-time-PCR was performed on the TaqMan using SYBR Green (Applied Biosystems, Rotkreuz, Switzerland). 

Phrase: "Real-time-PCR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0677874:pCR [Finding]
   734   C1550177:Real Time [Idea or Concept]

Phrase: "was"

Phrase: "performed on the TaqMan"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "SYBR Green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332583:Green [Qualitative Concept]

Phrase: "(Applied Biosystems,"

Phrase: "Rotkreuz,"

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")."
Processing 00000000.tx.81: The amplification mixtures contained 0.8 ng/l Template cDNA, 1x SYBR Green PCR buffer, 3 mM MgCl2, 1.25 mM dNTPs, 0.25 U AmpErase, 0.75 U AmpliTaq Gold, 10 M Forward Primer and 10 M Reverse Primer. 

Phrase: "The amplification mixtures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:mixtures [Substance]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "0.8 ng/l Template cDNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "1x SYBR Green PCR buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "3 mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1.25 mM dNTPs,"

Phrase: "0.25 U AmpErase,"

Phrase: "0.75 U AmpliTaq Gold,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0018026:Gold [Element, Ion, or Isotope,Pharmacologic Substance]
   804   C1304897:Gold [Functional Concept]

Phrase: "10 M Forward Primer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1953382:Forward primer [Cell]
   812   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "10 M Reverse Primer."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1953384:Reverse primer [Amino Acid, Peptide, or Protein]
   812   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.82: The Primers were designed to amplify the 3' end to middle of the ORF part, except for the citrine-AICD fusion protein where they spanned the fusion border. 

Phrase: "The Primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "amplify"

Phrase: "the 3' end to middle of the ORF part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0444930:End [Spatial Concept]
   742   C2746065:End [Temporal Concept]

Phrase: "except for the citrine-AICD fusion protein where"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0332466:Fusion [Functional Concept]
   804   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "they"

Phrase: "spanned"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "the fusion border."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205284:Border [Spatial Concept]
   861   C1522411:Border [Body Location or Region]
   861   C2828371:Border [Classification]
Processing 00000000.tx.83: Primer sequences are: GAPDH (sense: TGGGCTACACTGAGCACCAG; 

Phrase: "Primer sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "are"

Phrase: ":"

Phrase: "GAPDH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414968:GAPDH [Gene or Genome]

Phrase: "(sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: ":"

Phrase: "TGGGCTACACTGAGCACCAG"

Phrase: ";"
Processing 00000000.tx.84: reverse: CAGCGTCAAAGGTGGAGGAG), PGK (sense: TGAAGGACTGTGTAGGCCCAG; 

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: ":"

Phrase: "CAGCGTCAAAGGTGGAGGAG"

Phrase: ")"

Phrase: ","

Phrase: "PGK (sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036658:sense [Organ or Tissue Function]

Phrase: ":"

Phrase: "TGAAGGACTGTGTAGGCCCAG"

Phrase: ";"
Processing 00000000.tx.85: reverse: TTCTTCCTCCACATGAAAGCG), KAI1 (sense: CTACAACAGCAGTCGCGAGG; 

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: ":"

Phrase: "TTCTTCCTCCACATGAAAGCG"

Phrase: ")"

Phrase: ","

Phrase: "KAI1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0286983:KAI1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812444:KAI1 [Gene or Genome]
  1000   C1705784:KAI1 [Gene or Genome]

Phrase: "(sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: ":"

Phrase: "CTACAACAGCAGTCGCGAGG"

Phrase: ";"
Processing 00000000.tx.86: reverse: CGCAGCACTTCACCTGAGC), GSK3 (sense: ACAAGGACGGCAGCAAGGT; 

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: ":"

Phrase: "CGCAGCACTTCACCTGAGC"

Phrase: ")"

Phrase: ","

Phrase: "GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: ":"

Phrase: "ACAAGGACGGCAGCAAGGT"

Phrase: ";"
Processing 00000000.tx.87: reverse: ACTTCTTGTGGCCTGTCTGG), APP (sense: ACCAACTTGCATGACTACGGC; 

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: ":"

Phrase: "ACTTCTTGTGGCCTGTCTGG"

Phrase: ")"

Phrase: ","

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "(sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: ":"

Phrase: "ACCAACTTGCATGACTACGGC"

Phrase: ";"
Processing 00000000.tx.88: reverse: CACACAAACTCTACCCCTCGG) ADAM10 (sense: CTCCAC AGCCCATTCAGCA; 

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: ":"

Phrase: "CACACAAACTCTACCCCTCGG"

Phrase: ")"

Phrase: "ADAM10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412181:ADAM10 [Gene or Genome]
  1000   C2984597:ADAM 10 [Amino Acid, Peptide, or Protein]

Phrase: "(sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: ":"

Phrase: "CTCCAC AGCCCATTCAGCA"

Phrase: ";"
Processing 00000000.tx.89: reverse: GCGTCTCATGTGTCCCATTTG) BACE (sense: AGTCATCCACGGGCACTGTT; 

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: ":"

Phrase: "GCGTCTCATGTGTCCCATTTG"

Phrase: ")"

Phrase: "BACE (sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036658:sense [Organ or Tissue Function]

Phrase: ":"

Phrase: "AGTCATCCACGGGCACTGTT"

Phrase: ";"
Processing 00000000.tx.90: reverse: CTGAACTCATCGTGCACATGG), PSEN1 (sense: CTATAGCTCCCATGGCACCC; 

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: ":"

Phrase: "CTGAACTCATCGTGCACATGG"

Phrase: ")"

Phrase: ","

Phrase: "PSEN1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418985:PSEN1 [Gene or Genome]

Phrase: "(sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: ":"

Phrase: "CTATAGCTCCCATGGCACCC"

Phrase: ";"
Processing 00000000.tx.91: reverse: CTGAACCCGCCATCATCATT), Fe65 (sense: GAGAGTGTCGGGTGCGTTTC; 

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: ":"

Phrase: "CTGAACCCGCCATCATCATT"

Phrase: ")"

Phrase: ","

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "(sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: ":"

Phrase: "GAGAGTGTCGGGTGCGTTTC"

Phrase: ";"
Processing 00000000.tx.92: reverse: TGAATGCAAACGTGTGGACAT) Tip60 (sense: TGAGGACTCCCAGGACAGCT; 

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: ":"

Phrase: "TGAATGCAAACGTGTGGACAT"

Phrase: ")"

Phrase: "Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "(sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: ":"

Phrase: "TGAGGACTCCCAGGACAGCT"

Phrase: ";"
Processing 00000000.tx.93: reverse: TCGTGGCTTCGATCAGACAC) Hes1 (sense: ACGTGCGAGGGCGTTAATAC; 

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: ":"

Phrase: "TCGTGGCTTCGATCAGACAC"

Phrase: ")"

Phrase: "Hes1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412958:HES1 [Gene or Genome]
  1000   C1415725:HES1 [Gene or Genome]

Phrase: "(sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036658:sense [Organ or Tissue Function]

Phrase: ":"

Phrase: "ACGTGCGAGGGCGTTAATAC"

Phrase: ";"
Processing 00000000.tx.94: reverse: CATGGCATTGATCTGGGTCA) citrine-AICD (sense: CACTCTCGGCATGGACGAG; 

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: ":"

Phrase: "CATGGCATTGATCTGGGTCA"

Phrase: ")"

Phrase: "citrine-AICD (sense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036658:sense [Organ or Tissue Function]

Phrase: ":"

Phrase: "CACTCTCGGCATGGACGAG"

Phrase: ";"
Processing 00000000.tx.95: reverse: CGTCAACCTCCACCACACC). 

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: ":"

Phrase: "CGTCAACCTCCACCACACC"

Phrase: ")."
Processing 00000000.tx.96: Real-time-PCR was performed with an ABI PRISM 7700 Sequence Detector (Applied Biosystems, Rotkreuz, Switzerland). 

Phrase: "Real-time-PCR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0677874:pCR [Finding]
   734   C1550177:Real Time [Idea or Concept]

Phrase: "was"

Phrase: "performed with an ABI PRISM 7700 Sequence Detector"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   744   C0004793:Sequence [Nucleotide Sequence]
   744   C0162326:Sequence [Nucleotide Sequence]
   744   C0162327:Sequence [Nucleotide Sequence]
   744   C0180392:Detector [Medical Device]
   744   C0814195:PRISM [Intellectual Product]
   744   C0884358:Performed [Functional Concept]
   744   C1328319:ABI [Clinical Attribute]
   744   C1519249:Sequence [Functional Concept]
   744   C1705235:Detector [Manufactured Object]
   711 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Applied Biosystems,"

Phrase: "Rotkreuz,"

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")."
Processing 00000000.tx.97: The cycling conditions comprised a 2 minute pre-PCR at 50C, 10 minutes polymerase activation at 95C and 40 cycles at 95C for 15 seconds and 60C for 60 seconds. 

Phrase: "The cycling conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "comprised"

Phrase: "a 2 minute pre-PCR at 50C,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0677874:pCR [Finding]

Phrase: "10 minutes polymerase activation at 95C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "40 cycles at 95C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1511572:Cycle [Temporal Concept]

Phrase: "for 15 seconds"
Meta Candidates (Total=7; Excluded=6; Pruned=0; Remaining=1)
   861   C0457385:seconds [Temporal Concept]
   827 E C0205436:Second [Quantitative Concept]
   827 E C0565930:/second [Quantitative Concept]
   827 E C1561503:second [Idea or Concept]
   827 E C1705190:Second [Qualitative Concept]
   777 E C0027627:secondary [Neoplastic Process]
   777 E C0175668:Secondary [Temporal Concept]

Phrase: "and"

Phrase: "60C for 60 seconds."
Processing 00000000.tx.98: Sequence Detection Software (version 1.9.1) (Applied Biosystems, Rotkreuz, Switzerland) was used for data analyses.  

Phrase: "Sequence Detection Software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(version 1.9.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0333052:Version [Functional Concept]
   812   C2607870:Version [Spatial Concept]

Phrase: ")"

Phrase: "(Applied Biosystems,"

Phrase: "Rotkreuz,"

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")"

Phrase: "was"

Phrase: "used for data analyses."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C0010992:Data Analyses [Occupational Activity]
   770   C1273517:used [Finding]
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]
   737   C0002778:Analysis [Laboratory Procedure]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737   C0936012:Analysis [Research Activity]
   737   C1524024:analysis [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.99: Results Top Summary Introduction Materials and Methods Results Discussion References  Localization of AFT-complexes to nuclear spots An experimental difficulty in monitoring the subcellular trafficking of AICD is associated with its rapid degradation after -secretase cleavage (Cupers et al., 2001a; Kimberly et al., 2001). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Localization of AFT-complexes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "to nuclear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: "spots"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0015230:spots [Disease or Syndrome]
  1000   C0329155:Spot [Fish]
  1000   C0848332:Spots [Sign or Symptom]
  1000   C1427618:SPOT [Gene or Genome]
  1000   C1705203:Spot [Conceptual Entity]

Phrase: "An experimental difficulty in monitoring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1299586:Difficulty [Finding]

Phrase: "the subcellular"

Phrase: "trafficking of AICD"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0599896:trafficking [Cell Function]
   790   C0972395:aicd [Medical Device]
   790   C2611803:AICD [Cell Function]
   790   C3156099:AICD [Cell Function]
   790   C3537205:AICD [Cell Function]

Phrase: "is"

Phrase: "associated with its rapid degradation"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0243125:degradation [Functional Concept]
   760   C0439831:Rapid [Qualitative Concept]
   760   C0699900:Degradation [Organism Function]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "after -"

Phrase: "secretase cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "(Cupers et al.,"

Phrase: "2001a"

Phrase: "; Kimberly et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.100: To overcome this difficulty, we constructed ecdyson-inducible expression vectors (Suhr et al., 1998) to express citrine-AICD fusion proteins comprising the 50 C-terminal residues of S3-cleaved APP. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "overcome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2983310:Overcome [Activity]

Phrase: "this difficulty,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1299586:Difficulty [Finding]
   928 E C0332218:Difficult [Qualitative Concept]

Phrase: "we"

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "ecdyson-inducible expression vectors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0599566:expression vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0442335:Vectors [Spatial Concept]
   779 E C1705099:Vector [Idea or Concept]

Phrase: "(Suhr et al.,"

Phrase: "1998"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "citrine-AICD fusion proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332466:Fusion [Functional Concept]
   812   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "comprising"

Phrase: "the 50 C-terminal residues of S3-cleaved APP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   704   C1709915:Residue [Conceptual Entity]
   704   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.101: The fusion of citrine to the N-terminus of AICD may alter its properties; 

Phrase: "The fusion of citrine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332466:Fusion [Functional Concept]
   770   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "to the N-terminus"

Phrase: "of AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "may"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "its properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0871161:properties [Qualitative Concept]
  1000   C1292721:properties [Functional Concept]
   966 E C1882134:Property [Conceptual Entity]
   966 E C2347695:Property [Entity]

Phrase: ";"
Processing 00000000.tx.102: specifically we observed that citrine stabilizes the normally rapidly degraded AICD. 

Phrase: "specifically"

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that citrine"

Phrase: "stabilizes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184512:stabilize [Qualitative Concept]

Phrase: "the normally rapidly degraded AICD."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0972395:aicd [Medical Device]
   812   C2611803:AICD [Cell Function]
   812   C3156099:AICD [Cell Function]
   812   C3537205:AICD [Cell Function]
Processing 00000000.tx.103: The inducible expression vectors were flanked by inverted repeats for stable transfection with the sleeping beauty transposase system (Ivics et al., 1997). 

Phrase: "The inducible expression vectors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0599566:expression vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vectors [Spatial Concept]
   793 E C1705099:Vector [Idea or Concept]

Phrase: "were"

Phrase: "flanked by inverted repeats"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205341:repeats [Functional Concept]
   770   C0443241:Inverted [Qualitative Concept]
   770   C1705914:Repeats [Conceptual Entity]
   737   C0230171:Flank [Body Location or Region]
   737 E C1547730:Repeat [Temporal Concept]

Phrase: "for stable transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "with the sleeping beauty transposase system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "(Ivics et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.104: After inducing the expression of AICD with the ecdyson analogue tebufenozide in three isolated clonal lines identified by fluorescent microscopy, we found no evidence for degradation of the fusion protein on western blots (data not shown). 

Phrase: "After"

Phrase: "inducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Inducing [Functional Concept]

Phrase: "the expression of AICD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "with the ecdyson analogue tebufenozide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0527710:tebufenozide [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "in three isolated clonal lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205132:lines [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "identified by fluorescent microscopy,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0026022:FLUORESCENT MICROSCOPY [Laboratory Procedure]
   770   C0026018:Microscopy [Laboratory Procedure]
   770   C0205396:Identified [Qualitative Concept]
   770   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no evidence for degradation of the fusion protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "on western blots"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0949466:Western Blots [Laboratory Procedure]
   966 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1705493:Western [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.105: Citrine fluorescence detected in the microscope therefore tracks the subcellular localization of the expressed AICD. 

Phrase: "Citrine fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "detected in the microscope therefore"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0181839:Microscope [Medical Device]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1706379:Microscope [Medical Device]

Phrase: "tracks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040594:Track [Manufactured Object]

Phrase: "the subcellular localization of the expressed AICD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]
Processing 00000000.tx.106: Confocal analyses showed that AICD was localized homogenously in both cytosolic and nuclear compartments (Fig. 1A). 

Phrase: "Confocal analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "was"

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "homogenously in both cytosolic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1383501:Cytosolic [Cell Component]

Phrase: "and"

Phrase: "nuclear compartments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1185625:Compartments [Body Space or Junction]
   861   C1382196:Compartments [Natural Phenomenon or Process]
   827 E C2986730:Compartment [Spatial Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.107: The effect of APP-interacting proteins on AICD localization was analyzed with a Fe65 isoform containing the mini-exon 9, which has been shown to be expressed exclusively in neuronal cells (Hu et al., 1999). 

Phrase: "The effect of APP-interacting proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "on AICD localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "was"

Phrase: "analyzed with a Fe65 isoform"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0597298:Isoform [Amino Acid, Peptide, or Protein]
   760   C0936012:Analyzed [Research Activity]
   760   C1412459:FE65 [Gene or Genome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the mini-exon 9,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0026163:Mini-Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0445542:Mini [Organism Attribute]

Phrase: "which"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "expressed"

Phrase: "exclusively in neuronal cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(Hu et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.108: When we co-expressed AICD with Fe65 the two proteins localized both in cytosolic and nuclear compartments (Fig. 1B). 

Phrase: "When"

Phrase: "we"

Phrase: "co-expressed"

Phrase: "AICD with Fe65"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0972395:aicd [Medical Device]
   790   C2611803:AICD [Cell Function]
   790   C3156099:AICD [Cell Function]
   790   C3537205:AICD [Cell Function]

Phrase: "the two proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "both in cytosolic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0238767:Both [Spatial Concept]
   790   C1383501:Cytosolic [Cell Component]
   790   C1706086:Both [Qualitative Concept]

Phrase: "and"

Phrase: "nuclear compartments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1185625:Compartments [Body Space or Junction]
   861   C1382196:Compartments [Natural Phenomenon or Process]
   827 E C2986730:Compartment [Spatial Concept]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.109: Fe65 was described to be localized predominantly in nuclei in COS and H4 cells (Kimberly et al., 2001; Kinoshita et al., 2002; Minopoli et al., 2001). 

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "was"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "predominantly in nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0007610:Nucleus [Cell Component]

Phrase: "in COS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454802:Cos [Geographic Area]

Phrase: "and"

Phrase: "H4 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Kimberly et al.,"

Phrase: "2001"

Phrase: "; Kinoshita et al.,"

Phrase: "2002"

Phrase: "; Minopoli et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.110: In HEK293 cells, nuclear accumulation was only seen after blockade of nuclear export (Fig. 3). 

Phrase: "In HEK293 cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "nuclear accumulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0544910:Nuclear accumulation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "seen after blockade of nuclear export"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0887840:Nuclear Export [Cell Function]
   753   C0205397:Seen [Qualitative Concept]
   753   C0332206:Blockade [Functional Concept]
   753   C0521447:Nuclear [Spatial Concept]
   753   C0699789:Export [Phenomenon or Process]
   753   C3540676:Blockade [Pharmacologic Substance]
   719 E C0042789:see [Organism Function]
   719 E C1947903:See [Activity]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.111: Tip60 is a histone acetylase involved in many transcriptional signals via the modification of chromatin (Brady et al., 1999; Gaughan et al., 2001; Sterner and Berger, 2000). 

Phrase: "Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "is"

Phrase: "a histone acetylase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0062773:Histone Acetylase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0001053:Acetylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "involved in many transcriptional signals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0040649:Transcriptional [Genetic Function]
   760   C1314939:Involved [Functional Concept]
   726   C1710082:Signal [Phenomenon or Process]

Phrase: "via the modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392747:Modification [Functional Concept]
  1000   C1554963:modification [Qualitative Concept]

Phrase: "of chromatin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008546:Chromatin [Amino Acid, Peptide, or Protein]
  1000   C1325550:chromatin [Cell Component]

Phrase: "(Brady et al.,"

Phrase: "1999"

Phrase: "; Gaughan et al.,"

Phrase: "2001"

Phrase: "; Sterner"

Phrase: "and"

Phrase: "Berger,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.112: In the absence of Fe65, the CFP-Tip60 fusion protein was localized in nuclear structures with a speckle-like appearance (mean number=16.1, s.d.=6.8, median=14, n=29 cells, Fig. 1C). 

Phrase: "In the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of Fe65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "the CFP-Tip60 fusion protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   799   C0332466:Fusion [Functional Concept]
   799   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "localized in nuclear structures"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C1518439:Nuclear Structure [Cell Component]
   770   C0392752:Localized [Spatial Concept]
   770   C0521447:Nuclear [Spatial Concept]
   770   C0678594:structures [Spatial Concept]

Phrase: "with a speckle-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0439691:Speckled [Qualitative Concept]

Phrase: "like appearance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0233426:Appearance [Organism Attribute]
  1000   C0700364:Appearance [Qualitative Concept]

Phrase: "(mean number"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0237753:*Number [Quantitative Concept]
   861   C0444504:Mean [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]
   861   C2347634:Mean [Quantitative Concept]
   861   C2348143:Mean [Quantitative Concept]

Phrase: "=16.1,"

Phrase: "s.d.=6.8,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2603362:S' [Clinical Attribute]

Phrase: "median"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0549183:Median [Spatial Concept]
  1000   C0876920:Median [Quantitative Concept]
  1000   C2347635:Median [Quantitative Concept]
  1000   C2348144:Median [Quantitative Concept]
  1000   C2939193:Median [Spatial Concept]

Phrase: "=14,"

Phrase: "n"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: "=29 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "Fig. 1C"

Phrase: ")."
Processing 00000000.tx.113: This localization of Tip60 had no effects whatsoever on the cellular distribution of AICD (Fig. 1D), suggesting that AICD did not bind to Tip60 in the absence of Fe65. 

Phrase: "This localization of Tip60"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "had"

Phrase: "no effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "whatsoever on the cellular distribution of AICD (Fig. 1D"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind to Tip60"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]
   790   C1333931:TIP60 [Gene or Genome]
   790   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1705504:TIP60 [Gene or Genome]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of Fe65."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]
Processing 00000000.tx.114: By contrast, co-expression of Fe65 clearly resulted in binding to Tip60, and colocalization within circumscribed nuclear spots (Fig. 1E) with a distinct spherical geometry, clearly differing from the speckle-like morphology of the structures that included Tip60 alone. 

Phrase: "By contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "co-expression of Fe65 clearly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "resulted in binding"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756   C2825142:Result [Finding]

Phrase: "to Tip60,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "and"

Phrase: "colocalization within circumscribed nuclear spots"

Phrase: "(Fig. 1E"

Phrase: ")"

Phrase: "with a distinct spherical geometry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449829:Geometry [Spatial Concept]

Phrase: "clearly"

Phrase: "differing from the speckle-"

Phrase: "like morphology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0332437:Morphology [Qualitative Concept]
  1000   C0543482:morphology [Spatial Concept]
  1000   C0700329:Morphology, NOS [Finding]
  1000   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "of the structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "that included Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1333931:TIP60 [Gene or Genome]
   861   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1705504:TIP60 [Gene or Genome]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.115: Expression of AICD in cells that co-expressed Fe65 together with Tip60 revealed a striking colocalization of AICD with Fe65 and Tip60 (AFT-complex) in these spherical nuclear spots, together with a drop in cytosolic AICD levels (Fig. 1F). 

Phrase: "Expression of AICD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "co-expressed"

Phrase: "Fe65 together with Tip60"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1412459:FE65 [Gene or Genome]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a striking colocalization of AICD"

Phrase: "with Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "(AFT-complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: ")"

Phrase: "in these spherical nuclear spots,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0015230:spots [Disease or Syndrome]
   827   C0329155:Spot [Fish]
   827   C0848332:Spots [Sign or Symptom]
   827   C1427618:SPOT [Gene or Genome]
   827   C1705203:Spot [Conceptual Entity]

Phrase: "together with a drop"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1321095:Drop [Quantitative Concept]
  1000   C1705648:Drop [Activity]
  1000   C2347093:Drop [Quantitative Concept]
  1000   C2348338:Drop [Quantitative Concept]

Phrase: "in cytosolic AICD levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 1F"

Phrase: ")."
Processing 00000000.tx.116: This was observed consistently in virtually every cell co-expressing all three proteins (Fig. 1G). 

Phrase: "This"

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "consistently in virtually"

Phrase: "every cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "co-expressing"

Phrase: "all three proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 1G"

Phrase: ")."
Processing 00000000.tx.117: The mean diameter of AFT-complexes was 0.70 m (s.d.=0.24, n=48 spots) and for Tip60 expressed alone the minimal diameter averaged at 1.77 m (s.d.=0.45, n=49 spots). 

Phrase: "The mean diameter of AFT-complexes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0552409:Diameter.mean [Quantitative Concept]
   744   C0444504:Mean [Quantitative Concept]
   744   C1301886:Diameter [Quantitative Concept]
   744   C2347634:Mean [Quantitative Concept]
   744   C2348143:Mean [Quantitative Concept]

Phrase: "was"

Phrase: "0.70 m (s."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439493:m/s [Quantitative Concept]
   861   C1513009:M.S. [Intellectual Product]
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]

Phrase: "d.="

Phrase: "0.24,"

Phrase: "n"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: "=48 spots"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0015230:spots [Disease or Syndrome]
   861   C0329155:Spot [Fish]
   861   C0848332:Spots [Sign or Symptom]
   861   C1427618:SPOT [Gene or Genome]
   861   C1705203:Spot [Conceptual Entity]

Phrase: ")"

Phrase: "and for Tip60"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1333931:TIP60 [Gene or Genome]
   790   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1515981:And [Idea or Concept]
   790   C1705504:TIP60 [Gene or Genome]

Phrase: "expressed"

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "the minimal diameter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1301886:Diameter [Quantitative Concept]

Phrase: "averaged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1510992:Average [Quantitative Concept]
   966   C2825518:AVERAGE [Quantitative Concept]

Phrase: "at 1.77 m (s."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0439493:m/s [Quantitative Concept]
   840   C1513009:M.S. [Intellectual Product]
   804   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441923:M+ [Intellectual Product]

Phrase: "d.="

Phrase: "0.45,"

Phrase: "n"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: "=49 spots"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0015230:spots [Disease or Syndrome]
   861   C0329155:Spot [Fish]
   861   C0848332:Spots [Sign or Symptom]
   861   C1427618:SPOT [Gene or Genome]
   861   C1705203:Spot [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.118: On average, we observed 32.0 nuclear spots with AFT-complexes (s.d.=20.8, median=25, n=32 cells). 

Phrase: "On average,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1510992:Average [Quantitative Concept]
  1000   C2825518:AVERAGE [Quantitative Concept]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "32.0 nuclear spots with AFT-complexes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   745   C2752257:SPOTS complex [Cell Component]
   742   C0015230:spots [Disease or Syndrome]
   742   C0329155:Spot [Fish]
   742   C0848332:Spots [Sign or Symptom]
   742   C1427618:SPOT [Gene or Genome]
   742   C1705203:Spot [Conceptual Entity]

Phrase: "(s.d.=20.8,"

Phrase: "median"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0549183:Median [Spatial Concept]
  1000   C0876920:Median [Quantitative Concept]
  1000   C2347635:Median [Quantitative Concept]
  1000   C2348144:Median [Quantitative Concept]
  1000   C2939193:Median [Spatial Concept]

Phrase: "=25,"

Phrase: "n"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: "=32 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.119: Mutation of the NKSY sequence of Tip60 to NASA, shown to prevent AICD-mediated transactivation in the Gal4 system (Cao and Sdhof, 2001), still resulted in binding of Fe65-AICD-complexes to nuclear Tip60, but the formation of spherical spots was completely prevented (Fig. 1H). 

Phrase: "Mutation of the NKSY sequence of Tip60"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "to NASA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1254183:Nasa [Plant]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "AICD-mediated transactivation in the Gal4 system"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0040624:Transactivation [Genetic Function]

Phrase: "(Cao"

Phrase: "and"

Phrase: "Sdhof,"

Phrase: "2001"

Phrase: ")"

Phrase: ","

Phrase: "still"

Phrase: "resulted in binding of Fe65-AICD-complexes"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   748   C0243122:binding [Functional Concept]
   748   C0972395:aicd [Medical Device]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1412459:FE65 [Gene or Genome]
   748   C1704241:Complexes [Chemical Viewed Structurally]
   748   C2611803:AICD [Cell Function]
   748   C3156099:AICD [Cell Function]
   748   C3537205:AICD [Cell Function]
   714 E C0439855:Complex [Qualitative Concept]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "to nuclear Tip60,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1333931:TIP60 [Gene or Genome]
   861   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1705504:TIP60 [Gene or Genome]

Phrase: "but"

Phrase: "the formation of spherical spots"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "(Fig. 1H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442450:1H [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.120: By contrast, the AFT-complexes formed with NASA-Tip60 had a speckle-like morphology. 

Phrase: "By contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the AFT-complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1704241:Complexes [Chemical Viewed Structurally]
   779 E C0439855:Complex [Qualitative Concept]

Phrase: "formed with NASA-Tip60"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0205431:Formed [Functional Concept]
   770   C1254183:Nasa [Plant]
   770   C1333931:TIP60 [Gene or Genome]
   770   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1705504:TIP60 [Gene or Genome]
   737 E C0348078:Form [Qualitative Concept]
   737 E C0376315:Form [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "had"

Phrase: "a speckle-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0439691:Speckled [Qualitative Concept]

Phrase: "like morphology."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0332437:Morphology [Qualitative Concept]
  1000   C0543482:morphology [Spatial Concept]
  1000   C0700329:Morphology, NOS [Finding]
  1000   C0700619:Morphology [Biomedical Occupation or Discipline]
Processing 00000000.tx.121: The change from spots to speckle-like morphology of AFT-complexes may be associated with the known functional changes of the Tip60 NASA mutation (Cao and Sdhof, 2001). 

Phrase: "The change from spots"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0025320:The change [Physiologic Function]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "to speckle-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0439691:Speckled [Qualitative Concept]

Phrase: "like morphology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0332437:Morphology [Qualitative Concept]
  1000   C0543482:morphology [Spatial Concept]
  1000   C0700329:Morphology, NOS [Finding]
  1000   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "of AFT-complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1704241:Complexes [Chemical Viewed Structurally]
   779 E C0439855:Complex [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "associated with the known functional changes of the Tip60 NASA mutation"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   756   C0332281:Associated with [Qualitative Concept]
           Associated
   738   C0026882:Mutation [Genetic Function]
   738   C0205245:Functional [Functional Concept]
   738   C0205309:Known [Qualitative Concept]
   738   C0392747:changes [Functional Concept]
   738   C0443172:changes [Quantitative Concept]
   738   C0542341:Functional [Functional Concept]
   738   C1254183:Nasa [Plant]
   738   C1333931:TIP60 [Gene or Genome]
   738   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   738   C1705285:Mutation [Cell or Molecular Dysfunction]
   738   C1705504:TIP60 [Gene or Genome]
   738   C2700217:Functional [Conceptual Entity]
   704 E C0750490:Associate [Idea or Concept]
   704 E C1705241:Change [Quantitative Concept]
   704 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(Cao"

Phrase: "and"

Phrase: "Sdhof,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.122: View larger version (46K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(46K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.123: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.124: Confocal sections through nuclei show that AFT-complexes of AICD, Fe65 and Tip60 are localized to spherical nuclear spots. 

Phrase: "Confocal sections through nuclei"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   737   C0205155:Section [Spatial Concept]
   737   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   737   C1522472:Section [Substance]
   737   C1552923:Section [Quantitative Concept]
   737   C1705191:Section [Physical Object]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that AFT-complexes of AICD,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1704241:Complexes [Chemical Viewed Structurally]
   714 E C0439855:Complex [Qualitative Concept]

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "are"

Phrase: "localized to spherical nuclear spots."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0015230:spots [Disease or Syndrome]
   760   C0329155:Spot [Fish]
   760   C0332501:Spherical [Spatial Concept]
   760   C0392752:Localized [Spatial Concept]
   760   C0521447:Nuclear [Spatial Concept]
   760   C0848332:Spots [Sign or Symptom]
   760   C1427618:SPOT [Gene or Genome]
   760   C1705203:Spot [Conceptual Entity]
Processing 00000000.tx.125: (A,B) Both AICD (yellow) and Fe65 (red) localized homogenously throughout nuclear (blue) and cytosolic compartments in transfected HEK293 cells. 

Phrase: "(A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Both AICD (yellow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0221205:Yellow [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "(red)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "homogenously throughout nuclear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0521447:Nuclear [Spatial Concept]

Phrase: "(blue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260957:Blue [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "cytosolic compartments in transfected HEK293 cells."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C1185625:Compartments [Body Space or Junction]
   753   C1382196:Compartments [Natural Phenomenon or Process]
   750   C1948049:Cell (compartment) [Spatial Concept]
   750   C2349967:Cell compartment [Anatomical Structure]
   719 E C2986730:Compartment [Spatial Concept]
Processing 00000000.tx.126: Co-expression of Fe65 and AICD resulted in the same localization. 

Phrase: "Co-expression of Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "resulted in the same localization."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0445247:Same [Qualitative Concept]
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]
Processing 00000000.tx.127: (C) In the absence of AICD and Fe65 co-expression, the histone acetylase Tip60 (cyan) localized to speckle-like nuclear structures. 

Phrase: "(C) In"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "the absence of AICD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "and"

Phrase: "Fe65 co-expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "the histone acetylase Tip60"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1333931:TIP60 [Gene or Genome]
   827   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1705504:TIP60 [Gene or Genome]
   734   C0062773:Histone Acetylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(cyan"

Phrase: ")"

Phrase: "localized to speckle-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0392752:Localized [Spatial Concept]
   718   C0439691:Speckled [Qualitative Concept]

Phrase: "like nuclear structures."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1518439:Nuclear Structure [Cell Component]
   861   C0521447:Nuclear [Spatial Concept]
   861   C0678594:structures [Spatial Concept]
Processing 00000000.tx.128: (D) In the absence of Fe65 co-expression, Tip60 had no effect on AICD distribution. 

Phrase: "("

Phrase: "D) In the absence of Fe65 co-expression,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0332197:absence [Quantitative Concept]
   744   C1412459:FE65 [Gene or Genome]
   744   C1689985:Absence [Anatomical Abnormality]

Phrase: "Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "had"

Phrase: "no effect on AICD distribution."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.129: (E) In the absence of AICD, Fe65 colocalized with Tip60 in nuclei and reorganized the speckle-like morphology into spherical nuclear spots. 

Phrase: "(E) In the absence of AICD,"

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "colocalized with Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1333931:TIP60 [Gene or Genome]
   790   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1705504:TIP60 [Gene or Genome]

Phrase: "in nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007610:Nucleus [Cell Component]

Phrase: "and"

Phrase: "reorganized"

Phrase: "the speckle-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0439691:Speckled [Qualitative Concept]

Phrase: "like morphology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0332437:Morphology [Qualitative Concept]
  1000   C0543482:morphology [Spatial Concept]
  1000   C0700329:Morphology, NOS [Finding]
  1000   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "into spherical nuclear spots."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0015230:spots [Disease or Syndrome]
   827   C0329155:Spot [Fish]
   827   C0848332:Spots [Sign or Symptom]
   827   C1427618:SPOT [Gene or Genome]
   827   C1705203:Spot [Conceptual Entity]
Processing 00000000.tx.130: (F,G) In cells co-expressing AICD, Fe65 and Tip60, AICD was relocalized from the cytosol into AFT-complexes predominantly found in spherical nuclear spots. 

Phrase: "(F,G) In cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0524983:G Cells [Cell]
   770   C0439267:g% [Quantitative Concept]

Phrase: "co-expressing"

Phrase: "AICD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "Tip60,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "was"

Phrase: "relocalized from the cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1383501:Cytosol [Cell Component]

Phrase: "into AFT-complexes predominantly"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C1704241:Complexes [Chemical Viewed Structurally]
   771 E C0439855:Complex [Qualitative Concept]

Phrase: "found in spherical nuclear spots."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0015230:spots [Disease or Syndrome]
   760   C0150312:Found [Quantitative Concept]
   760   C0329155:Spot [Fish]
   760   C0332501:Spherical [Spatial Concept]
   760   C0521447:Nuclear [Spatial Concept]
   760   C0848332:Spots [Sign or Symptom]
   760   C1427618:SPOT [Gene or Genome]
   760   C1705203:Spot [Conceptual Entity]
   726 E C0243095:Find [Finding]
Processing 00000000.tx.131: AFT-complexes were found throughout nuclei in all cells co-expressing the three proteins. 

Phrase: "AFT-complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1704241:Complexes [Chemical Viewed Structurally]
   779 E C0439855:Complex [Qualitative Concept]

Phrase: "were"

Phrase: "found throughout nuclei"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0150312:Found [Quantitative Concept]
   756   C0007610:Nucleus [Cell Component]
   756 E C0243095:Find [Finding]

Phrase: "in all cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "co-expressing"

Phrase: "the three proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.132: Confocal xz sections of the same nuclei confirmed nuclear localization. 

Phrase: "Confocal xz sections of the same nuclei"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   714   C0205155:Section [Spatial Concept]
   714   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   714   C1522472:Section [Substance]
   714   C1552923:Section [Quantitative Concept]
   714   C1705191:Section [Physical Object]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "nuclear localization."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]
Processing 00000000.tx.133: (H) The NASA mutant of the putative Fe65-binding motif NKSY in Tip60 ineffectively localized some Fe65 and AICD to speckle-like nuclear structures, but completely abolished the formation of spherical nuclear spots. 

Phrase: "(H)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "The NASA mutant of the putative Fe65-binding motif NKSY"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "in Tip60 ineffectively"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1333931:TIP60 [Gene or Genome]
   861   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1705504:TIP60 [Gene or Genome]

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "some Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "AICD to speckle-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0972395:aicd [Medical Device]
   790   C2611803:AICD [Cell Function]
   790   C3156099:AICD [Cell Function]
   790   C3537205:AICD [Cell Function]

Phrase: "like nuclear structures,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1518439:Nuclear Structure [Cell Component]
   861   C0521447:Nuclear [Spatial Concept]
   861   C0678594:structures [Spatial Concept]

Phrase: "but"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "abolished"

Phrase: "the formation of spherical nuclear spots."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]
Processing 00000000.tx.134: Bar, 10 m.  

Phrase: "Bar,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "10 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.135: View larger version (39K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(39K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.136: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.137: Fe65 transports AICD to nuclei where it can regulate transcription. 

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "transports"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005528:Transport, NOS [Cell Function]
  1000   C1317949:Transport [Manufactured Object]
  1000   C3495449:transport [Medical Device]

Phrase: "AICD to nuclei where"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0972395:aicd [Medical Device]
   770   C2611803:AICD [Cell Function]
   770   C3156099:AICD [Cell Function]
   770   C3537205:AICD [Cell Function]

Phrase: "it"

Phrase: "can"

Phrase: "regulate"

Phrase: "transcription."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]
Processing 00000000.tx.138: (A) Blocking nuclear export with leptomycin B for 9 hours leads to an accumulation of Fe65 and AICD in nuclei. 

Phrase: "(A"

Phrase: ")"

Phrase: "Blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "nuclear export with leptomycin B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0887840:Nuclear Export [Cell Function]
   760   C0699789:Export [Phenomenon or Process]

Phrase: "for 9 hours"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "leads to an accumulation of Fe65"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0181586:leads [Medical Device]
   753   C1412459:FE65 [Gene or Genome]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "AICD in nuclei."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0972395:aicd [Medical Device]
   790   C2611803:AICD [Cell Function]
   790   C3156099:AICD [Cell Function]
   790   C3537205:AICD [Cell Function]
Processing 00000000.tx.139: In cells co-expressing Fe65 and AICD, leptomycin B caused the formation of nuclear AICD-containing spots that were never observed in cells without the cotransfection of Fe65, or in the absence of leptomycin B (compare Fig. 1A,B). 

Phrase: "In cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "co-expressing"

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "AICD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "leptomycin B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064771:leptomycin B [Lipid,Pharmacologic Substance]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "the formation of nuclear AICD-containing spots"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]

Phrase: "that"

Phrase: "were"

Phrase: "never"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2003901:Never [Temporal Concept]

Phrase: "observed in cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1441672:Observed [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "without the cotransfection"

Phrase: "of Fe65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "or in the absence of leptomycin B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0064771:leptomycin B [Lipid,Pharmacologic Substance]
   748   C0332197:absence [Quantitative Concept]
   748   C1689985:Absence [Anatomical Abnormality]

Phrase: "("

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "Fig. 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.140: Bar, 10 m. 

Phrase: "Bar,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "10 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.141: (B) Leptomycin B (24 hours) increased fluorescence signal intensity ratios of nuclear versus extranuclear staining for AICD and Fe65 in co-expressing cells. 

Phrase: "(B) Leptomycin B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0064771:leptomycin B [Lipid,Pharmacologic Substance]

Phrase: "(24 hours"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0439584:24 hours [Temporal Concept]
  1000   C0456696:/24 hours [Temporal Concept]
  1000   C1442770:24 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: ")"

Phrase: "increased fluorescence signal intensity ratios of nuclear"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   778   C0871362:signal intensity [Quantitative Concept]
   748   C0456603:Ratios [Quantitative Concept]
   748   C0522510:Intensity [Qualitative Concept]
   748   C1610540:*Ratios [Quantitative Concept]
   748   C1710082:Signal [Phenomenon or Process]
   714 E C1547037:Ratio [Intellectual Product]

Phrase: "versus"

Phrase: "extranuclear staining for AICD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "Fe65 in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1412459:FE65 [Gene or Genome]

Phrase: "co-expressing"

Phrase: "cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.142: Without the expression of Fe65, leptomycin B treatment did not change the nuclear/extranuclear signal ratio for AICD. 

Phrase: "Without the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of Fe65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "leptomycin B treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0064771:leptomycin B [Lipid,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "the nuclear/extranuclear signal ratio for AICD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0456603:Ratio [Quantitative Concept]
   748   C1547037:Ratio [Intellectual Product]
Processing 00000000.tx.143: (C) Western blots of nuclear (n) and post-nuclear supernatant (PNS) fractions from AICD- and Fe65-expressing cells treated with lepomycin B (0 to 24 hours) showed increased nuclear retention of Fe65. 

Phrase: "(C) Western blots of nuclear (n)"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C0949466:Western Blots [Laboratory Procedure]
   773 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "post-nuclear supernatant (PNS) fractions from AICD-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1264633:Fractions [Quantitative Concept]
   719 E C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "Fe65-expressing cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "treated with lepomycin B (0"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "to 24 hours"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0439584:24 hours [Temporal Concept]
  1000   C0456696:/24 hours [Temporal Concept]
  1000   C1442770:24 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "increased nuclear retention of Fe65."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0035280:Retention [Mental Process]
   760   C0333117:Retention [Functional Concept]
   760   C1753315:retention [Cell Function]
Processing 00000000.tx.144: The nuclear/PNS signal ratio for Fe65 increased to 247% after 9 hours and to 527% after 24 hours, as compared with a 100% baseline. 

Phrase: "The nuclear/PNS signal ratio for Fe65"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0456603:Ratio [Quantitative Concept]
   742   C1547037:Ratio [Intellectual Product]

Phrase: "increased to 247%"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "after 9 hours"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "and to 527%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "after 24 hours,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0439584:24 hours [Temporal Concept]
  1000   C0456696:/24 hours [Temporal Concept]
  1000   C1442770:24 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "as"

Phrase: "compared with a 100% baseline."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0168634:baseline [Biomedical or Dental Material]
   760   C1442488:Baseline [Quantitative Concept]
   760   C1707455:Compared [Activity]
Processing 00000000.tx.145: Marker proteins are 19, 28, 39, 51, 64, 97 and 191 kDa. 

Phrase: "Marker proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "19,"

Phrase: "28,"

Phrase: "39,"

Phrase: "51,"

Phrase: "64,"

Phrase: "97"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "and"

Phrase: "191 kDa."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]
Processing 00000000.tx.146: (D,E) Real-time PCR of clonal cell lines with and without the induced expression of citrine-AICD revealed that AICD increased the expression of APP, BACE and Tip60 (Mann-Whitney U, P<0.05). 

Phrase: "("

Phrase: "D,"

Phrase: "E) Real-time PCR of clonal cell lines"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   800   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   744   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0677874:pCR [Finding]

Phrase: "with"

Phrase: "and without the induced expression of citrine-AICD"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0205263:Induced [Functional Concept]
   744   C0972395:aicd [Medical Device]
   744   C1515981:And [Idea or Concept]
   744   C2611803:AICD [Cell Function]
   744   C3156099:AICD [Cell Function]
   744   C3537205:AICD [Cell Function]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the expression of APP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1171362:expression protein [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "BACE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412727:BACE [Gene or Genome]

Phrase: "and"

Phrase: "Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "(Mann-Whitney U,"

Phrase: "P<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.147: AICD did not change the expression of Fe65, Tip60, ADAM10, PSEN1, or the Notch-effector gene Hes1. 

Phrase: "AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "the expression of Fe65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "Tip60,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "ADAM10,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412181:ADAM10 [Gene or Genome]
  1000   C2984597:ADAM 10 [Amino Acid, Peptide, or Protein]

Phrase: "PSEN1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418985:PSEN1 [Gene or Genome]

Phrase: "or"

Phrase: "the Notch-effector gene Hes1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1412958:HES1 [Gene or Genome]
   812   C1415725:HES1 [Gene or Genome]
Processing 00000000.tx.148: The AICD-induced expression of KAI1 and Gsk3 was confirmed. 

Phrase: "The AICD-induced expression of KAI1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Gsk3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "confirmed."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.149: All values were normalized against GAPDH expression levels and expressed as fold baseline without induction of AICD expression. 

Phrase: "All values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "normalized against GAPDH expression levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   773   C3244092:expression level [Idea or Concept]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0441889:Levels [Qualitative Concept]
   760   C1414968:GAPDH [Gene or Genome]
   760   C1882115:Normalized [Research Activity]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "expressed as fold baseline"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0168634:baseline [Biomedical or Dental Material]
   770   C0332462:Fold [Spatial Concept]
   770   C1442488:Baseline [Quantitative Concept]
   770   C1880834:FOLD [Phenomenon or Process]

Phrase: "without induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "of AICD expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.150: Data represent means  s.e.m. of five experiments, each done in triplicate. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "means"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "s."

Phrase: "e.m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "of five experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "each"

Phrase: "done in triplicate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205174:Triplicate [Quantitative Concept]
   790   C1272695:Done [Qualitative Concept]
   790   C2746065:Done [Temporal Concept]
Processing 00000000.tx.151: (F,G) Clonal HEK293 grown for 48 hours without (F) or with (G) the induction of AICD-citrine expression. 

Phrase: "(F,G) Clonal HEK293"

Phrase: "grown for 48 hours"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0439586:48 hours [Temporal Concept]
   833   C1442464:48 Hours [Temporal Concept]
   770   C0439227:hours [Temporal Concept]
   737 E C0564385:/hour [Quantitative Concept]

Phrase: "without"

Phrase: "(F)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "or with"

Phrase: "(G)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "the induction of AICD-citrine expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205263:Induction [Functional Concept]
   753   C0857127:induction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.152: 6E10-staining for endogenous APP reveals increased protein levels induced by AICD. 

Phrase: "6E10-staining for endogenous APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0487602:Staining [Laboratory Procedure]
   748   C1704680:Staining [Finding]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "increased protein levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   867   C0428479:Protein level [Laboratory or Test Result]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "induced by AICD."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0205263:Induced [Functional Concept]
   790   C0972395:aicd [Medical Device]
   790   C2611803:AICD [Cell Function]
   790   C3156099:AICD [Cell Function]
   790   C3537205:AICD [Cell Function]
Processing 00000000.tx.153: Bar, 20 m. 

Phrase: "Bar,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "20 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.154: (H) Whole cell extracts of naive HEK293 and AICD-expressing clonal cell lines. 

Phrase: "(H) Whole cell"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0007634:Cell [Cell]
   827   C0444667:Whole [Quantitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "extracts of naive HEK293"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2828366:Extract [Substance]

Phrase: "and"

Phrase: "AICD-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "expressing"

Phrase: "clonal cell lines."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0007600:Cell lines [Cell]
   865   C0009013:Clone Cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.155: Western blots were analyzed with antibodies against the N- or C-terminus of APP, against GFP to detect the citrine-AICD fusion protein and GAPDH as a loading control. 

Phrase: "Western blots"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0949466:Western Blots [Laboratory Procedure]
   966 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1705493:Western [Spatial Concept]

Phrase: "were"

Phrase: "analyzed with antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   790   C0936012:Analyzed [Research Activity]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against the N-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "or"

Phrase: "C-terminus of APP,"

Phrase: "against GFP to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the citrine-AICD fusion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332466:Fusion [Functional Concept]
   812   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "GAPDH as a loading control."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1414968:GAPDH [Gene or Genome]
Processing 00000000.tx.156: Naive HEK293 (C, lane 1) were also treated with the -secretase inhibitor DAPT, which leads to accumulation of - and -stubs (DAPT, lane 2). 

Phrase: "Naive HEK293"

Phrase: "(C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "also"

Phrase: "treated with the -secretase inhibitor DAPT,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0634829:dapt [Lipid]
   753   C1522326:Treated [Functional Concept]
   753   C1999216:Inhibitor [Qualitative Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "which"

Phrase: "leads to accumulation of -"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0181586:leads [Medical Device]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and -"

Phrase: "stubs"

Phrase: "(DAPT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0634829:dapt [Lipid]

Phrase: "lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.157: Clonal HEK293 were induced for 3, 6 or 48 hours (lane 4 to 6) to express citrine-AICD. 

Phrase: "Clonal HEK293"

Phrase: "were"

Phrase: "induced for 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205263:Induced [Functional Concept]

Phrase: "6"

Phrase: "or"

Phrase: "48 hours"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0439586:48 hours [Temporal Concept]
  1000   C1442464:48 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "(lane 4 to 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "citrine-AICD."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0972395:aicd [Medical Device]
   861   C2611803:AICD [Cell Function]
   861   C3156099:AICD [Cell Function]
   861   C3537205:AICD [Cell Function]
Processing 00000000.tx.158: Bar diagram shows densitometric analysis of full-length APP and -together with -stubs from three independent experiments. 

Phrase: "Bar diagram"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0681494:Diagram [Intellectual Product]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "densitometric analysis of full-length APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1514534:Protein Analysis [Molecular Biology Research Technique]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "and -together with -stubs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1515981:And [Idea or Concept]
   770   C1883357:Together [Qualitative Concept]

Phrase: "from three independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.159: Relative protein levels are determined with respect to uninduced cells (0 hrs).  

Phrase: "Relative protein levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   867   C0428479:Protein level [Laboratory or Test Result]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "determined with respect to uninduced cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0007634:Cells [Cell]
   753   C0679133:respect [Social Behavior]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(0 hrs"

Phrase: ")."
Processing 00000000.tx.160: Molecular association of AICD with the histone acetylase Tip60 in the presence of Fe65 To verify the molecular association of Tip60 and AICD in the AFT-complex, we performed fluorescence resonance energy transfer (FRET) measurements in cells with nuclear AICD-spots. 

Phrase: "Molecular association of AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "with the histone acetylase Tip60"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1333931:TIP60 [Gene or Genome]
   827   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1705504:TIP60 [Gene or Genome]
   734   C0062773:Histone Acetylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of Fe65 To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412459:FE65 [Gene or Genome]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "the molecular association of Tip60"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "AICD in the AFT-complex,"

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "fluorescence resonance energy transfer"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0597717:Fluorescence Resonance Energy Transfer [Laboratory Procedure]
   861   C0014274:Energy Transfer [Molecular Function]
   812   C0016315:Fluorescence [Natural Phenomenon or Process]
   812   C0040671:Transfer [Mental Process]
   812   C0231881:Resonance [Finding]
   812   C0424589:Energy [Finding]
   812   C0459800:resonance [Natural Phenomenon or Process]
   812   C0542479:Energy [Natural Phenomenon or Process]
   812   C0684213:Resonance [Qualitative Concept]
   812   C1442080:Energy [Quantitative Concept]
   812   C1705822:Transfer [Activity]
   741 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   741 E C0577554:Resonant [Qualitative Concept]

Phrase: "(FRET"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0597717:Fluorescence Resonance Energy Transfer [Laboratory Procedure]
   861   C0014274:Energy Transfer [Molecular Function]
   812   C0016315:Fluorescence [Natural Phenomenon or Process]
   812   C0040671:Transfer [Mental Process]
   812   C0231881:Resonance [Finding]
   812   C0424589:Energy [Finding]
   812   C0459800:resonance [Natural Phenomenon or Process]
   812   C0542479:Energy [Natural Phenomenon or Process]
   812   C0684213:Resonance [Qualitative Concept]
   812   C1442080:Energy [Quantitative Concept]
   812   C1705822:Transfer [Activity]
   741 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   741 E C0577554:Resonant [Qualitative Concept]

Phrase: ")"

Phrase: "measurements in cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0242485:measurements [Functional Concept]

Phrase: "with nuclear AICD-spots."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0015230:spots [Disease or Syndrome]
   827   C0329155:Spot [Fish]
   827   C0848332:Spots [Sign or Symptom]
   827   C1427618:SPOT [Gene or Genome]
   827   C1705203:Spot [Conceptual Entity]
Processing 00000000.tx.161: We followed described FRET protocols (Gordon et al., 1998; Xia and Liu, 2001) to calculate the sensitized emission of citrine-AICD after excitation of CFP-Tip60 (Fig. 2A). 

Phrase: "We"

Phrase: "followed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332283:followed [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "described FRET protocols"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0442711:Protocols [Intellectual Product]
   766 E C1507394:Protocol [Intellectual Product]
   766 E C1522729:Protocol [Intellectual Product]
   766 E C2348563:Protocol [Intellectual Product]
   734   C0597717:Fluorescence Resonance Energy Transfer [Laboratory Procedure]

Phrase: "(Gordon et al.,"

Phrase: "1998"

Phrase: "; Xia"

Phrase: "and"

Phrase: "Liu,"

Phrase: "2001"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "calculate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441506:Calculate [Activity]

Phrase: "the sensitized emission of citrine-AICD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0233929:Emission [Body Substance]
   753   C2349995:Emission [Substance]

Phrase: "after excitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549255:Excitation [Activity]

Phrase: "of CFP-Tip60"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1333931:TIP60 [Gene or Genome]
   812   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1705504:TIP60 [Gene or Genome]
   756   C1121779:Cyan Fluorescent Protein [Amino Acid, Peptide, or Protein]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.162: FRET was measured in 172 nuclear spots in 16 different nuclei, and an average NFRET value of 0.322 (s.d.=0.181) was calculated. 

Phrase: "FRET"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0597717:Fluorescence Resonance Energy Transfer [Laboratory Procedure]
   861   C0014274:Energy Transfer [Molecular Function]
   812   C0016315:Fluorescence [Natural Phenomenon or Process]
   812   C0040671:Transfer [Mental Process]
   812   C0231881:Resonance [Finding]
   812   C0424589:Energy [Finding]
   812   C0459800:resonance [Natural Phenomenon or Process]
   812   C0542479:Energy [Natural Phenomenon or Process]
   812   C0684213:Resonance [Qualitative Concept]
   812   C1442080:Energy [Quantitative Concept]
   812   C1705822:Transfer [Activity]
   741 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   741 E C0577554:Resonant [Qualitative Concept]

Phrase: "was"

Phrase: "measured in 172 nuclear spots"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   760   C0015230:spots [Disease or Syndrome]
   760   C0329155:Spot [Fish]
   760   C0444706:Measured [Qualitative Concept]
   760   C0521447:Nuclear [Spatial Concept]
   760   C0848332:Spots [Sign or Symptom]
   760   C1427618:SPOT [Gene or Genome]
   760   C1705203:Spot [Conceptual Entity]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "in 16 different nuclei,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0007610:Nucleus [Cell Component]

Phrase: "and"

Phrase: "an average NFRET value of 0.322"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1522609:Value [Quantitative Concept]

Phrase: "(s.d.=0.181"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2603362:S' [Clinical Attribute]

Phrase: ")"

Phrase: "was"

Phrase: "calculated."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]
Processing 00000000.tx.163: The co-expression of CFP and citrine tagged with a nuclear localization sequence resulted in strong nuclear signals from both fluorophores, but only a marginal FRET signal (Fig. 2B) (Average NFRET=0.066, s.d.=0.012, n=9 nuclei). 

Phrase: "The co-expression of CFP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "citrine"

Phrase: "tagged with a nuclear localization sequence"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C0475264:Localisation [Functional Concept]
   753   C0521447:Nuclear [Spatial Concept]
   753   C1519249:Sequence [Functional Concept]
   753   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   753   C1708632:Tagged [Qualitative Concept]
   753   C1744691:localisation [Biologic Function]
   719 E C0037293:Tag [Neoplastic Process]
   719 E C0181496:Tag [Manufactured Object]
   719 E C1710492:TAG [Gene or Genome]

Phrase: "resulted in strong nuclear signals"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0442821:Strong [Qualitative Concept]
   760   C0521447:Nuclear [Spatial Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C1710082:Signal [Phenomenon or Process]
   726   C2825142:Result [Finding]

Phrase: "from both fluorophores,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0598447:fluorophore [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "but"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a marginal FRET signal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1710082:Signal [Phenomenon or Process]
   734   C0597717:Fluorescence Resonance Energy Transfer [Laboratory Procedure]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")"

Phrase: "(Average NFRET"

Phrase: "=0.066,"

Phrase: "s.d.=0.012,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450301:0.012" [Quantitative Concept]
   812   C2603362:S' [Clinical Attribute]

Phrase: "n"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: "=9 nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0007610:Nucleus [Cell Component]

Phrase: ")."
Processing 00000000.tx.164: This NFRET value is higher than described for values with no existing FRET (Xia and Liu, 2001), probably due to dense packing of CFP and citrine in the nuclear compartment, which leads to molecular encounters; 

Phrase: "This NFRET value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1522609:Value [Quantitative Concept]

Phrase: "is"

Phrase: "higher than"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0205250:High [Qualitative Concept]
   799   C1299351:High [Qualitative Concept]
   799   C2700149:HIGH [Intellectual Product]
   750 E C0489786:Height [Organism Attribute]

Phrase: "described for values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0042295:Values [Qualitative Concept]
   790   C1552738:described [Idea or Concept]
   756 E C1522609:Value [Quantitative Concept]

Phrase: "with no existing FRET"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   937   C0597717:Fluorescence Resonance Energy Transfer [Laboratory Procedure]
   840   C0014274:Energy Transfer [Molecular Function]
   804   C0016315:Fluorescence [Natural Phenomenon or Process]
   804   C0040671:Transfer [Mental Process]
   804   C0231881:Resonance [Finding]
   804   C0424589:Energy [Finding]
   804   C0459800:resonance [Natural Phenomenon or Process]
   804   C0542479:Energy [Natural Phenomenon or Process]
   804   C0684213:Resonance [Qualitative Concept]
   804   C1442080:Energy [Quantitative Concept]
   804   C1705822:Transfer [Activity]
   733 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   733 E C0577554:Resonant [Qualitative Concept]

Phrase: "(Xia"

Phrase: "and"

Phrase: "Liu,"

Phrase: "2001"

Phrase: ")"

Phrase: ","

Phrase: "probably due to dense packing of CFP"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C1121779:Cyan Fluorescent Protein [Amino Acid, Peptide, or Protein]
   764   C0678226:Due to [Functional Concept]
           due
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0184967:Packing [Therapeutic or Preventive Procedure]
   742   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   742   C0439794:Dense [Qualitative Concept]
   742   C0750492:Probably [Idea or Concept]
   742   C1289829:Packing [Medical Device]
   742   C2828395:Packing [Activity]
   742   C3146286:Due [Idea or Concept]

Phrase: "and"

Phrase: "citrine in the nuclear compartment,"

Phrase: "which"

Phrase: "leads to molecular encounters"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0181586:leads [Medical Device]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1521991:Molecular [Qualitative Concept]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]
   737   C0545082:Encounter [Behavior]
   737   C1512346:encounter [Health Care Activity]
   737   C1947978:Encounter [Behavior]

Phrase: ";"
Processing 00000000.tx.165: however, it is still fivefold lower than for FRET from CFP-Tip60 to citrine-AICD. 

Phrase: "however,"

Phrase: "it"

Phrase: "is"

Phrase: "still fivefold lower than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "for FRET"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0597717:Fluorescence Resonance Energy Transfer [Laboratory Procedure]
   861   C0014274:Energy Transfer [Molecular Function]
   812   C0016315:Fluorescence [Natural Phenomenon or Process]
   812   C0040671:Transfer [Mental Process]
   812   C0231881:Resonance [Finding]
   812   C0424589:Energy [Finding]
   812   C0459800:resonance [Natural Phenomenon or Process]
   812   C0542479:Energy [Natural Phenomenon or Process]
   812   C0684213:Resonance [Qualitative Concept]
   812   C1442080:Energy [Quantitative Concept]
   812   C1705822:Transfer [Activity]
   741 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   741 E C0577554:Resonant [Qualitative Concept]

Phrase: "from CFP-Tip60"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1333931:TIP60 [Gene or Genome]
   812   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1705504:TIP60 [Gene or Genome]
   756   C1121779:Cyan Fluorescent Protein [Amino Acid, Peptide, or Protein]

Phrase: "to citrine-AICD."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0972395:aicd [Medical Device]
   861   C2611803:AICD [Cell Function]
   861   C3156099:AICD [Cell Function]
   861   C3537205:AICD [Cell Function]
Processing 00000000.tx.166: In cells showing sensitized emission of citrine-AICD (Fig. 2C) we also measured increased CFP-Tip60 fluorescence after bleaching of the citrine-AICD acceptor (Fig. 2D). 

Phrase: "In cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "sensitized emission of citrine-AICD (Fig. 2C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0233929:Emission [Body Substance]
   748   C2349995:Emission [Substance]

Phrase: ")"

Phrase: "we also"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "increased CFP-Tip60 fluorescence after bleaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0016315:Fluorescence [Natural Phenomenon or Process]

Phrase: "of the citrine-AICD acceptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0000901:acceptor [Population Group]

Phrase: "(Fig. 2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1705052:2D [Spatial Concept]
   861   C2986796:2D [Functional Concept]

Phrase: ")."
Processing 00000000.tx.167: The graphs show the change in mean CFP-fluorescence from pre- to post-bleach in individual spots. 

Phrase: "The graphs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0681493:graphs [Intellectual Product]
   966 E C2698021:Graph [Conceptual Entity]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the change in mean CFP-fluorescence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0025320:The change [Physiologic Function]
   744   C0392747:Change [Functional Concept]
   744   C0443172:change [Quantitative Concept]
   744   C1705241:Change [Quantitative Concept]

Phrase: "from pre-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332152:Pre [Temporal Concept]
  1000   C0740175:Pre [Qualitative Concept]
  1000   C2257086:PRE [Genetic Function]

Phrase: "to post-bleach in individual spots."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0303749:Bleach [Inorganic Chemical]
   753   C0687676:Post [Temporal Concept]
   753   C1704687:Post [Manufactured Object]
Processing 00000000.tx.168: Unquenching of donor fluorescence was measured for all bleached nuclear spots, confirming the close molecular association of Tip60 and AICD, whereas unbleached spots had identical or diminished fluorescence (post-/pre-bleach ratio of 38 bleached spots: mean=1.114, s.d.=0.036; 

Phrase: "Unquenching of donor fluorescence"

Phrase: "was"

Phrase: "measured for all bleached nuclear spots,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   753   C0015230:spots [Disease or Syndrome]
   753   C0303749:bleached [Inorganic Chemical]
   753   C0329155:Spot [Fish]
   753   C0444706:Measured [Qualitative Concept]
   753   C0521447:Nuclear [Spatial Concept]
   753   C0848332:Spots [Sign or Symptom]
   753   C1427618:SPOT [Gene or Genome]
   753   C1705203:Spot [Conceptual Entity]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the close molecular association of Tip60"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "AICD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "whereas"

Phrase: "unbleached spots"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0015230:spots [Disease or Syndrome]
   861   C0329155:Spot [Fish]
   861   C0848332:Spots [Sign or Symptom]
   861   C1427618:SPOT [Gene or Genome]
   861   C1705203:Spot [Conceptual Entity]

Phrase: "had"

Phrase: "identical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205280:Identical [Qualitative Concept]

Phrase: "or"

Phrase: "diminished fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(post-/pre-bleach ratio of 38 bleached spots"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0456603:Ratio [Quantitative Concept]
   744   C1547037:Ratio [Intellectual Product]

Phrase: ":"

Phrase: "mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "=1.114,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "s.d.=0.036"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2603362:S' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.169: ratio of 40 unbleached spots: 1.001, s.d.=0.032; 

Phrase: "ratio of 40 unbleached spots"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: ":"

Phrase: "1.001,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "s.d.=0.032"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2603362:S' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.170: t-test P<0.001). 

Phrase: "t-test P<0.001"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0871472:t-Test [Intellectual Product]
   804   C0022885:Test [Laboratory Procedure]
   804   C0039593:Test [Functional Concept]
   804   C0392366:test [Intellectual Product]
   804   C2603360:T' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.171: View larger version (39K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(39K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.172: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.173: Both FRET and immunoprecipitation reveal a close molecular association of Tip60 and AICD in AFT-complexes. 

Phrase: "Both FRET"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0597717:Fluorescence Resonance Energy Transfer [Laboratory Procedure]
   861   C0014274:Energy Transfer [Molecular Function]
   812   C0016315:Fluorescence [Natural Phenomenon or Process]
   812   C0040671:Transfer [Mental Process]
   812   C0231881:Resonance [Finding]
   812   C0424589:Energy [Finding]
   812   C0459800:resonance [Natural Phenomenon or Process]
   812   C0542479:Energy [Natural Phenomenon or Process]
   812   C0684213:Resonance [Qualitative Concept]
   812   C1442080:Energy [Quantitative Concept]
   812   C1705822:Transfer [Activity]
   741 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   741 E C0577554:Resonant [Qualitative Concept]

Phrase: "and"

Phrase: "immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "a close molecular association of Tip60"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "AICD in AFT-complexes."
Processing 00000000.tx.174: (A) Two cells with nuclear AFT-complexes. 

Phrase: "(A"

Phrase: ")"

Phrase: "Two cells with nuclear AFT-complexes."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.175: Sensitized emission of citrine after excitation of cyan fluorescent protein (CFP) was calculated from raw FRET values with correction for CFP bleach-through and citrine cross-excitation. 

Phrase: "Sensitized emission of citrine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0233929:Emission [Body Substance]
   770   C2349995:Emission [Substance]

Phrase: "after excitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549255:Excitation [Activity]

Phrase: "of cyan fluorescent protein (CFP)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1121779:Cyan Fluorescent Protein [Amino Acid, Peptide, or Protein]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "calculated from raw FRET values"
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   833   C0597717:Fluorescence Resonance Energy Transfer [Laboratory Procedure]
   770   C0014274:Energy Transfer [Molecular Function]
   744   C0001884:R AW [Organ or Tissue Function]
   744   C0016315:Fluorescence [Natural Phenomenon or Process]
   744   C0040671:Transfer [Mental Process]
   744   C0042295:Values [Qualitative Concept]
   744   C0231881:Resonance [Finding]
   744   C0424589:Energy [Finding]
   744   C0444686:Calculated [Functional Concept]
   744   C0459800:resonance [Natural Phenomenon or Process]
   744   C0542479:Energy [Natural Phenomenon or Process]
   744   C0684213:Resonance [Qualitative Concept]
   744   C1441506:Calculated [Activity]
   744   C1442080:Energy [Quantitative Concept]
   744   C1443182:Calculated [Laboratory Procedure]
   744   C1705822:Transfer [Activity]
   744   C1709843:Raw [Qualitative Concept]
   711 E C1522609:Value [Quantitative Concept]

Phrase: "with correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "for CFP bleach-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0303749:Bleach [Inorganic Chemical]
   756   C1121779:Cyan Fluorescent Protein [Amino Acid, Peptide, or Protein]

Phrase: "through"

Phrase: "and"

Phrase: "citrine cross-excitation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0549255:Excitation [Activity]
Processing 00000000.tx.176: To prevent quenching of citrine emission, Fe65 was labeled with a Cy5-conjugated antibody (data not shown). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "quenching of citrine emission,"

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "was"

Phrase: "labeled with a Cy5-conjugated antibody"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0522529:Conjugated [Spatial Concept]
   753   C1708632:Labeled [Qualitative Concept]
   719 E C0181496:Label [Manufactured Object]
   719 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.177: (B) Control cells co-expressing CFP and citrine targeted to the nucleus with nuclear localization signals showed very little sensitized emission of citrine. 

Phrase: "(B) Control cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   913   C0004561:B-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "co-expressing"

Phrase: "CFP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1121779:Cyan Fluorescent Protein [Amino Acid, Peptide, or Protein]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "citrine"

Phrase: "targeted to the nucleus"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0007610:Nucleus [Cell Component]
   770   C1521840:Targeted [Functional Concept]
   737 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "with nuclear localization signals"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0525021:Nuclear Localization Signals [Amino Acid Sequence]
   827   C0475264:Localisation [Functional Concept]
   827   C0521447:Nuclear [Spatial Concept]
   827   C1744691:localisation [Biologic Function]
   793   C1710082:Signal [Phenomenon or Process]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "very little sensitized emission of citrine."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0233929:Emission [Body Substance]
   753   C2349995:Emission [Substance]
Processing 00000000.tx.178: (C) FRET measurements of AFT-complex-containing spherical nuclear spots showed sensitized emission from citrine-AICD in the absence of the Cy5-conjugated antibodies against Fe65. 

Phrase: "(C) FRET measurements"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0242485:measurements [Functional Concept]
   734   C0597717:Fluorescence Resonance Energy Transfer [Laboratory Procedure]

Phrase: "of AFT-complex-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "spherical nuclear spots"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0015230:spots [Disease or Syndrome]
   827   C0329155:Spot [Fish]
   827   C0848332:Spots [Sign or Symptom]
   827   C1427618:SPOT [Gene or Genome]
   827   C1705203:Spot [Conceptual Entity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "sensitized emission from citrine-AICD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0233929:Emission [Body Substance]
   760   C2349995:Emission [Substance]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of the Cy5-conjugated antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against Fe65."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]
Processing 00000000.tx.179: (D) Citrine-AICD was bleached in one nucleus and the intensity of CFP measured in single spots before (pre) and after bleaching (post). 

Phrase: "("

Phrase: "D)"

Phrase: "Citrine-AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0972395:aicd [Medical Device]
   861   C2611803:AICD [Cell Function]
   861   C3156099:AICD [Cell Function]
   861   C3537205:AICD [Cell Function]

Phrase: "was"

Phrase: "bleached in one nucleus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007610:Nucleus [Cell Component]
   770   C0205447:One [Quantitative Concept]
   770   C0303749:bleached [Inorganic Chemical]

Phrase: "and"

Phrase: "the intensity of CFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0522510:Intensity [Qualitative Concept]

Phrase: "measured in single spots"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   770   C0015230:spots [Disease or Syndrome]
   770   C0037179:Single [Population Group]
   770   C0087136:single [Finding]
   770   C0205171:Single [Quantitative Concept]
   770   C0329155:Spot [Fish]
   770   C0444706:Measured [Qualitative Concept]
   770   C0848332:Spots [Sign or Symptom]
   770   C1427618:SPOT [Gene or Genome]
   770   C1705203:Spot [Conceptual Entity]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "before"

Phrase: "(pre)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332152:Pre [Temporal Concept]
  1000   C0740175:Pre [Qualitative Concept]
  1000   C2257086:PRE [Genetic Function]

Phrase: "and after bleaching"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0303749:bleaching [Inorganic Chemical]
   790   C1515981:And [Idea or Concept]

Phrase: "(post"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0687676:Post [Temporal Concept]
  1000   C1704687:Post [Manufactured Object]
   928 E C1514253:Postal [Functional Concept]

Phrase: ")."
Processing 00000000.tx.180: The graphs show the mean pixel intensity of the measured CFP-fluorescence. 

Phrase: "The graphs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0681493:graphs [Intellectual Product]
   966 E C2698021:Graph [Conceptual Entity]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the mean pixel intensity of the measured CFP-fluorescence."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0522510:Intensity [Qualitative Concept]
Processing 00000000.tx.181: The pre/post values of single spots are connected by a line. 

Phrase: "The pre/post values of single spots"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0042295:Values [Qualitative Concept]
   714 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "connected by a line."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205132:Line [Spatial Concept]
   770   C1550648:Line [Substance]
   770   C1552960:Line [Quantitative Concept]
   737   C2986575:Connect [Activity]
Processing 00000000.tx.182: After bleaching, CFP fluorescence intensities increased in spots in the bleached nucleus, but not in surrounding spots in unbleached nuclei. 

Phrase: "After bleaching,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0303749:bleaching [Inorganic Chemical]

Phrase: "CFP fluorescence intensities"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0522510:intensities [Qualitative Concept]
   717   C1121779:Cyan Fluorescent Protein [Amino Acid, Peptide, or Protein]

Phrase: "increased in spots"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0015230:spots [Disease or Syndrome]
   790   C0205217:Increased [Quantitative Concept]
   790   C0329155:Spot [Fish]
   790   C0442805:Increased [Functional Concept]
   790   C0848332:Spots [Sign or Symptom]
   790   C1427618:SPOT [Gene or Genome]
   790   C1705203:Spot [Conceptual Entity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "in the bleached nucleus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0007610:Nucleus [Cell Component]

Phrase: "but"

Phrase: "not in surrounding spots"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0015230:spots [Disease or Syndrome]
   770   C0329155:Spot [Fish]
   770   C0848332:Spots [Sign or Symptom]
   770   C1282914:Surrounding [Spatial Concept]
   770   C1427618:SPOT [Gene or Genome]
   770   C1518422:Not [Functional Concept]
   770   C1705203:Spot [Conceptual Entity]

Phrase: "in unbleached nuclei."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0007610:Nucleus [Cell Component]
Processing 00000000.tx.183: Bar, 10 m. 

Phrase: "Bar,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "10 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.184: (E) Immunoprecipitation (IP) of AFT-complex components from nuclear fractions. 

Phrase: "(E) Immunoprecipitation (IP) of AFT-complex components"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "from nuclear fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.185: Antibodies against AICD or Tip60 co-precipitate Fe65 as detected by western blot (WB) of the HA tag. 

Phrase: "Antibodies against AICD"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "or"

Phrase: "Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "co-precipitate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "as"

Phrase: "detected by western blot (WB) of the HA tag."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0949466:Western Blot [Laboratory Procedure]
   744   C0037293:Tag [Neoplastic Process]
   744   C0181496:Tag [Manufactured Object]
   744   C0442726:Detected [Finding]
   744   C1511790:Detected [Therapeutic or Preventive Procedure]
   744   C1705493:Western [Spatial Concept]
   744   C1710492:TAG [Gene or Genome]
Processing 00000000.tx.186: IP with antibodies against AICD precipitated Tip60 and, vice versa, antibodies against Tip60 precipitated AICD, as shown by staining with an antibody against fluorescent proteins that detects both CFP and citrine. 

Phrase: "IP with antibodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "against AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "precipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "and"

Phrase: ","

Phrase: "vice versa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0814670:vice [Idea or Concept]

Phrase: "antibodies against Tip60"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "precipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "AICD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "as"

Phrase: "shown by staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0487602:Staining [Laboratory Procedure]
   790   C1704680:Staining [Finding]
   756   C1547282:Show [Intellectual Product]

Phrase: "with an antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against fluorescent proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "detects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "both CFP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1121779:Cyan Fluorescent Protein [Amino Acid, Peptide, or Protein]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "citrine."
Processing 00000000.tx.187: The lower band in panel 4 is unspecific, and results from the detection of the antibody used for immunoprecipitation by the secondary antibody used in western blots. 

Phrase: "The lower band in panel 4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0175723:Band [Medical Device]
   753   C0439645:Band [Spatial Concept]
   753   C1521913:band [Cell Component]

Phrase: "is"

Phrase: "unspecific,"

Phrase: "and"

Phrase: "results from the detection of the antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C0430425:Antibody detection [Laboratory Procedure]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C1274040:Result [Functional Concept]
   748   C1511790:Detection [Therapeutic or Preventive Procedure]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]

Phrase: "used for immunoprecipitation"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "by the secondary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "used in western blots."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   833   C0949466:Western Blots [Laboratory Procedure]
   799 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   770   C1273517:used [Finding]
   770   C1705493:Western [Spatial Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.188: Marker proteins are 19, 28, 39, 51, 64, 97 and 191 kDa.  

Phrase: "Marker proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "19,"

Phrase: "28,"

Phrase: "39,"

Phrase: "51,"

Phrase: "64,"

Phrase: "97"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "and"

Phrase: "191 kDa."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]
Processing 00000000.tx.189: For a further support of the molecular interaction of AICD, Fe65 and Tip60 in the nucleus, we performed immunoprecipitations from nuclear fractions. 

Phrase: "For a further support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0183683:Support [Medical Device]
   861   C1521721:Support [Conceptual Entity]

Phrase: "of the molecular interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1167622:Molecular Interaction [Molecular Function]
   861   C1704675:Interaction [Functional Concept]

Phrase: "of AICD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "Tip60 in the nucleus,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1333931:TIP60 [Gene or Genome]
   770   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1705504:TIP60 [Gene or Genome]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "immunoprecipitations from nuclear fractions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0021069:Immunoprecipitation [Laboratory Procedure]
Processing 00000000.tx.190: Antibodies directed against both AICD and Tip60 are able to pull down Fe65 in cells expressing all three proteins (Fig. 2E). 

Phrase: "Antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "directed against both AICD"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0972395:aicd [Medical Device]
   770   C2611803:AICD [Cell Function]
   770   C3156099:AICD [Cell Function]
   770   C3537205:AICD [Cell Function]
   737   C0439851:Direct [Qualitative Concept]
   737   C1947931:Direct [Qualitative Concept]

Phrase: "and"

Phrase: "Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "are"

Phrase: "able to pull down Fe65 in cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1412459:FE65 [Gene or Genome]

Phrase: "expressing"

Phrase: "all three proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 2E"

Phrase: ")."
Processing 00000000.tx.191: Precipitation with an antibody against AICD also enriches for Tip60, as shown by an antibody recognizing the CFP fused to Tip60, with more Tip60 pulled down when Fe65 is co-expressed. 

Phrase: "Precipitation with an antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0032931:Precipitation [Natural Phenomenon or Process]
   770   C0032932:Precipitation [Molecular Function]
   770   C1642401:% precipitation [Quantitative Concept]
   770   C2584299:Precipitation [Natural Phenomenon or Process]

Phrase: "against AICD also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0972395:aicd [Medical Device]
   861   C2611803:AICD [Cell Function]
   861   C3156099:AICD [Cell Function]
   861   C3537205:AICD [Cell Function]

Phrase: "enriches for Tip60,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0359583:Enrich [Food]
   790   C1333931:TIP60 [Gene or Genome]
   790   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1705504:TIP60 [Gene or Genome]

Phrase: "as"

Phrase: "shown by an antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   737   C1547282:Show [Intellectual Product]

Phrase: "recognizing"

Phrase: "the CFP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1121779:Cyan Fluorescent Protein [Amino Acid, Peptide, or Protein]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "fused to Tip60,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0699952:Fused [Functional Concept]
   790   C1333931:TIP60 [Gene or Genome]
   790   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1705504:TIP60 [Gene or Genome]
   756 E C1414861:FUSE [Gene or Genome]
   756 E C1708111:Fuse [Manufactured Object]

Phrase: "with more Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1333931:TIP60 [Gene or Genome]
   861   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1705504:TIP60 [Gene or Genome]

Phrase: "pulled down"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0580846:pulled [Finding]

Phrase: "when"

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "is"

Phrase: "co-expressed."
Processing 00000000.tx.192: Although nuclear citrine-AICD can be imaged in the confocal microscope (Fig. 1A) it is not detectable by immunoprecipitation from nuclear fractions in the absence of co-expressed Fe65. 

Phrase: "Although"

Phrase: "nuclear citrine-AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0972395:aicd [Medical Device]
   827   C2611803:AICD [Cell Function]
   827   C3156099:AICD [Cell Function]
   827   C3537205:AICD [Cell Function]

Phrase: "can"

Phrase: "be"

Phrase: "imaged in the confocal microscope"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1626420:Confocal microscope [Medical Device]
   760   C0181839:Microscope [Medical Device]
   760   C1706379:Microscope [Medical Device]
   726   C1704254:Image [Intellectual Product]
   726   C1704922:Image [Entity]
   726   C3542466:Image [Intellectual Product]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: "it"

Phrase: "is"

Phrase: "not detectable by immunoprecipitation"

Phrase: "from nuclear fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of"

Phrase: "co-expressed"

Phrase: "Fe65."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]
Processing 00000000.tx.193: Expression of Fe65, together with Tip60 leads to depletion of AICD from the cytosol and accumulation in nuclear spots (Fig. 1E,F), resulting in much higher nuclear levels of AICD, now detectable by immunoprecipitation. 

Phrase: "Expression of Fe65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "together with Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "leads to depletion of AICD"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0181586:leads [Medical Device]
   760   C0333668:Depletion [Functional Concept]
   760   C0972395:aicd [Medical Device]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C2611803:AICD [Cell Function]
   760   C3156099:AICD [Cell Function]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]
   760   C3537205:AICD [Cell Function]

Phrase: "from the cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: "and"

Phrase: "accumulation in nuclear spots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   819   C0544910:Nuclear accumulation [Cell or Molecular Dysfunction]

Phrase: "(Fig. 1E,"

Phrase: "F),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "resulting in much higher nuclear levels of AICD,"
Meta Candidates (Total=17; Excluded=6; Pruned=0; Remaining=11)
   770   C0332294:Resulting in [Functional Concept]
   744   C0441889:Levels [Qualitative Concept]
   744   C0521447:Nuclear [Spatial Concept]
   744   C0678226:resulting [Functional Concept]
   744   C0972395:aicd [Medical Device]
   744   C2611803:AICD [Cell Function]
   744   C3156099:AICD [Cell Function]
   744   C3537205:AICD [Cell Function]
   711   C0205250:High [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1274040:Result [Functional Concept]
   711   C1299351:High [Qualitative Concept]
   711 E C1546471:Result [Idea or Concept]
   711 E C1547707:Level [Geographic Area]
   711   C2700149:HIGH [Intellectual Product]
   711 E C2825142:Result [Finding]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "now detectable by immunoprecipitation."
Processing 00000000.tx.194: Alternatively, it is possible that free nuclear AICD, as seen in Fig. 

Phrase: "Alternatively,"

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that free nuclear AICD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0972395:aicd [Medical Device]
   827   C2611803:AICD [Cell Function]
   827   C3156099:AICD [Cell Function]
   827   C3537205:AICD [Cell Function]

Phrase: "as"

Phrase: "seen in Fig."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205397:Seen [Qualitative Concept]
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]
Processing 00000000.tx.195: 1A, diffuses out of the nuclei during the preparation of nuclear fractions. 

Phrase: "1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450344:1A [Intellectual Product]
  1000   C1553633:1a [Medical Device]

Phrase: "diffuses out of the nuclei"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205219:Diffuse [Qualitative Concept]
   760   C0439787:Out [Spatial Concept]
   760   C0849355:Out [Qualitative Concept]
   726   C0007610:Nucleus [Cell Component]

Phrase: "during the preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: "of nuclear fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.196: AICD bound to a Tip60/Fe65-containing complex, which might be associated with chromatin, would not be washed away during the purification of nuclear fractions. 

Phrase: "AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "bound to a Tip60/Fe65-containing complex,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   748   C0332256:Containing [Functional Concept]
   748   C0332297:bound [Spatial Concept]
   748   C0439855:Complex [Qualitative Concept]
   748   C1145667:Bound [Activity]
   748   C1167622:Bound [Molecular Function]
   748   C1333931:TIP60 [Gene or Genome]
   748   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1412459:FE65 [Gene or Genome]
   748   C1689898:% bound [Quantitative Concept]
   748   C1704241:Complex [Chemical Viewed Structurally]
   748   C1705504:TIP60 [Gene or Genome]
   748   C2349209:Bound [Conceptual Entity]
   748   C2700400:Containing [Activity]

Phrase: "which"

Phrase: "might"

Phrase: "be"

Phrase: "associated with chromatin,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0008546:Chromatin [Amino Acid, Peptide, or Protein]
   790   C1325550:chromatin [Cell Component]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "would"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "away during the purification of nuclear fractions."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   757   C1264633:Fraction of [Quantitative Concept]
           Fractions
   748   C0243114:purification [Functional Concept]
   748   C0521447:Nuclear [Spatial Concept]
   748   C1998793:Purification [Functional Concept]
   714 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.197: After precipitation with antibodies against Tip60, the GFP antibodies also detect the citrine-AICD fusion protein, again only when Fe65 is cotransformed. 

Phrase: "After precipitation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0032931:Precipitation [Natural Phenomenon or Process]
  1000   C0032932:Precipitation [Molecular Function]
  1000   C1642401:% precipitation [Quantitative Concept]
  1000   C2584299:Precipitation [Natural Phenomenon or Process]

Phrase: "with antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against Tip60,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "the GFP antibodies also"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the citrine-AICD fusion protein,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332466:Fusion [Functional Concept]
   812   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "again only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "when"

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "is"

Phrase: "cotransformed."
Processing 00000000.tx.198: The lower band in Fig. 

Phrase: "The lower band in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0175723:Band [Medical Device]
   760   C0439645:Band [Spatial Concept]
   760   C1521913:band [Cell Component]
Processing 00000000.tx.199: 2E, panel 4, is unspecific, resulting from the detection of the antibody used for immunoprecipitation by the secondary antibody used in western blots. 

Phrase: "2E,"

Phrase: "panel 4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "is"

Phrase: "unspecific,"

Phrase: "resulting from the detection of the antibody"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   774   C0430425:Antibody detection [Laboratory Procedure]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0678226:resulting [Functional Concept]
   748   C1511790:Detection [Therapeutic or Preventive Procedure]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C2825142:Result [Finding]

Phrase: "used for immunoprecipitation"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "by the secondary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "used in western blots."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   833   C0949466:Western Blots [Laboratory Procedure]
   799 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   770   C1273517:used [Finding]
   770   C1705493:Western [Spatial Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.200: Active nuclear export of Fe65 is consistent with a function as a shuttle for AICD To determine if Fe65 was actively cycling between nuclei and the cytosol, we blocked nuclear export by leptomycin B (Ni et al., 2001). 

Phrase: "Active nuclear export of Fe65"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0887840:Nuclear Export [Cell Function]
   760   C0699789:Export [Phenomenon or Process]

Phrase: "is"

Phrase: "consistent with a function"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "as a shuttle"

Phrase: "for AICD To"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0972395:aicd [Medical Device]
   861   C2611803:AICD [Cell Function]
   861   C3156099:AICD [Cell Function]
   861   C3537205:AICD [Cell Function]

Phrase: "determine"

Phrase: "if"

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "was"

Phrase: "actively"

Phrase: "cycling between nuclei"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0007610:Nucleus [Cell Component]
   756   C1511572:Cycle [Temporal Concept]

Phrase: "and"

Phrase: "the cytosol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: "we"

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "nuclear export by leptomycin B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0887840:Nuclear Export [Cell Function]
   760   C0699789:Export [Phenomenon or Process]

Phrase: "(Ni et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.201: After 9 hours of blocked export, Fe65 accumulated in nuclei (Fig. 3A). 

Phrase: "After 9 hours"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "of blocked export,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0699789:Export [Phenomenon or Process]

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "accumulated in nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0007610:Nucleus [Cell Component]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.202: We measured the mean fluorescence intensity of nuclear and extranuclear compartments, as determined by DRAQ5 staining, after 24 hours of leptomycin B treatment. 

Phrase: "We"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the mean fluorescence intensity of nuclear"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0016315:Fluorescence [Natural Phenomenon or Process]
   753   C0522510:Intensity [Qualitative Concept]

Phrase: "and"

Phrase: "extranuclear compartments,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1185625:Compartments [Body Space or Junction]
   861   C1382196:Compartments [Natural Phenomenon or Process]
   827 E C2986730:Compartment [Spatial Concept]

Phrase: "as"

Phrase: "determined by DRAQ5 staining,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]

Phrase: "after"

Phrase: "24 hours of leptomycin B treatment."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0439584:24 hours [Temporal Concept]
   790   C0456696:/24 hours [Temporal Concept]
   790   C1442770:24 Hours [Temporal Concept]
   753   C0439227:hours [Temporal Concept]
   719 E C0564385:/hour [Quantitative Concept]
Processing 00000000.tx.203: In control cells, the ratio of nuclear to extranuclear intensity measured in single confocal sections was 1.20 (s.e.m.=0.06, n=35 cells). 

Phrase: "In control cells,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0007634:Cells [Cell]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "the ratio of nuclear to extranuclear intensity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0456603:Ratio [Quantitative Concept]
   748   C1547037:Ratio [Intellectual Product]

Phrase: "measured in single confocal sections"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]
   760   C0444706:Measured [Qualitative Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726   C0205155:Section [Spatial Concept]
   726 E C0242485:Measure [Functional Concept]
   726   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   726   C1522472:Section [Substance]
   726   C1552923:Section [Quantitative Concept]
   726   C1705191:Section [Physical Object]

Phrase: "was"

Phrase: "1.20"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "("

Phrase: "s."

Phrase: "e.m.=0.06,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]

Phrase: "n"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: "=35 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.204: Leptomycin B treatment increased this ratio to 2.65 after 24 hours (s.e.m.=0.30, n=35 cells, t-test P<0.001, Fig. 3B). 

Phrase: "Leptomycin B treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0064771:leptomycin B [Lipid,Pharmacologic Substance]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "this ratio to 2.65"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "after 24 hours"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0439584:24 hours [Temporal Concept]
  1000   C0456696:/24 hours [Temporal Concept]
  1000   C1442770:24 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "("

Phrase: "s."

Phrase: "e.m.=0.30,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]

Phrase: "n"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: "=35 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "t-test P<0.001,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0871472:t-Test [Intellectual Product]
   804   C0022885:Test [Laboratory Procedure]
   804   C0039593:Test [Functional Concept]
   804   C0392366:test [Intellectual Product]
   804   C2603360:T' [Clinical Attribute]

Phrase: "Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.205: A similar increase was found for AICD, which changed from a nuclear/extranuclear intensity ratio of 0.76 (s.e.m.=0.04, n=35 cells) to 1.84 (s.e.m.=0.29, n=35 cells). 

Phrase: "A similar increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "found for AICD,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0150312:Found [Quantitative Concept]
   790   C0972395:aicd [Medical Device]
   790   C2611803:AICD [Cell Function]
   790   C3156099:AICD [Cell Function]
   790   C3537205:AICD [Cell Function]
   756 E C0243095:Find [Finding]

Phrase: "which"

Phrase: "changed from a nuclear/extranuclear intensity ratio of 0.76"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   741   C0428760:Intensity change [Laboratory or Test Result]
   739   C0392747:Changed [Functional Concept]
   739   C0443172:Changed [Quantitative Concept]
   739   C0456603:Ratio [Quantitative Concept]
   739   C0521447:Nuclear [Spatial Concept]
   739   C0522510:Intensity [Qualitative Concept]
   739   C1547037:Ratio [Intellectual Product]
   706 E C1705241:Change [Quantitative Concept]

Phrase: "("

Phrase: "s."

Phrase: "e.m.=0.04,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]

Phrase: "n"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: "=35 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "to 1.84"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "("

Phrase: "s."

Phrase: "e.m.=0.29,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]

Phrase: "n"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: "=35 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.206: In most of the Fe65-expressing cells we also observed the accumulation of AICD in nuclear spots after the inhibition of nuclear export (Fig. 3A), an observation we never made in cells co-expressing AICD and Fe65, and with intact nuclear export. 

Phrase: "In most"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205393:Most [Quantitative Concept]

Phrase: "of the Fe65-expressing cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "we also"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "the accumulation of AICD"

Phrase: "in nuclear spots"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0015230:spots [Disease or Syndrome]
   861   C0329155:Spot [Fish]
   861   C0848332:Spots [Sign or Symptom]
   861   C1427618:SPOT [Gene or Genome]
   861   C1705203:Spot [Conceptual Entity]

Phrase: "after the inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of nuclear export"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0887840:Nuclear Export [Cell Function]
   861   C0699789:Export [Phenomenon or Process]

Phrase: "(Fig. 3A"

Phrase: ")"

Phrase: ","

Phrase: "an observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "we never"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2003901:Never [Temporal Concept]

Phrase: "made in cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756   C1881534:Make [Functional Concept]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "co-expressing"

Phrase: "AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "and"

Phrase: "Fe65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "and with intact nuclear export."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0887840:Nuclear Export [Cell Function]
   760   C0205266:Intact [Qualitative Concept]
   760   C0521447:Nuclear [Spatial Concept]
   760   C0699789:Export [Phenomenon or Process]
   760   C1515981:And [Idea or Concept]
   760   C1554187:Intact [Idea or Concept]
Processing 00000000.tx.207: In cells showing nuclear AICD spots we did not observe Fe65 enriched in these spots. 

Phrase: "In cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "nuclear AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0972395:aicd [Medical Device]
   861   C2611803:AICD [Cell Function]
   861   C3156099:AICD [Cell Function]
   861   C3537205:AICD [Cell Function]

Phrase: "spots"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0015230:spots [Disease or Syndrome]
  1000   C0329155:Spot [Fish]
  1000   C0848332:Spots [Sign or Symptom]
  1000   C1427618:SPOT [Gene or Genome]
  1000   C1705203:Spot [Conceptual Entity]

Phrase: "we"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observe"

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "enriched in these spots."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0015230:spots [Disease or Syndrome]
   770   C0329155:Spot [Fish]
   770   C0359583:enriched [Food]
   770   C0848332:Spots [Sign or Symptom]
   770   C1427618:SPOT [Gene or Genome]
   770   C1705203:Spot [Conceptual Entity]
Processing 00000000.tx.208: This could be due to the general distribution of Fe65 in the nucleus, leading to less distinct labeling of spots. 

Phrase: "This"

Phrase: "could"

Phrase: "be due to the general distribution of Fe65"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0678226:Due to [Functional Concept]
           due
   744   C0205246:General [Spatial Concept]
   744   C0520511:distribution [Idea or Concept]
   744   C1412459:FE65 [Gene or Genome]
   744   C1553889:General [Idea or Concept]
   744   C1704711:Distribution [Functional Concept]
   744   C2987476:Be [Conceptual Entity]
   744   C3146286:Due [Idea or Concept]

Phrase: "in the nucleus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "leading"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332152:Leading [Temporal Concept]
  1000   C1522538:Leading [Functional Concept]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to less distinct labeling of spots."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1167624:Labeling [Mental Process]
   753   C1947902:Labeling [Manufactured Object]
   753   C2827499:Labeling [Governmental or Regulatory Activity]
Processing 00000000.tx.209: In addition, Fe65 is detected by antibody staining, which might differ in the multiprotein-complex-containing spots, whereas AICD is directly detected via the fused fluorescent protein. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "is"

Phrase: "detected by antibody staining,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0442726:Detected [Finding]
   770   C0487602:Staining [Laboratory Procedure]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1704680:Staining [Finding]

Phrase: "which"

Phrase: "might"

Phrase: "differ in the multiprotein-complex-containing spots,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   774   C2752257:SPOTS complex [Cell Component]
   748   C0015230:spots [Disease or Syndrome]
   748   C0329155:Spot [Fish]
   748   C0332256:Containing [Functional Concept]
   748   C0439855:Complex [Qualitative Concept]
   748   C0848332:Spots [Sign or Symptom]
   748   C1427618:SPOT [Gene or Genome]
   748   C1704241:Complex [Chemical Viewed Structurally]
   748   C1705203:Spot [Conceptual Entity]
   748   C2700400:Containing [Activity]

Phrase: "whereas"

Phrase: "AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "is"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "detected via the fused fluorescent protein."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0442726:Detected [Finding]
   753   C0699952:Fused [Functional Concept]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   719 E C1414861:FUSE [Gene or Genome]
   719 E C1708111:Fuse [Manufactured Object]
Processing 00000000.tx.210: Cells expressing only AICD and treated with leptomycin B had no significant change in the ratio of nuclear-to-extranuclear intensity (control=1.74, s.e.m.=0.06; 24 hours leptomycin B=1.50, s.e.m.=0.05, n=35 cells each, Fig. 3B). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "only AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0972395:aicd [Medical Device]
   861   C2611803:AICD [Cell Function]
   861   C3156099:AICD [Cell Function]
   861   C3537205:AICD [Cell Function]

Phrase: "and"

Phrase: "treated with leptomycin B"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0064771:leptomycin B [Lipid,Pharmacologic Substance]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "had"

Phrase: "no significant change in the ratio of nuclear-to-extranuclear intensity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   754   C0428760:Intensity change [Laboratory or Test Result]
   754   C0442739:No change [Finding]
   754   C1548568:No change [Intellectual Product]
   738   C0392747:Change [Functional Concept]
   738   C0443172:change [Quantitative Concept]
   738   C1705241:Change [Quantitative Concept]

Phrase: "(control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "=1.74,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "s."

Phrase: "e.m.=0.06"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]

Phrase: "; 24 hours leptomycin B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0064771:leptomycin B [Lipid,Pharmacologic Substance]

Phrase: "=1.50,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "s."

Phrase: "e.m.=0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]

Phrase: "n"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: "=35 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "each,"

Phrase: "Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.211: Furthermore, we never observed nuclear AICD-spots after leptomycin B treatment in the absence of Fe65 co-expression. 

Phrase: "Furthermore,"

Phrase: "we never"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2003901:Never [Temporal Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "nuclear AICD-spots after leptomycin B treatment"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0015230:spots [Disease or Syndrome]
   748   C0329155:Spot [Fish]
   748   C0848332:Spots [Sign or Symptom]
   748   C1427618:SPOT [Gene or Genome]
   748   C1705203:Spot [Conceptual Entity]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of Fe65 co-expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.212: We further treated cells co-expressing AICD and Fe65 with leptomycin B for 9 or 24 hours and prepared nuclear and postnuclear supernatant (PNS) fractions. 

Phrase: "We further treated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "co-expressing"

Phrase: "AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "and"

Phrase: "Fe65 with leptomycin B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1412459:FE65 [Gene or Genome]

Phrase: "for 9"

Phrase: "or"

Phrase: "24 hours"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0439584:24 hours [Temporal Concept]
  1000   C0456696:/24 hours [Temporal Concept]
  1000   C1442770:24 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "and"

Phrase: "prepared nuclear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0521447:Nuclear [Spatial Concept]

Phrase: "and"

Phrase: "postnuclear supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550101:Supernatant [Body Substance]

Phrase: "(PNS"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0521447:Nuclear [Spatial Concept]
   827   C0687676:Post [Temporal Concept]
   827   C1550101:Supernatant [Body Substance]
   827   C1704687:Post [Manufactured Object]
   755 E C1514253:Postal [Functional Concept]

Phrase: ")"

Phrase: "fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.213: Western blot analysis of Fe65 (Fig. 3C) again showed an increasing nuclear/PNS ratio with increasing time of inhibited nuclear export. 

Phrase: "Western blot analysis of Fe65"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]

Phrase: "(Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")"

Phrase: "again"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "an increasing nuclear/PNS ratio with increasing time"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C1264675:Time ratio [Quantitative Concept]
   757   C1547051:*Time Ratio [Temporal Concept]
   739   C0456603:Ratio [Quantitative Concept]
   739   C1547037:Ratio [Intellectual Product]

Phrase: "of inhibited nuclear export."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0887840:Nuclear Export [Cell Function]
   827   C0699789:Export [Phenomenon or Process]
Processing 00000000.tx.214: Compared with intact nuclear export, the nuclear/PNS ratio increased to 247% after 9 hours and to 527% after 24 hours of leptomycin B treatment. 

Phrase: "Compared with intact nuclear export,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0887840:Nuclear Export [Cell Function]
   760   C0205266:Intact [Qualitative Concept]
   760   C0521447:Nuclear [Spatial Concept]
   760   C0699789:Export [Phenomenon or Process]
   760   C1554187:Intact [Idea or Concept]
   760   C1707455:Compared [Activity]

Phrase: "the nuclear/PNS ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0456603:Ratio [Quantitative Concept]
   804   C1547037:Ratio [Intellectual Product]

Phrase: "increased to 247%"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "after 9 hours"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "and to 527%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "after 24 hours"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0439584:24 hours [Temporal Concept]
  1000   C0456696:/24 hours [Temporal Concept]
  1000   C1442770:24 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "of leptomycin B treatment."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0064771:leptomycin B [Lipid,Pharmacologic Substance]
Processing 00000000.tx.215: Regulation of AICD-effector genes We isolated RNA populations from clonal cells with or without 48 hours of AICD induction. 

Phrase: "Regulation of AICD-effector genes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C2610899:regulation of AICD [Cell Function]
   797   C0017263:genes regulation [Genetic Function]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "We"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "RNA populations from clonal cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0032659:Population [Quantitative Concept]
   760   C1257890:Population [Population Group]

Phrase: "with"

Phrase: "or without 48 hours of AICD induction."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   778   C0439586:48 hours [Temporal Concept]
   778   C1442464:48 Hours [Temporal Concept]
   748   C0205263:Induction [Functional Concept]
   748   C0439227:hours [Temporal Concept]
   748   C0857127:induction [Therapeutic or Preventive Procedure]
   748   C0972395:aicd [Medical Device]
   748   C2611803:AICD [Cell Function]
   748   C3156099:AICD [Cell Function]
   748   C3537205:AICD [Cell Function]
   714 E C0564385:/hour [Quantitative Concept]
Processing 00000000.tx.216: To determine whether inducible expression of AICD actually results in the regulation of the transcription of target genes, we performed real-time PCR experiments with genes coding for proteins involved in APP processing (ADAM10, BACE, PSEN1) or signaling (Fe65, Tip60). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "inducible expression of AICD actually"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "results in the regulation of the transcription of target genes,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   764   C1710463:Transcription Regulation Gene [Gene or Genome]
   757   C0017263:genes regulation [Genetic Function]
   757   C0040649:genes transcription [Genetic Function]
           Transcription
   757   C1158770:Transcription Regulation [Genetic Function]
   743   C1332838:Target Gene [Gene or Genome]
   739   C0017337:Genes [Gene or Genome]
   739   C0851285:Regulation [Governmental or Regulatory Activity]
   739   C1274040:Result [Functional Concept]
   739   C1327622:Regulation [Biologic Function]
   739   C1521840:Target [Functional Concept]
   739   C1546471:Result [Idea or Concept]
   739   C2825142:Result [Finding]
   739   C2986546:TARGET [Diagnostic Procedure]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "real-time PCR experiments with genes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0681814:Experiments [Research Activity]
   719 E C1706386:Experiment [Conceptual Entity]

Phrase: "coding for proteins"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0009219:Coding [Occupational Activity]
   790   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756 E C0805701:Code [Intellectual Product]

Phrase: "involved in APP processing"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0033666:protein processing [Molecular Function]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1314939:Involved [Functional Concept]
   753   C1709634:Precursor [Idea or Concept]
   753   C1709694:Processing [Activity]

Phrase: "(ADAM10,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412181:ADAM10 [Gene or Genome]
  1000   C2984597:ADAM 10 [Amino Acid, Peptide, or Protein]

Phrase: "BACE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412727:BACE [Gene or Genome]

Phrase: "PSEN1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418985:PSEN1 [Gene or Genome]

Phrase: ")"

Phrase: "or"

Phrase: "signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]

Phrase: "(Fe65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.217: In addition, we analyzed the expression of KAI1 and GSK3, described candidate target genes of AICD (Baek et al., 2002; Kim et al., 2003). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the expression of KAI1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "GSK3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "described candidate target genes of AICD (Baek et al.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1332838:Candidate Genes [Gene or Genome]
           Target Gene
   742   C0017337:Genes [Gene or Genome]

Phrase: "2002"

Phrase: "; Kim et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.218: The increase in citrine-AICD transcripts after 48 hours of induction was 17.4 fold (range=3.2, data not shown). 

Phrase: "The increase in citrine-AICD transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "after 48 hours"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0439586:48 hours [Temporal Concept]
  1000   C1442464:48 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "of induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "17.4 fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "(range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514721:Range [Quantitative Concept]
  1000   C2348147:Range [Quantitative Concept]
  1000   C3542016:Range [Intellectual Product]

Phrase: "=3.2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.219: We detected significantly increased transcript levels for APP, BACE and Tip60, as well as confirmed the regulation of KAI1 and GSK3, 48 hours after the induction of AICD expression (Mann-Whitney U, P<0.05, Fig. 3D). 

Phrase: "We"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "significantly increased transcript levels for APP,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   750   C0428479:Protein level [Laboratory or Test Result]
   744   C0441889:Levels [Qualitative Concept]
   744   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "BACE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412727:BACE [Gene or Genome]

Phrase: "and"

Phrase: "Tip60,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "as well as"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the regulation of KAI1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "GSK3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "48 hours after the induction of AICD expression"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0439586:48 hours [Temporal Concept]
   770   C1442464:48 Hours [Temporal Concept]
   744   C0439227:hours [Temporal Concept]
   711 E C0564385:/hour [Quantitative Concept]

Phrase: "(Mann-Whitney U,"

Phrase: "P<0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Fig. 3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450363:3D [Spatial Concept]
   861   C2986797:3D [Functional Concept]

Phrase: ")."
Processing 00000000.tx.220: ADAM10, PSEN1 and Fe65 showed no regulation by AICD (Fig. 3E). 

Phrase: "ADAM10,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412181:ADAM10 [Gene or Genome]
  1000   C2984597:ADAM 10 [Amino Acid, Peptide, or Protein]

Phrase: "PSEN1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418985:PSEN1 [Gene or Genome]

Phrase: "and"

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no regulation by AICD (Fig. 3E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: ")."
Processing 00000000.tx.221: The induction of AICD did not affect the expression of Hes1, a Notch-effector gene regulated by NICD (Ohtsuka et al., 1999). 

Phrase: "The induction of AICD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the expression of Hes1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "a Notch-effector gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Gene [Gene or Genome]

Phrase: "regulated by NICD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "(Ohtsuka et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.222: Normalizations were performed with GAPDH and PGK, yielding similar results. 

Phrase: "Normalizations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882115:Normalization [Research Activity]

Phrase: "were"

Phrase: "performed with GAPDH"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0884358:Performed [Functional Concept]
   790   C1414968:GAPDH [Gene or Genome]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "PGK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1150521:PGK [Molecular Function]
  1000   C1418929:PGK [Gene or Genome]

Phrase: "yielding"

Phrase: "similar results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.223: To judge variation, PGK is also plotted against GAPDH. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "judge"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221191:Judge [Professional or Occupational Group]

Phrase: "variation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:Variation [Qualitative Concept]

Phrase: "PGK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1150521:PGK [Molecular Function]
  1000   C1418929:PGK [Gene or Genome]

Phrase: "is"

Phrase: "also"

Phrase: "plotted against GAPDH."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1414968:GAPDH [Gene or Genome]
Processing 00000000.tx.224: The fact that AICD regulates the transcription of its precursor prompted us to test whether protein levels of APP are also upregulated. 

Phrase: "The fact"

Phrase: "that AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "regulates"

Phrase: "the transcription of its precursor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0040649:Transcription [Genetic Function]

Phrase: "prompted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871157:prompted [Functional Concept]
   966 E C1602245:Prompt [Pharmacologic Substance]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "whether"

Phrase: "protein levels of APP"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   814   C0085151:Amyloid Protein Precursor [Amino Acid, Peptide, or Protein]
   783   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756   C0428479:Protein level [Laboratory or Test Result]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "also"

Phrase: "upregulated."
Processing 00000000.tx.225: We induced AICD-citrine expression for 48 hours in clonal HEK293 lines. 

Phrase: "We"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "AICD-citrine expression for 48 hours"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in clonal HEK293 lines."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.226: Staining with antibody 6E10, which stains the A-domain of endogenous APP and thus detects sAPP, A and -stubs besides full-length APP, was performed identically on uninduced cells to determine baseline expression. 

Phrase: "Staining with antibody 6E10,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]

Phrase: "which"

Phrase: "stains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "the A-domain of endogenous APP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0162808:Protein Domain [Spatial Concept]
   767   C1514562:Protein Domain [Amino Acid Sequence]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "thus"

Phrase: "detects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "sAPP,"

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and -"

Phrase: "stubs besides full-length APP,"

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "identically on uninduced cells to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "determine"

Phrase: "baseline expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.227: Confocal images, acquired with identical instrument settings, showed a strong increase in cellular APP levels (Fig. 3F,G). 

Phrase: "Confocal images,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]

Phrase: "acquired with identical instrument settings,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0205280:Identical [Qualitative Concept]
   760   C0348000:Instrument [Medical Device]
   760   C0439661:Acquired [Temporal Concept]
   760   C3245488:acquired [Intellectual Product]
   726   C0542559:setting [Functional Concept]
   726   C1318139:{Setting} [Quantitative Concept]
   726 E C1706701:Acquire [Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a strong increase in cellular APP levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "(Fig. 3F,"

Phrase: "G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.228: Therefore, AICD induces not only the transcription of APP but also results in increased protein levels. 

Phrase: "Therefore,"

Phrase: "AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "the transcription of APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0040649:Transcription [Genetic Function]

Phrase: "but"

Phrase: "also"

Phrase: "results in increased protein levels."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   773   C0428479:Protein level [Laboratory or Test Result]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205217:Increased [Quantitative Concept]
   760   C0441889:Levels [Qualitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.229: We next analyzed APP expression with western blots of wild-type HEK293 and clonal lines with different induction times of AICD expression (Fig. 3H). 

Phrase: "We next analyzed APP expression with western blots"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1171362:protein expression [Genetic Function]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of wild-type HEK293"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "and"

Phrase: "clonal lines with different induction times of AICD expression"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   742   C0205132:lines [Spatial Concept]
   708 E C1550648:Line [Substance]
   708 E C1552960:Line [Quantitative Concept]

Phrase: "(Fig. 3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442460:3H [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.230: There was no significant increase in the levels of full-length APP at 3, 6 and 48 hours of AICD expression, compared with uninduced cells (normalized to GAPDH). 

Phrase: "There"

Phrase: "was"

Phrase: "no significant increase in the levels of full-length APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0442805:Increase [Functional Concept]

Phrase: "at 3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "6"

Phrase: "and"

Phrase: "48 hours of AICD expression,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0439586:48 hours [Temporal Concept]
   806   C1442464:48 Hours [Temporal Concept]
   760   C0439227:hours [Temporal Concept]
   726 E C0564385:/hour [Quantitative Concept]

Phrase: "compared with uninduced cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1707455:Compared [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "("

Phrase: "normalized to GAPDH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1414968:GAPDH [Gene or Genome]
   790   C1882115:Normalized [Research Activity]

Phrase: ")."
Processing 00000000.tx.231: By contrast, we detected increases in - and -stubs, reaching 2.2-fold (s.e.m.=0.2, n=3) of the levels seen in uninduced cells after 48 hours of induction of citrine-AICD expression (Mann-Whitney U, P<0.05, Fig. 3H). 

Phrase: "By contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "we"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:increases [Functional Concept]

Phrase: "in -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:In [Quantitative Concept]
  1000   C0332285:In [Spatial Concept]

Phrase: "and -"

Phrase: "stubs,"

Phrase: "reaching"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reaching [Organism Function]

Phrase: "2.2-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "("

Phrase: "s."

Phrase: "e.m.=0.2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C1817569:E-2' [Molecular Function]
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]

Phrase: "n"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: "=3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "of the levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "seen in uninduced cells"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0205397:Seen [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C0042789:see [Organism Function]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1947903:See [Activity]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "after 48 hours"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0439586:48 hours [Temporal Concept]
  1000   C1442464:48 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "of induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "of citrine-AICD expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(Mann-Whitney U,"

Phrase: "P<0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Fig. 3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442460:3H [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.232: Furthermore, after 48 hours of expression of citrine-AICD we could detect endogenous AICD in addition to - and -stubs. 

Phrase: "Furthermore,"

Phrase: "after"

Phrase: "48 hours of expression of citrine-AICD"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   778   C0439586:48 hours [Temporal Concept]
   778   C1442464:48 Hours [Temporal Concept]
   748   C0439227:hours [Temporal Concept]
   714 E C0564385:/hour [Quantitative Concept]

Phrase: "we"

Phrase: "could"

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "endogenous AICD in addition to -"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0972395:aicd [Medical Device]
   760   C2611803:AICD [Cell Function]
   760   C3156099:AICD [Cell Function]
   760   C3537205:AICD [Cell Function]

Phrase: "and -"

Phrase: "stubs."
Processing 00000000.tx.233: The increase in - and -stubs was also seen in naive HEK293 cells after inhibition of -secretase with DAPT. 

Phrase: "The increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "in -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:In [Quantitative Concept]
  1000   C0332285:In [Spatial Concept]

Phrase: "and -"

Phrase: "stubs"

Phrase: "was"

Phrase: "also"

Phrase: "seen in naive HEK293 cells"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   806   C2936239:HEK293 Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0205397:Seen [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C0042789:see [Organism Function]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1947903:See [Activity]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "after inhibition of -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "with DAPT."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0634829:dapt [Lipid]
Processing 00000000.tx.234: Compared with naive HEK293 we could detect nearly twofold higher levels of full-length APP and stubs in uninduced AICD-expressing cell lines. 

Phrase: "Compared with naive HEK293"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Compared [Activity]

Phrase: "we"

Phrase: "could"

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "nearly twofold higher levels of full-length APP"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   741   C0428479:Protein level [Laboratory or Test Result]
   739   C0441889:Levels [Qualitative Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "stubs in uninduced AICD-expressing cell lines."
Processing 00000000.tx.235: This might be due to leakage of AICD expression with our inducible system, which is not evident via confocal microscopy (Fig. 3F) but can be detected in western blots (Fig. 3H). 

Phrase: "This"

Phrase: "might"

Phrase: "be due to leakage of AICD expression"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0678226:Due to [Functional Concept]
           due
   748   C0015376:Leakage [Pathologic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0972395:aicd [Medical Device]
   748   C2611803:AICD [Cell Function]
   748   C2987476:Be [Conceptual Entity]
   748   C3146286:Due [Idea or Concept]
   748   C3156099:AICD [Cell Function]
   748   C3537205:AICD [Cell Function]

Phrase: "with our inducible system,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "which"

Phrase: "is"

Phrase: "not evident via confocal microscopy"

Phrase: "(Fig. 3F"

Phrase: ")"

Phrase: "but"

Phrase: "can"

Phrase: "be"

Phrase: "detected in western blots"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0949466:Western Blots [Laboratory Procedure]
   799 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1705493:Western [Spatial Concept]

Phrase: "(Fig. 3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442460:3H [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.236: Jip1 targets AICD to Tip60 whereas X11 traps it to extranuclear sites The jun-interacting protein (Jip1) is another APP-adaptor protein (Matsuda et al., 2001; Scheinfeld et al., 2002b; Taru et al., 2002a; Taru et al., 2002b) that shows transactivation activity in the Gal4 system (Scheinfeld et al., 2003). 

Phrase: "Jip1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C3536909:JUN Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "targets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "AICD to Tip60"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0972395:aicd [Medical Device]
   790   C2611803:AICD [Cell Function]
   790   C3156099:AICD [Cell Function]
   790   C3537205:AICD [Cell Function]

Phrase: "whereas"

Phrase: "X11 traps"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0184047:traps [Medical Device]

Phrase: "it to extranuclear sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "The jun-interacting protein (Jip1)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C3536909:JUN Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "another APP-adaptor protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "(Matsuda et al.,"

Phrase: "2001"

Phrase: "; Scheinfeld et al.,"

Phrase: "2002b"

Phrase: "; Taru et al.,"

Phrase: "2002a"

Phrase: "; Taru et al.,"

Phrase: "2002b"

Phrase: ")"

Phrase: "that"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "transactivation activity in the Gal4 system"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "(Scheinfeld et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.237: Jip1b is a splice variant with an insertion of 47 amino acids in the COOH-terminal phosphotyrosine binding (PTB) domain of Jip1 (Whitmarsh et al., 1998). 

Phrase: "Jip1b"

Phrase: "is"

Phrase: "a splice variant with an insertion of 47 amino acids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0205419:Variant [Qualitative Concept]

Phrase: "in the COOH-terminal phosphotyrosine binding (PTB) domain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C1518827:Phosphotyrosine Binding Domain [Amino Acid Sequence]
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]
   722   C1149341:COOH-terminal binding [Molecular Function]

Phrase: "of Jip1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C3536909:JUN Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Whitmarsh et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.238: Transfection of Jip1b into AICD-expressing cells reveals an extranuclear localization. 

Phrase: "Transfection of Jip1b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "into AICD-expressing cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "an extranuclear localization."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]
Processing 00000000.tx.239: Binding of AICD by Jip1b is evident from the clearance of AICD from the nucleus (Fig. 4A). 

Phrase: "Binding of AICD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]

Phrase: "by Jip1b"

Phrase: "is"

Phrase: "evident from the clearance of AICD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332120:Evidence of [Functional Concept]

Phrase: "from the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.240: Surprisingly, when Tip60 is co-expressed Jip1b localizes to nuclear speckles (Fig. 4B). 

Phrase: "Surprisingly,"

Phrase: "when"

Phrase: "Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "is"

Phrase: "co-expressed"

Phrase: "Jip1b"

Phrase: "localizes to nuclear speckles"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1750270:nuclear speckles [Cell Component]
   770   C0392752:localize [Spatial Concept]
   770   C0521447:Nuclear [Spatial Concept]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.241: In contrast to Fe65, the speckles show the same morphology as Tip60 alone. 

Phrase: "In contrast to Fe65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "the speckles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0439691:Speckled [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the same morphology as Tip60"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0332437:Morphology [Qualitative Concept]
   760   C0543482:morphology [Spatial Concept]
   760   C0700329:Morphology, NOS [Finding]
   760   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.242: AICD is also localized to these speckles, although at lower levels than seen with Fe65, and AICD is still detected in the cytosol (Fig. 4C). 

Phrase: "AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "is"

Phrase: "also"

Phrase: "localized to these speckles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392752:Localized [Spatial Concept]

Phrase: "although at lower levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0441889:Levels [Qualitative Concept]
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "than"

Phrase: "seen with Fe65,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205397:Seen [Qualitative Concept]
   790   C1412459:FE65 [Gene or Genome]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "and"

Phrase: "AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "is"

Phrase: "still"

Phrase: "detected in the cytosol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0442726:Detected [Finding]
   770   C1383501:Cytosol [Cell Component]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.243: The number of speckles per nucleus was 10.7 (s.d.=5.1, median=10, n=63 nuclei), which was significantly lower than spot numbers with Fe65-containing complexes. 

Phrase: "The number of speckles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "per nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "was"

Phrase: "10.7"

Phrase: "(s.d.=5.1,"

Phrase: "median"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0549183:Median [Spatial Concept]
  1000   C0876920:Median [Quantitative Concept]
  1000   C2347635:Median [Quantitative Concept]
  1000   C2348144:Median [Quantitative Concept]
  1000   C2939193:Median [Spatial Concept]

Phrase: "=10,"

Phrase: "n"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: "=63 nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0007610:Nucleus [Cell Component]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "was"

Phrase: "significantly lower than spot numbers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0441994:Lower [Spatial Concept]
   760   C1548802:Lower [Body Location or Region]
   760   C2003888:Lower [Activity]

Phrase: "with Fe65-containing complexes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1704241:Complexes [Chemical Viewed Structurally]
   793 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.244: From our data we cannot determine whether the interaction between Tip60 and Jip1b is direct or indirect via the recruitment of additional endogenous proteins. 

Phrase: "From our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "we"

Phrase: "cannot"

Phrase: "determine"

Phrase: "whether"

Phrase: "the interaction between Tip60"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "Jip1b"

Phrase: "is"

Phrase: "direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "or"

Phrase: "indirect via the recruitment of additional endogenous proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0439852:Indirect [Qualitative Concept]
Processing 00000000.tx.245: When Jip1b was transformed together with the functionally impaired, NASA-mutated Tip60 (Cao and Sdhof, 2001) it still localized together with Tip60 in speckle-like structures (not shown). 

Phrase: "When"

Phrase: "Jip1b"

Phrase: "was"

Phrase: "transformed together with the functionally"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1510411:Transformed [Pathologic Function]
   760   C1883357:Together [Qualitative Concept]

Phrase: "impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: ","

Phrase: "NASA-mutated Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1333931:TIP60 [Gene or Genome]
   827   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1705504:TIP60 [Gene or Genome]

Phrase: "(Cao"

Phrase: "and"

Phrase: "Sdhof,"

Phrase: "2001"

Phrase: ")"

Phrase: "it still"

Phrase: "localized together with Tip60"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0392752:Localized [Spatial Concept]
   770   C1333931:TIP60 [Gene or Genome]
   770   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1705504:TIP60 [Gene or Genome]
   770   C1883357:Together [Qualitative Concept]

Phrase: "in speckle-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0439691:Speckled [Qualitative Concept]

Phrase: "like structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.246: View larger version (79K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(79K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.247: 4. 

Phrase: "4."
Processing 00000000.tx.248: APP-interacting proteins Jip1b and X11 have different effects on nuclear AICD localization. 

Phrase: "APP-interacting proteins Jip1b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   709   C1456454:Amyloid Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "X11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412456:X11 [Gene or Genome]
  1000   C3538726:X11 [Gene or Genome]

Phrase: "have"

Phrase: "different effects on nuclear AICD localization."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.249: (A) Extranuclear localization of Jip1b. 

Phrase: "(A"

Phrase: ")"

Phrase: "Extranuclear localization of Jip1b."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]
Processing 00000000.tx.250: Binding of AICD to Jip1b was associated with decreased nuclear levels of AICD. 

Phrase: "Binding of AICD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]

Phrase: "to Jip1b"

Phrase: "was"

Phrase: "associated with decreased nuclear levels of AICD."
Meta Candidates (Total=17; Excluded=6; Pruned=0; Remaining=11)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0205216:Decreased [Quantitative Concept]
   748   C0392756:Decreased [Qualitative Concept]
   748   C0441889:Levels [Qualitative Concept]
   748   C0442797:decreased [Qualitative Concept]
   748   C0521447:Nuclear [Spatial Concept]
   748   C0972395:aicd [Medical Device]
   748   C2611803:AICD [Cell Function]
   748   C3156099:AICD [Cell Function]
   748   C3537205:AICD [Cell Function]
   714 E C0456079:Level [Classification]
   714 E C0547047:Decrease [Quantitative Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1547707:Level [Geographic Area]
   714 E C1706221:Associate [Professional or Occupational Group]
   714 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.251: (B) Co-expression of Tip60 relocalized Jip1b into nuclear speckles. 

Phrase: "(B) Co-expression of Tip60 relocalized Jip1b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "into nuclear speckles."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1750270:nuclear speckles [Cell Component]
   777   C0439691:Speckled [Qualitative Concept]
Processing 00000000.tx.252: (C) Additional co-expression of AICD resulted in the formation of nuclear AICD-Jip1-Tip60 (AJT) complexes with a distinct speckle-like morphology, as compared with the smaller spherical spots generated by AFT-complexes. 

Phrase: "(C) Additional co-expression of AICD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "resulted in the formation of nuclear AICD-Jip1-Tip60"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   754   C0028589:Nuclear Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C0597295:protein formation [Molecular Function]
   754   C0949374:Nuclear Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C3536909:JUN Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           JUN
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0220781:formation [Biologic Function]
   738   C0439634:formation [Spatial Concept]
   738   C0521447:Nuclear [Spatial Concept]
   738   C0972395:aicd [Medical Device]
   738   C1333931:TIP60 [Gene or Genome]
   738   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   738   C1522492:Formation [Functional Concept]
   738   C1705504:TIP60 [Gene or Genome]
   738   C2611803:AICD [Cell Function]
   738   C3156099:AICD [Cell Function]
   738   C3537205:AICD [Cell Function]
   704   C1274040:Result [Functional Concept]
   704   C1546471:Result [Idea or Concept]
   704   C2825142:Result [Finding]

Phrase: "(AJT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1333931:TIP60 [Gene or Genome]
   827   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1705504:TIP60 [Gene or Genome]

Phrase: ")"

Phrase: "complexes with a distinct speckle-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1704241:Complexes [Chemical Viewed Structurally]
   726 E C0439855:Complex [Qualitative Concept]

Phrase: "like morphology,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0332437:Morphology [Qualitative Concept]
  1000   C0543482:morphology [Spatial Concept]
  1000   C0700329:Morphology, NOS [Finding]
  1000   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "as"

Phrase: "compared with the smaller spherical spots"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0015230:spots [Disease or Syndrome]
   753   C0329155:Spot [Fish]
   753   C0332501:Spherical [Spatial Concept]
   753   C0547044:Smaller [Qualitative Concept]
   753   C0700321:Smaller [Quantitative Concept]
   753   C0848332:Spots [Sign or Symptom]
   753   C1427618:SPOT [Gene or Genome]
   753   C1705203:Spot [Conceptual Entity]
   753   C1707455:Compared [Activity]

Phrase: "generated by AFT-complexes."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   753   C0972395:aicd [Medical Device]
   753   C1333931:TIP60 [Gene or Genome]
   753   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1412459:FE65 [Gene or Genome]
   753   C1704241:Complexes [Chemical Viewed Structurally]
   753   C1705504:TIP60 [Gene or Genome]
   753   C2611803:AICD [Cell Function]
   753   C3146294:Generated [Activity]
   753   C3156099:AICD [Cell Function]
   753   C3537205:AICD [Cell Function]
   719 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.253: (D) Exclusive extranuclear localization of X11. 

Phrase: "("

Phrase: "D)"

Phrase: "Exclusive extranuclear localization of X11."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]
Processing 00000000.tx.254: Binding of AICD to X11 was associated with decreased nuclear levels of AICD. 

Phrase: "Binding of AICD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]

Phrase: "to X11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412456:X11 [Gene or Genome]
  1000   C3538726:X11 [Gene or Genome]

Phrase: "was"

Phrase: "associated with decreased nuclear levels of AICD."
Meta Candidates (Total=17; Excluded=6; Pruned=0; Remaining=11)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0205216:Decreased [Quantitative Concept]
   748   C0392756:Decreased [Qualitative Concept]
   748   C0441889:Levels [Qualitative Concept]
   748   C0442797:decreased [Qualitative Concept]
   748   C0521447:Nuclear [Spatial Concept]
   748   C0972395:aicd [Medical Device]
   748   C2611803:AICD [Cell Function]
   748   C3156099:AICD [Cell Function]
   748   C3537205:AICD [Cell Function]
   714 E C0456079:Level [Classification]
   714 E C0547047:Decrease [Quantitative Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1547707:Level [Geographic Area]
   714 E C1706221:Associate [Professional or Occupational Group]
   714 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.255: (E) Co-expression of Tip60 had no effect on the extranuclear localization of either X11 or AICD. 

Phrase: "(E) Co-expression of Tip60"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "had"

Phrase: "no effect on the extranuclear localization of either X11"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1301751:No effect [Qualitative Concept]
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "AICD."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]
Processing 00000000.tx.256: Bar, 10 m.  

Phrase: "Bar,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "10 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.257: Cotransformation of X11 (MINT1), another APP-adaptor protein (Borg et al., 1996), showed a subcellular distribution similar to Jip1b, with no signal detected in the nucleus. 

Phrase: "Cotransformation of X11"

Phrase: "(MINT1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412456:MINT1 [Gene or Genome]
  1000   C3538726:MINT1 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "another APP-adaptor protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "(Borg et al.,"

Phrase: "1996"

Phrase: ")"

Phrase: ","

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a subcellular distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]

Phrase: "similar to Jip1b,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "with no signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]

Phrase: "detected in the nucleus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007610:Nucleus [Cell Component]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.258: Again, the binding of AICD to X11 led to a clearance of AICD from the nucleus (Fig. 4D). 

Phrase: "Again,"

Phrase: "the binding of AICD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "to X11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412456:X11 [Gene or Genome]
  1000   C3538726:X11 [Gene or Genome]

Phrase: "led to a clearance of AICD"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   753   C0449297:Clearance [Qualitative Concept]
   753   C0972395:aicd [Medical Device]
   753   C1382187:Clearance [Clinical Attribute]
   753   C1708698:LED [Manufactured Object]
   753   C2611803:AICD [Cell Function]
   753   C2825073:Clearance [Natural Phenomenon or Process]
   753   C3156099:AICD [Cell Function]
   753   C3537205:AICD [Cell Function]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719 E C1522538:Lead [Functional Concept]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "from the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "(Fig. 4D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450377:4d [Intellectual Product]
   861   C2986754:4D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.259: X11 has an inhibitory effect on AICD-mediated transactivation in the Gal4 system (Biederer et al., 2002). 

Phrase: "X11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412456:X11 [Gene or Genome]
  1000   C3538726:X11 [Gene or Genome]

Phrase: "has"

Phrase: "an inhibitory effect on AICD-mediated transactivation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "in the Gal4 system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "(Biederer et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.260: Tip60 did not relocate X11 to nuclear spots and no nuclear AICD was detectable (Fig. 4E). 

Phrase: "Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "relocate"

Phrase: "X11 to nuclear spots"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1412456:X11 [Gene or Genome]
   770   C3538726:X11 [Gene or Genome]

Phrase: "and"

Phrase: "no nuclear AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0972395:aicd [Medical Device]
   861   C2611803:AICD [Cell Function]
   861   C3156099:AICD [Cell Function]
   861   C3537205:AICD [Cell Function]

Phrase: "was"

Phrase: "detectable"

Phrase: "(Fig. 4E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450378:4e [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.261: X11 thus traps AICD in the cytosol and therefore differs from the effects of Fe65 and Jip1b on nuclear AICD localization. 

Phrase: "X11 thus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1412456:X11 [Gene or Genome]
   861   C3538726:X11 [Gene or Genome]

Phrase: "traps"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184047:trap [Medical Device]

Phrase: "AICD in the cytosol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0972395:aicd [Medical Device]
   770   C2611803:AICD [Cell Function]
   770   C3156099:AICD [Cell Function]
   770   C3537205:AICD [Cell Function]

Phrase: "and"

Phrase: "therefore"

Phrase: "differs from the effects of Fe65"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C1280500:effects [Qualitative Concept]
   753   C1412459:FE65 [Gene or Genome]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "Jip1b on nuclear AICD localization."
Processing 00000000.tx.262: Full-length APP-derived AICD translocates to nuclei  inhibition by -secretase inhibitors To verify whether AICD generated from full-length APP also translocates to the nucleus we expressed APP695-citrine fusion proteins via the ecdyson-inducible system. 

Phrase: "Full-length APP-derived AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C0972395:aicd [Medical Device]
   795   C2611803:AICD [Cell Function]
   795   C3156099:AICD [Cell Function]
   795   C3537205:AICD [Cell Function]

Phrase: "translocates to nuclei  inhibition"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]
   737   C0007610:Nucleus [Cell Component]

Phrase: "by -secretase inhibitors To"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "whether"

Phrase: "AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "generated from full-length APP also"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0443225:Full [Qualitative Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1444754:Length [Quantitative Concept]
   744   C1706316:LENGTH [Research Activity]
   744   C1709634:Precursor [Idea or Concept]
   744   C3146294:Generated [Activity]

Phrase: "translocates to the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0007610:Nucleus [Cell Component]

Phrase: "we"

Phrase: "expressed"

Phrase: "APP695-citrine fusion proteins via the ecdyson-inducible system."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0332466:Fusion [Functional Concept]
   742   C1293131:Fusion [Therapeutic or Preventive Procedure]
   731   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
Processing 00000000.tx.263: The citrine cDNA was cloned downstream of the C-terminus of APP, either via a short spacer or a longer spacer coding for a tandem HA tag (see Materials and Methods). 

Phrase: "The citrine cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "cloned downstream of the C-terminus of APP,"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   782   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   782   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   760   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   757   C1168438:Protein C [Laboratory Procedure]
   757   C1418943:PROTEIN C [Gene or Genome]
   757   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   757   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0009013:cloned [Cell]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0522506:Downstream [Spatial Concept]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1709634:Precursor [Idea or Concept]
   706 E C1522642:Clone [Tissue]

Phrase: "either via a short spacer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0221874:Spacer [Medical Device]
   760   C1282927:short [Qualitative Concept]
   760   C1704737:Spacer [Medical Device]
   760   C1806781:Short [Quantitative Concept]
   760   C2350002:Short [Quantitative Concept]

Phrase: "or"

Phrase: "a longer spacer coding for a tandem HA tag ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0009219:Coding [Occupational Activity]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.264: Sixteen hours after the induction of transgene expression citrine fluorescence was detected in the perinuclear endoplasmic reticulum and the Golgi complex, and highly colocalized with the HA tag staining (Fig. 5A). 

Phrase: "Sixteen hours after the induction of transgene expression citrine fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0439227:hours [Temporal Concept]
   706 E C0564385:/hour [Quantitative Concept]

Phrase: "was"

Phrase: "detected in the perinuclear endoplasmic reticulum"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C3157075:perinuclear endoplasmic reticulum [Cell Component]
   790   C0014239:Endoplasmic Reticulum [Cell Component]
   753   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the Golgi complex,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018042:Golgi Complex [Cell Component]
           Golgi
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "colocalized with the HA tag staining"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0037293:Tag [Neoplastic Process]
   753   C0181496:Tag [Manufactured Object]
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]
   753   C1710492:TAG [Gene or Genome]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.265: Furthermore, APP-fluorescence was seen in spots covering the membrane surface of the soma and all processes. 

Phrase: "Furthermore,"

Phrase: "APP-fluorescence"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0016315:Fluorescence [Natural Phenomenon or Process]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   741 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "seen in spots"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0015230:spots [Disease or Syndrome]
   790   C0205397:Seen [Qualitative Concept]
   790   C0329155:Spot [Fish]
   790   C0848332:Spots [Sign or Symptom]
   790   C1427618:SPOT [Gene or Genome]
   790   C1705203:Spot [Conceptual Entity]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "covering"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0180153:covering [Medical Device]
  1000   C0439844:covering [Functional Concept]
   966 E C1707529:Cover [Medical Device]
   966 E C1999244:Cover [Functional Concept]

Phrase: "the membrane surface of the soma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205148:Surface [Spatial Concept]

Phrase: "and"

Phrase: "all processes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1184743:Process [Body Part, Organ, or Organ Component]
   966   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.266: This pattern resembled the distribution of endogenous APP. 

Phrase: "This pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449774:Pattern [Spatial Concept]

Phrase: "resembled"

Phrase: "the distribution of endogenous APP."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0872250:protein distribution [Cell Function]
   748   C0520511:distribution [Idea or Concept]
   748   C1704711:Distribution [Functional Concept]
Processing 00000000.tx.267: No fluorescence was detected in the nucleus when observing confocal sections. 

Phrase: "No fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "detected in the nucleus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007610:Nucleus [Cell Component]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "when"

Phrase: "observing"

Phrase: "confocal sections."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]
Processing 00000000.tx.268: Cotransformation of Fe65 and Tip60 again led to the appearance of AICD-citrine fluorescence in nuclear spots (Fig. 5B). 

Phrase: "Cotransformation of Fe65"

Phrase: "and"

Phrase: "Tip60 again"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1333931:TIP60 [Gene or Genome]
   861   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1705504:TIP60 [Gene or Genome]

Phrase: "led to the appearance of AICD-citrine fluorescence"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   744   C0016315:Fluorescence [Natural Phenomenon or Process]
   744   C0233426:Appearance [Organism Attribute]
   744   C0700364:Appearance [Qualitative Concept]
   744   C0972395:aicd [Medical Device]
   744   C1708698:LED [Manufactured Object]
   744   C2611803:AICD [Cell Function]
   744   C3156099:AICD [Cell Function]
   744   C3537205:AICD [Cell Function]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C1522538:Lead [Functional Concept]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in nuclear spots"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0015230:spots [Disease or Syndrome]
   861   C0329155:Spot [Fish]
   861   C0848332:Spots [Sign or Symptom]
   861   C1427618:SPOT [Gene or Genome]
   861   C1705203:Spot [Conceptual Entity]

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.269: One APP-citrine construct contained a tandem HA tag preceding the citrine. 

Phrase: "One APP-citrine construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C2827421:Construct [Classification]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "a tandem HA tag"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037293:Tag [Neoplastic Process]
   827   C0181496:Tag [Manufactured Object]
   827   C1710492:TAG [Gene or Genome]

Phrase: "preceding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332152:Preceding [Temporal Concept]

Phrase: "the citrine."
Processing 00000000.tx.270: The HA tag antibody stained APP in the ER/Golgi and processes, but it failed to label nuclear AFT-complexes, which were readily detected via the citrine fluorescence (Fig. 5C). 

Phrase: "The HA tag antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "APP in the ER/Golgi"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1423498:golgi protein [Gene or Genome]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "processes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1184743:Process [Body Part, Organ, or Organ Component]
   966   C1522240:Process [Phenomenon or Process]

Phrase: "but"

Phrase: "it"

Phrase: "failed to label nuclear AFT-complexes,"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   744   C0181496:Label [Manufactured Object]
   744   C0231175:Failed [Functional Concept]
   744   C0521447:Nuclear [Spatial Concept]
   744   C0972395:aicd [Medical Device]
   744   C1333931:TIP60 [Gene or Genome]
   744   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1412459:FE65 [Gene or Genome]
   744   C1704241:Complexes [Chemical Viewed Structurally]
   744   C1705504:TIP60 [Gene or Genome]
   744   C2611803:AICD [Cell Function]
   744   C2827499:Label [Governmental or Regulatory Activity]
   744   C3156099:AICD [Cell Function]
   744   C3537205:AICD [Cell Function]
   711 E C0439855:Complex [Qualitative Concept]

Phrase: "which"

Phrase: "were"

Phrase: "readily"

Phrase: "detected via the citrine fluorescence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0016315:Fluorescence [Natural Phenomenon or Process]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 5C"

Phrase: ")."
Processing 00000000.tx.271: With the formation of nuclear AFT-complexes, antibody access to the HA tag was obviously prevented. 

Phrase: "With the formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "of nuclear AFT-complexes,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C1704241:Complexes [Chemical Viewed Structurally]
   771 E C0439855:Complex [Qualitative Concept]

Phrase: "antibody access to the HA tag"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0444454:Access [Spatial Concept]
   753   C1554204:access [Idea or Concept]

Phrase: "was"

Phrase: "obviously"

Phrase: "prevented."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]
Processing 00000000.tx.272: Owing to the low percentage of cells transformed by all four constructs (APP, Fe65, Tip60, ecdysone transactivator), we were not able to immunoprecipitate AICD from nuclear fractions and test for HA tag staining in western blots. 

Phrase: "Owing to the low percentage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439165:Percentage [Quantitative Concept]
   861   C1549488:Percentage [Idea or Concept]
   861   C1561533:Percentage [Idea or Concept]

Phrase: "of cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "transformed by all four constructs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205450:Four [Quantitative Concept]
   760   C1510411:Transformed [Pathologic Function]
   726   C2827421:Construct [Classification]

Phrase: "(APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "Fe65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "Tip60,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "ecdysone transactivator"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040627:Trans-Activator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "were"

Phrase: "not able to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]
   827   C1518422:Not [Functional Concept]

Phrase: "immunoprecipitate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "AICD from nuclear fractions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0972395:aicd [Medical Device]
   770   C2611803:AICD [Cell Function]
   770   C3156099:AICD [Cell Function]
   770   C3537205:AICD [Cell Function]

Phrase: "and"

Phrase: "test for HA tag staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0022885:Test [Laboratory Procedure]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]

Phrase: "in western blots."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0949466:Western Blots [Laboratory Procedure]
   966 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   861   C1705493:Western [Spatial Concept]
Processing 00000000.tx.273: Nevertheless, using homogenates of transfected cells, we could detect an approximately 35 kDa band of AICD-2HA-citrine, which was detected by antibodies against GFP and the HA-tag in western blots (data not shown). 

Phrase: "Nevertheless,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "homogenates of transfected cells,"

Phrase: "we"

Phrase: "could"

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "an approximately 35 kDa band of AICD-2HA-citrine,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0175723:Band [Medical Device]
   742   C0439645:Band [Spatial Concept]
   742   C1521913:band [Cell Component]

Phrase: "which"

Phrase: "was"

Phrase: "detected by antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against GFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "the HA-tag in western blots"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0037293:Tag [Neoplastic Process]
   753   C0181496:Tag [Manufactured Object]
   753   C1710492:TAG [Gene or Genome]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.274: The integrity of the secretase-generated AICD-HA tag-citrine fusion protein can be inferred from the fact that citrine alone was not targeted to nuclear spots containing Fe65 and Tip60 (data not shown). 

Phrase: "The integrity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205266:integrity [Qualitative Concept]
  1000   C0872403:integrity [Individual Behavior]
  1000   C1947912:Integrity [Qualitative Concept]

Phrase: "of the secretase-generated AICD-HA tag-citrine fusion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0332466:Fusion [Functional Concept]
   793   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "can"

Phrase: "be"

Phrase: "inferred from the fact"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0679201:Inferred [Mental Process]
   770   C3245504:inferred [Idea or Concept]

Phrase: "that citrine alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Alone [Quantitative Concept]
   861   C0439044:alone [Finding]
   861   C0679994:alone [Group Attribute]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "targeted to nuclear spots"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0015230:spots [Disease or Syndrome]
   770   C0329155:Spot [Fish]
   770   C0521447:Nuclear [Spatial Concept]
   770   C0848332:Spots [Sign or Symptom]
   770   C1427618:SPOT [Gene or Genome]
   770   C1521840:Targeted [Functional Concept]
   770   C1705203:Spot [Conceptual Entity]
   737 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.275: As the AICD sequence is responsible for localization to nuclear spots where citrine fluorescence is observable, the connecting HA tag must be intact. 

Phrase: "As the AICD sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "is"

Phrase: "responsible for localization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1273518:Responsible [Finding]

Phrase: "to nuclear spots where citrine fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0016315:Fluorescence [Natural Phenomenon or Process]
   733 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "is"

Phrase: "observable,"

Phrase: "the connecting HA tag"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037293:Tag [Neoplastic Process]
   827   C0181496:Tag [Manufactured Object]
   827   C1710492:TAG [Gene or Genome]

Phrase: "must"

Phrase: "be"

Phrase: "intact."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205266:Intact [Qualitative Concept]
  1000   C1554187:Intact [Idea or Concept]
Processing 00000000.tx.276: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.277: 5D shows another cell with the HA tag of APP stained with Cy5 to enable FRET measurements. 

Phrase: "5D"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "another cell with the HA tag of APP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C0018956:precursor cell [Cell]
   739   C0007634:Cell [Cell]
   739   C1269647:Cell [Cell]
   739   C1704653:Cell [Medical Device]
   739   C1948049:Cell [Spatial Concept]

Phrase: "stained with Cy5 to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "enable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562342:enable [Mental Process]
  1000   C1171285:enable [Mental Process]

Phrase: "FRET measurements."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0242485:measurements [Functional Concept]
   771   C0597717:Fluorescence Resonance Energy Transfer [Laboratory Procedure]
Processing 00000000.tx.278: Again, the HA tag-staining detected APP in the soma and processes, but failed to label nuclear AFT-complexes. 

Phrase: "Again,"

Phrase: "the HA tag-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037293:Tag [Neoplastic Process]
   861   C0181496:Tag [Manufactured Object]
   861   C1710492:TAG [Gene or Genome]

Phrase: "staining"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "detected APP in the soma"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "processes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1184743:Process [Body Part, Organ, or Organ Component]
   966   C1522240:Process [Phenomenon or Process]

Phrase: "but"

Phrase: "failed to label nuclear AFT-complexes."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   744   C0181496:Label [Manufactured Object]
   744   C0231175:Failed [Functional Concept]
   744   C0521447:Nuclear [Spatial Concept]
   744   C0972395:aicd [Medical Device]
   744   C1333931:TIP60 [Gene or Genome]
   744   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1412459:FE65 [Gene or Genome]
   744   C1704241:Complexes [Chemical Viewed Structurally]
   744   C1705504:TIP60 [Gene or Genome]
   744   C2611803:AICD [Cell Function]
   744   C2827499:Label [Governmental or Regulatory Activity]
   744   C3156099:AICD [Cell Function]
   744   C3537205:AICD [Cell Function]
   711 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.279: Excitation of CFP-Tip60 resulted in sensitized emission from APP-derived AICD-citrine, localized in nuclear spherical spots. 

Phrase: "Excitation of CFP-Tip60"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0549255:Excitation [Activity]

Phrase: "resulted in sensitized emission"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0233929:Emission [Body Substance]
   770   C2349995:Emission [Substance]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "from APP-derived AICD-citrine,"

Phrase: "localized in nuclear spherical spots."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0015230:spots [Disease or Syndrome]
   760   C0329155:Spot [Fish]
   760   C0332501:Spherical [Spatial Concept]
   760   C0392752:Localized [Spatial Concept]
   760   C0521447:Nuclear [Spatial Concept]
   760   C0848332:Spots [Sign or Symptom]
   760   C1427618:SPOT [Gene or Genome]
   760   C1705203:Spot [Conceptual Entity]
Processing 00000000.tx.280: Together with the failure of anti-HA antibody staining of nuclear spots, this shows the close molecular interaction in AFT-complexes. 

Phrase: "Together with the failure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231174:Failure [Functional Concept]
  1000   C0680095:failure [Individual Behavior]

Phrase: "of anti-HA antibody staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0487602:Staining [Laboratory Procedure]
   812   C1704680:Staining [Finding]
   708   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "of nuclear spots,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0015230:spots [Disease or Syndrome]
   861   C0329155:Spot [Fish]
   861   C0848332:Spots [Sign or Symptom]
   861   C1427618:SPOT [Gene or Genome]
   861   C1705203:Spot [Conceptual Entity]

Phrase: "this"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the close molecular interaction in AFT-complexes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C1167622:Molecular Interaction [Molecular Function]
   742   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.281: View larger version (33K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(33K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.282: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.283: AICD derived from full-length APP translocates to the nucleus and generates AFT-complexes. 

Phrase: "AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "derived from full-length APP"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0443225:Full [Qualitative Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1441547:Derived [Qualitative Concept]
   748   C1444754:Length [Quantitative Concept]
   748   C1706316:LENGTH [Research Activity]
   748   C1709634:Precursor [Idea or Concept]
   748   C3245521:derived [Idea or Concept]

Phrase: "translocates to the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0007610:Nucleus [Cell Component]

Phrase: "and"

Phrase: "generates"

Phrase: "AFT-complexes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1704241:Complexes [Chemical Viewed Structurally]
   779 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.284: (A) Cells expressing APP fused to a C-terminal HA tag (red) followed in tandem by citrine (yellow). 

Phrase: "(A"

Phrase: ")"

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "fused to a C-terminal HA tag ("
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C1707271:C-Terminal [Amino Acid Sequence]
   748   C0037293:Tag [Neoplastic Process]
   748   C0181496:Tag [Manufactured Object]
   748   C0205088:Terminal [Temporal Concept]
   748   C0699952:Fused [Functional Concept]
   748   C1705314:Terminal [Manufactured Object]
   748   C1705315:Terminal [Spatial Concept]
   748   C1710492:TAG [Gene or Genome]
   714 E C1414861:FUSE [Gene or Genome]
   714 E C1708111:Fuse [Manufactured Object]

Phrase: "red)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "followed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332283:followed [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "in tandem by citrine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0075804:TANDEM [Organic Chemical,Pharmacologic Substance]

Phrase: "(yellow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221205:Yellow [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.285: As expected, full-length APP was localized in the ER/Golgi and in vesicles in the processes and somata, but not in nuclei. 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "full-length APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "was"

Phrase: "localized in the ER/Golgi"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0018042:Golgi [Cell Component]
   760   C0392752:Localized [Spatial Concept]

Phrase: "and in vesicles"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0333262:VESICLES [Acquired Abnormality]
   790   C1515981:And [Idea or Concept]
   756 E C1622418:vesicle [Cell Component]
   706 E C0205378:Vesicular [Qualitative Concept]

Phrase: "in the processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1184743:Process [Body Part, Organ, or Organ Component]
   966   C1522240:Process [Phenomenon or Process]

Phrase: "and"

Phrase: "somata,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0599444:soma [Cell Component]
   966   C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   928 E C0007248:Carisoprodol [Organic Chemical,Pharmacologic Substance]
   900 E C2986476:Somatic [Qualitative Concept]

Phrase: "but"

Phrase: "not in nuclei."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1518422:Not [Functional Concept]
   756   C0007610:Nucleus [Cell Component]
Processing 00000000.tx.286: Staining of APP with antibodies directed against the C-terminal HA tag colocalized with citrine fluorescence in extranuclear localizations. 

Phrase: "Staining of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]

Phrase: "with antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "directed against the C-terminal HA tag"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C1707271:C-Terminal [Amino Acid Sequence]
   748   C0037293:Tag [Neoplastic Process]
   748   C0181496:Tag [Manufactured Object]
   748   C0205088:Terminal [Temporal Concept]
   748   C1705314:Terminal [Manufactured Object]
   748   C1705315:Terminal [Spatial Concept]
   748   C1710492:TAG [Gene or Genome]
   714   C0439851:Direct [Qualitative Concept]
   714   C1947931:Direct [Qualitative Concept]

Phrase: "colocalized with citrine fluorescence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0016315:Fluorescence [Natural Phenomenon or Process]

Phrase: "in extranuclear localizations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0475264:localizations [Functional Concept]
   827 E C1744691:localization [Biologic Function]
Processing 00000000.tx.287: Confocal xz-scans through nuclei confirmed the extranuclear localization of full-length APP. 

Phrase: "Confocal xz-scans through nuclei"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0034606:Scan [Diagnostic Procedure]
   760   C0441633:Scan [Diagnostic Procedure]
   760   C2826292:SCAN [Finding]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the extranuclear localization of full-length APP."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0597704:protein localisation [Cell Function]
   762   C1159772:Protein Localization [Cell Function]
   742   C0475264:Localisation [Functional Concept]
   742   C1744691:localisation [Biologic Function]
Processing 00000000.tx.288: (B) Cells co-expressing full-length APP together with Fe65 and Tip60 formed nuclear AFT-complexes with spherical spot morphology. 

Phrase: "(B) Cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0004561:B-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "co-expressing"

Phrase: "full-length APP together with Fe65"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "nuclear AFT-complexes with spherical spot morphology."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C1704241:Complexes [Chemical Viewed Structurally]
   708 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.289: (C) In contrast to the extranuclear colocalization of HA antibody staining with citrine fluorescence, HA antibodies failed to detect the nuclear AFT-complexes that emitted strong citrine fluorescence signals. 

Phrase: "(C) In contrast to the extranuclear colocalization of HA antibody staining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1979874:Contrast [Qualitative Concept]

Phrase: "with citrine fluorescence,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "HA antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the nuclear AFT-complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C1704241:Complexes [Chemical Viewed Structurally]
   771 E C0439855:Complex [Qualitative Concept]

Phrase: "that"

Phrase: "emitted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0162676:EMIT [Laboratory Procedure]
   966   C1623049:EMIT [Laboratory Procedure]

Phrase: "strong citrine fluorescence signals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.290: (D) FRET measurements showed close molecular association of APP-derived AICD with Tip60 in nuclear AFT-complexes. 

Phrase: "("

Phrase: "D)"

Phrase: "FRET measurements"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0242485:measurements [Functional Concept]
   771   C0597717:Fluorescence Resonance Energy Transfer [Laboratory Procedure]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "close molecular association of APP-derived AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0004083:Association [Mental Process]
   742   C0439849:Association [Qualitative Concept]
   742   C0596306:Association [Phenomenon or Process]
   742   C0699792:association [Social Behavior]

Phrase: "with Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "in nuclear AFT-complexes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C1704241:Complexes [Chemical Viewed Structurally]
   771 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.291: Antibodies against the C-terminal HA tag of APP, stained with Cy5 (blue), consistently failed to detect AICD in AFT-complexes. 

Phrase: "Antibodies against the C-terminal HA tag of APP,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   754   C0368815:antibodies c [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   737   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   704 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "stained with Cy5"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(blue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260957:Blue [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "consistently"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "AICD in AFT-complexes."
Processing 00000000.tx.292: Bar, 10 m in A to C, 20 m in D upper row and 5 m in D lower row.  

Phrase: "Bar,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "10 m in A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]

Phrase: "to C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "20 m in D upper row"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1512018:M.D. [Intellectual Product]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "5 m in D"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1440942:M-5 [Immunologic Factor]
   819   C1512018:M.D. [Intellectual Product]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "row."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552846:Row [Idea or Concept]
Processing 00000000.tx.293: Sequential cleavage of transmembrane APP by secretases liberates AICD from the membrane. 

Phrase: "Sequential cleavage of transmembrane APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0597304:Protein Cleavage [Molecular Function]
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]

Phrase: "by secretases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:Secretases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "liberates"

Phrase: "AICD from the membrane."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0972395:aicd [Medical Device]
   770   C2611803:AICD [Cell Function]
   770   C3156099:AICD [Cell Function]
   770   C3537205:AICD [Cell Function]
Processing 00000000.tx.294: Inhibition of -secretase by L-685,458 (Shearman et al., 2000) or DAPT (Geling et al., 2002; Sastre et al., 2001) completely abolished the formation of nuclear AICD spots from APP-citrine fusion proteins. 

Phrase: "Inhibition of -secretase by L-685,458"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Shearman et al.,"

Phrase: "2000"

Phrase: ")"

Phrase: "or"

Phrase: "DAPT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0634829:dapt [Lipid]

Phrase: "(Geling et al.,"

Phrase: "2002"

Phrase: "; Sastre et al.,"

Phrase: "2001"

Phrase: ")"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "abolished"

Phrase: "the formation of nuclear AICD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "spots from APP-citrine fusion proteins."
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1456454:Amyloid Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
           Amyloid protein
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0015230:spots [Disease or Syndrome]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Proteins
   744   C0329155:Spot [Fish]
   744   C0332466:Fusion [Functional Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0848332:Spots [Sign or Symptom]
   744   C1293131:Fusion [Therapeutic or Preventive Procedure]
   744   C1427618:SPOT [Gene or Genome]
   744   C1705203:Spot [Conceptual Entity]
   744   C1709634:Precursor [Idea or Concept]
   737   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
Processing 00000000.tx.295: None of the cells co-expressing APP, Fe65 and Tip60 showed nuclear AICD localization (n=15 cells with L-685,458, n=27 cells with DAPT). 

Phrase: "None of the cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0456148:None [Quantitative Concept]
   770   C0549184:None [Quantitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "co-expressing"

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "nuclear AICD localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0475264:Localisation [Functional Concept]
   827   C1744691:localisation [Biologic Function]

Phrase: "(n"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: "=15 cells with L-685,458,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   783   C0347983:cells/L [Quantitative Concept]
   767 E C0022827:cell l [Cell]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "n"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: "=27 cells with DAPT"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.296: In cells with low-to-medium levels of APP expression Fe65 localized to spherical nuclear spots together with Tip60 (n=25 cells), despite the inhibition of nuclear AICD localization (Fig. 6A, upper cell and 6B). 

Phrase: "In cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "with low-to-medium levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "of APP expression Fe65"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1412459:FE65 [Gene or Genome]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "localized to spherical nuclear spots"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0015230:spots [Disease or Syndrome]
   760   C0329155:Spot [Fish]
   760   C0332501:Spherical [Spatial Concept]
   760   C0392752:Localized [Spatial Concept]
   760   C0521447:Nuclear [Spatial Concept]
   760   C0848332:Spots [Sign or Symptom]
   760   C1427618:SPOT [Gene or Genome]
   760   C1705203:Spot [Conceptual Entity]

Phrase: "together with Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "(n"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: "=25 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "despite the inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of nuclear AICD localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0475264:Localisation [Functional Concept]
   827   C1744691:localisation [Biologic Function]

Phrase: "(Fig. 6A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: "upper cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "6B"

Phrase: ")."
Processing 00000000.tx.297: The nuclear localization of Fe65 was prevented in cells with high APP expression (n=17 cells) (Fig. 6A, lower cell); 

Phrase: "The nuclear localization of Fe65"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "was"

Phrase: "prevented in cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756   C0309872:PREVENT [Pharmacologic Substance]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "with high APP expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C1171362:protein expression [Genetic Function]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "(n"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: "=17 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "(Fig. 6A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.298: instead it closely resembled the distribution of APP. 

Phrase: "instead"

Phrase: "it closely"

Phrase: "resembled"

Phrase: "the distribution of APP."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0872250:protein distribution [Cell Function]
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]
Processing 00000000.tx.299: Without the inhibition of -secretase the formation of nuclear spots with spherical AFT-complexes was seen in 69 out of 76 cells expressing all three proteins (Fig. 6C). 

Phrase: "Without the inhibition of -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "the formation of nuclear spots"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "with spherical AFT-complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C1704241:Complexes [Chemical Viewed Structurally]
   771 E C0439855:Complex [Qualitative Concept]

Phrase: "was"

Phrase: "seen in 69"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205397:Seen [Qualitative Concept]
   790   C0450388:69 [Intellectual Product]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "out of 76 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "all three proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 6C"

Phrase: ")."
Processing 00000000.tx.300: View larger version (51K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(51K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.301: 6. 

Phrase: "6."
Processing 00000000.tx.302: Pharmacological inhibition of -secretase processing of APP blocks the formation of nuclear AFT-complexes. 

Phrase: "Pharmacological inhibition of -secretase processing of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0033666:protein processing [Molecular Function]
   742   C1709694:Processing [Activity]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the formation of nuclear AFT-complexes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C1522492:Formation [Functional Concept]
Processing 00000000.tx.303: (A,B) The -secretase inhibitors DAPT and L-685,458 prevented the localization of APP-derived AICD into nuclear AFT-complexes. 

Phrase: "(A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "The -secretase inhibitors DAPT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0634829:dapt [Lipid]

Phrase: "and"

Phrase: "L-685,458"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0915177:L-685,458 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0439394:l's [Quantitative Concept]
   827   C1706495:L- [Intellectual Product]
   827   C3642217:/L [Quantitative Concept]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the localization of APP-derived AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0597704:protein localisation [Cell Function]
   767   C1159772:Protein Localization [Cell Function]
   744   C0475264:Localisation [Functional Concept]
   744   C1744691:localisation [Biologic Function]

Phrase: "into nuclear AFT-complexes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C1704241:Complexes [Chemical Viewed Structurally]
   771 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.304: In cells with lower APP expression Fe65 was targeted to nuclear spots, whereas in cells with high levels of APP, Fe65 was retained at extranuclear localizations of APP including the ER/Golgi and vesicular structures. 

Phrase: "In cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "with lower APP expression Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1412459:FE65 [Gene or Genome]

Phrase: "was"

Phrase: "targeted to nuclear spots,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0015230:spots [Disease or Syndrome]
   770   C0329155:Spot [Fish]
   770   C0521447:Nuclear [Spatial Concept]
   770   C0848332:Spots [Sign or Symptom]
   770   C1427618:SPOT [Gene or Genome]
   770   C1521840:Targeted [Functional Concept]
   770   C1705203:Spot [Conceptual Entity]
   737 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "whereas in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "with high levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "was"

Phrase: "retained at extranuclear localizations of APP"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   750   C0597704:protein localization [Cell Function]
   750   C1159772:Protein Localization [Cell Function]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0333118:Retained [Functional Concept]
   744   C0475264:localizations [Functional Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1709634:Precursor [Idea or Concept]
   711 E C1744691:localization [Biologic Function]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the ER/Golgi"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018042:Golgi [Cell Component]

Phrase: "and"

Phrase: "vesicular structures."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:structures [Spatial Concept]
Processing 00000000.tx.305: (C) Control experiment in the absence of -secretase inhibitors confirmed the formation of APP-derived nuclear AFT-complexes. 

Phrase: "(C) Control experiment in the absence of -secretase inhibitors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0243148:control [Qualitative Concept]
   742   C0681814:Experiment [Research Activity]
   742   C1550141:Control [Substance]
   742   C1706386:Experiment [Conceptual Entity]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C3274648:Control [Qualitative Concept]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "of APP-derived nuclear AFT-complexes."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   850   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   850   C1523872:protein complex [Cell Component]
   791   C1704241:Complexes [Chemical Viewed Structurally]
   758 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.306: Bar, 10 m.  

Phrase: "Bar,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0687760:bar [Manufactured Object]
  1000   C1551065:bar [Quantitative Concept]

Phrase: "10 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.307: Formation of nuclear AFT- and AJT-complexes in differentiated neuroblastoma cells Transient transfections were also done in SH-SY5Y cells differentiated for 10 days with retinoic acid and BDNF. 

Phrase: "Formation of nuclear AFT-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "AJT-complexes in differentiated neuroblastoma cells Transient transfections"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C1704241:Complexes [Chemical Viewed Structurally]
   706 E C0439855:Complex [Qualitative Concept]

Phrase: "were"

Phrase: "also"

Phrase: "done in SH-SY5Y cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0007634:Cells [Cell]
   760   C0038108:SH [Geographic Area]
   760   C1272695:Done [Qualitative Concept]
   760   C2746065:Done [Temporal Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "differentiated for 10 days"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C1547061:10 days [Temporal Concept]
   770   C0007589:Differentiated [Cell Function]
   770   C0205615:Differentiated [Qualitative Concept]
   770   C0439228:days [Temporal Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: "with retinoic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "BDNF."
Processing 00000000.tx.308: In these cells Fe65 was already concentrated in the nucleus without the addition of Tip60 (Fig. 7A). 

Phrase: "In these cells Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412459:FE65 [Gene or Genome]

Phrase: "was"

Phrase: "already"

Phrase: "concentrated in the nucleus"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0007610:Nucleus [Cell Component]
   770   C1880165:Concentrated [Biomedical or Dental Material]
   737 E C1880310:Concentrate [Manufactured Object]
   737 E C2003864:Concentrate [Substance]

Phrase: "without the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "(Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.309: Co-expression of AICD, Fe65 and Tip60 again led to the formation of spherical nuclear spots of AFT-complexes (Fig. 7B). 

Phrase: "Co-expression of AICD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "Tip60 again"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1333931:TIP60 [Gene or Genome]
   861   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1705504:TIP60 [Gene or Genome]

Phrase: "led to the formation of spherical nuclear spots"
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   744   C0015230:spots [Disease or Syndrome]
   744   C0220781:formation [Biologic Function]
   744   C0329155:Spot [Fish]
   744   C0332501:Spherical [Spatial Concept]
   744   C0439634:formation [Spatial Concept]
   744   C0521447:Nuclear [Spatial Concept]
   744   C0848332:Spots [Sign or Symptom]
   744   C1427618:SPOT [Gene or Genome]
   744   C1522492:Formation [Functional Concept]
   744   C1705203:Spot [Conceptual Entity]
   744   C1708698:LED [Manufactured Object]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C1522538:Lead [Functional Concept]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "of AFT-complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1704241:Complexes [Chemical Viewed Structurally]
   779 E C0439855:Complex [Qualitative Concept]

Phrase: "(Fig. 7B"

Phrase: ")."
Processing 00000000.tx.310: As seen in HEK293 cells, Jip1b and X11 had an extranuclear localization leading to a similar localization of AICD. 

Phrase: "As"

Phrase: "seen in HEK293 cells,"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   833   C2936239:HEK293 Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0205397:Seen [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C0042789:see [Organism Function]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1947903:See [Activity]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "Jip1b"

Phrase: "and"

Phrase: "X11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412456:X11 [Gene or Genome]
  1000   C3538726:X11 [Gene or Genome]

Phrase: "had"

Phrase: "an extranuclear localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "leading to a similar localization of AICD."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   748   C0332152:Leading [Temporal Concept]
   748   C0475264:Localisation [Functional Concept]
   748   C0972395:aicd [Medical Device]
   748   C1522538:Leading [Functional Concept]
   748   C1744691:localisation [Biologic Function]
   748   C2348205:Similar [Qualitative Concept]
   748   C2611803:AICD [Cell Function]
   748   C3156099:AICD [Cell Function]
   748   C3537205:AICD [Cell Function]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.311: Co-expression of Tip60 resulted in the relocalization of Jip1 and AICD to nuclear AJT-complexes, with speckle-like morphology (Fig. 7C). 

Phrase: "Co-expression of Tip60"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "resulted in the relocalization of Jip1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C3536909:JUN Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           JUN
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]

Phrase: "and"

Phrase: "AICD to nuclear AJT-complexes,"

Phrase: "with speckle-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0439691:Speckled [Qualitative Concept]

Phrase: "like morphology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0332437:Morphology [Qualitative Concept]
  1000   C0543482:morphology [Spatial Concept]
  1000   C0700329:Morphology, NOS [Finding]
  1000   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "(Fig. 7C"

Phrase: ")."
Processing 00000000.tx.312: Finally, co-expression of full-length APP with Fe65 and Tip60 also resulted in the appearance of AICD in nuclear spots (Fig. 7D). 

Phrase: "Finally,"

Phrase: "co-expression of full-length APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "with Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "Tip60 also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1333931:TIP60 [Gene or Genome]
   861   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1705504:TIP60 [Gene or Genome]

Phrase: "resulted in the appearance of AICD"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0233426:Appearance [Organism Attribute]
   753   C0700364:Appearance [Qualitative Concept]
   753   C0972395:aicd [Medical Device]
   753   C2611803:AICD [Cell Function]
   753   C3156099:AICD [Cell Function]
   753   C3537205:AICD [Cell Function]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "in nuclear spots"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0015230:spots [Disease or Syndrome]
   861   C0329155:Spot [Fish]
   861   C0848332:Spots [Sign or Symptom]
   861   C1427618:SPOT [Gene or Genome]
   861   C1705203:Spot [Conceptual Entity]

Phrase: "(Fig. 7D"

Phrase: ")."
Processing 00000000.tx.313: Thus, cells differentiated into a neuronal phenotype also show the formation of AFT- and AJT-complexes in the nuclear compartment. 

Phrase: "Thus,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "differentiated into a neuronal phenotype also"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0007589:Differentiated [Cell Function]
   753   C0031437:Phenotype [Organism Attribute]
   753   C0205615:Differentiated [Qualitative Concept]
   753   C0521390:Neuronal [Immunologic Factor]
   753   C1285572:Phenotype [Laboratory Procedure]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the formation of AFT-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "AJT-complexes in the nuclear compartment."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1704241:Complexes [Chemical Viewed Structurally]
   711 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.314: View larger version (33K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(33K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.315: 7. 

Phrase: "7."
Processing 00000000.tx.316: Formation of APP-derived nuclear AFT- and AJT-complexes in differentiated human neuroblastoma cells. 

Phrase: "Formation of APP-derived nuclear AFT-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C1327111:amyloid precursor protein formation [Molecular Function]
   757   C0597295:protein formation [Molecular Function]
   739   C0220781:formation [Biologic Function]
   739   C0439634:formation [Spatial Concept]
   739   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "AJT-complexes in differentiated human neuroblastoma cells."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C1704241:Complexes [Chemical Viewed Structurally]
   708 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.317: (A) Nuclear and cytoplasmic localization of Fe65 expressed in SH-SY5Y cells differentiated with retinoic acid and BDNF. 

Phrase: "(A"

Phrase: ")"

Phrase: "Nuclear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: "and"

Phrase: "cytoplasmic localization of Fe65"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "expressed in SH-SY5Y cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C0038108:SH [Geographic Area]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "differentiated with retinoic acid"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0040845:Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   770   C0001128:Acid [Chemical]
   770   C0007589:Differentiated [Cell Function]
   770   C0202406:Acid [Laboratory Procedure]
   770   C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "BDNF."
Processing 00000000.tx.318: (B) Co-expression of Tip60, Fe65 and AICD led to the formation of nuclear AFT-complexes with spherical spot morphology. 

Phrase: "(B) Co-expression of Tip60,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "led to the formation of nuclear AFT-complexes"
Meta Candidates (Total=20; Excluded=6; Pruned=0; Remaining=14)
   739   C0220781:formation [Biologic Function]
   739   C0439634:formation [Spatial Concept]
   739   C0521447:Nuclear [Spatial Concept]
   739   C0972395:aicd [Medical Device]
   739   C1333931:TIP60 [Gene or Genome]
   739   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1412459:FE65 [Gene or Genome]
   739   C1522492:Formation [Functional Concept]
   739   C1704241:Complexes [Chemical Viewed Structurally]
   739   C1705504:TIP60 [Gene or Genome]
   739   C1708698:LED [Manufactured Object]
   739   C2611803:AICD [Cell Function]
   739   C3156099:AICD [Cell Function]
   739   C3537205:AICD [Cell Function]
   706 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   706 E C0439855:Complex [Qualitative Concept]
   706 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   706 E C1522538:Lead [Functional Concept]
   706 E C2348269:Lead [Element, Ion, or Isotope]
   706 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "with spherical spot morphology."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0332437:Morphology [Qualitative Concept]
   827   C0543482:morphology [Spatial Concept]
   827   C0700329:Morphology, NOS [Finding]
   827   C0700619:Morphology [Biomedical Occupation or Discipline]
Processing 00000000.tx.319: (C) Co-expression of Tip60, Jip1b and AICD led to the formation of nuclear AJT-complexes with speckle-like morphology. 

Phrase: "(C) Co-expression of Tip60,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "Jip1b"

Phrase: "and"

Phrase: "AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "led to the formation of nuclear AJT-complexes"
Meta Candidates (Total=19; Excluded=6; Pruned=0; Remaining=13)
   739   C0220781:formation [Biologic Function]
   739   C0439634:formation [Spatial Concept]
   739   C0521447:Nuclear [Spatial Concept]
   739   C0972395:aicd [Medical Device]
   739   C1333931:TIP60 [Gene or Genome]
   739   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1522492:Formation [Functional Concept]
   739   C1704241:Complexes [Chemical Viewed Structurally]
   739   C1705504:TIP60 [Gene or Genome]
   739   C1708698:LED [Manufactured Object]
   739   C2611803:AICD [Cell Function]
   739   C3156099:AICD [Cell Function]
   739   C3537205:AICD [Cell Function]
   706 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   706 E C0439855:Complex [Qualitative Concept]
   706 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   706 E C1522538:Lead [Functional Concept]
   706 E C2348269:Lead [Element, Ion, or Isotope]
   706 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "with speckle-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0439691:Speckled [Qualitative Concept]

Phrase: "like morphology."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0332437:Morphology [Qualitative Concept]
  1000   C0543482:morphology [Spatial Concept]
  1000   C0700329:Morphology, NOS [Finding]
  1000   C0700619:Morphology [Biomedical Occupation or Discipline]
Processing 00000000.tx.320: (D) AICD derived from full-length APP is targeted to nuclear AFT-complexes with spherical spot morphology. 

Phrase: "("

Phrase: "D)"

Phrase: "AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "derived from full-length APP"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0443225:Full [Qualitative Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1441547:Derived [Qualitative Concept]
   748   C1444754:Length [Quantitative Concept]
   748   C1706316:LENGTH [Research Activity]
   748   C1709634:Precursor [Idea or Concept]
   748   C3245521:derived [Idea or Concept]

Phrase: "is"

Phrase: "targeted to nuclear AFT-complexes"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   748   C0521447:Nuclear [Spatial Concept]
   748   C0972395:aicd [Medical Device]
   748   C1333931:TIP60 [Gene or Genome]
   748   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1412459:FE65 [Gene or Genome]
   748   C1521840:Targeted [Functional Concept]
   748   C1704241:Complexes [Chemical Viewed Structurally]
   748   C1705504:TIP60 [Gene or Genome]
   748   C2611803:AICD [Cell Function]
   748   C3156099:AICD [Cell Function]
   748   C3537205:AICD [Cell Function]
   714 E C0439855:Complex [Qualitative Concept]
   714 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "with spherical spot morphology."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0332437:Morphology [Qualitative Concept]
   827   C0543482:morphology [Spatial Concept]
   827   C0700329:Morphology, NOS [Finding]
   827   C0700619:Morphology [Biomedical Occupation or Discipline]
Processing 00000000.tx.321: The inset shows a higher magnification of the soma, with a lower exposure to visualize nuclear spots, which are over-exposed in the overview. 

Phrase: "The inset"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a higher magnification of the soma,"

Phrase: "with a lower exposure to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0332157:Exposure to [Clinical Attribute]
           Exposure
   827   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "visualize"

Phrase: "nuclear spots,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0015230:spots [Disease or Syndrome]
   861   C0329155:Spot [Fish]
   861   C0848332:Spots [Sign or Symptom]
   861   C1427618:SPOT [Gene or Genome]
   861   C1705203:Spot [Conceptual Entity]

Phrase: "which"

Phrase: "are"

Phrase: "over-exposed in the overview."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205136:Over [Spatial Concept]
   760   C0332157:Exposed [Clinical Attribute]
   760   C0814812:overview [Intellectual Product]
Processing 00000000.tx.322: Bar in A: 20 m for A,D; 

Phrase: "Bar in A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0687760:bar [Manufactured Object]
   790   C1551065:bar [Quantitative Concept]

Phrase: ":"

Phrase: "20 m for A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ";"
Processing 00000000.tx.323: 10 m for B,C,D inset.   

Phrase: "10 m for B,C,D inset."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1512018:M.D. [Intellectual Product]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.324: Discussion Top Summary Introduction Materials and Methods Results Discussion References  The results of this study show that the APP-binding adaptor proteins Fe65, Jip1b and X11 (MINT1) differentially regulate the formation of nuclear AICD-containing complexes. 

Phrase: "Discussion Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The results of this study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0683954:results study [Finding]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the APP-binding adaptor proteins Fe65,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C1412459:FE65 [Gene or Genome]
   710   C1456454:Amyloid Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "Jip1b"

Phrase: "and"

Phrase: "X11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412456:X11 [Gene or Genome]
  1000   C3538726:X11 [Gene or Genome]

Phrase: "(MINT1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412456:MINT1 [Gene or Genome]
  1000   C3538726:MINT1 [Gene or Genome]

Phrase: ")"

Phrase: "differentially"

Phrase: "regulate"

Phrase: "the formation of nuclear AICD-containing complexes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]
Processing 00000000.tx.325: Our data also establish that AICD increased the transcription of the AICD-effector genes APP, BACE and Tip60, in addition to GSK3 and KAI1. 

Phrase: "Our data also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "that AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the transcription of the AICD-effector genes APP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0040649:genes transcription [Genetic Function]
           Transcription

Phrase: "BACE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412727:BACE [Gene or Genome]

Phrase: "and"

Phrase: "Tip60,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "in addition to GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "KAI1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0286983:KAI1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812444:KAI1 [Gene or Genome]
  1000   C1705784:KAI1 [Gene or Genome]
Processing 00000000.tx.326: Regulation of nuclear AICD targeting To characterize the cellular trafficking of the APP-derived AICD generated by -secretase, we expressed citrine-AICD fusion proteins representing the S3-cleaved APP C-terminus by using an ecdyson-inducible expression system. 

Phrase: "Regulation of nuclear AICD targeting To"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   820   C2610899:regulation of AICD [Cell Function]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "characterize"

Phrase: "the cellular"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0007634:Cellular [Cell]
  1000   C0178539:Cellular [Functional Concept]
   928 E C1516377:Cellularity [Qualitative Concept]

Phrase: "trafficking of the APP-derived AICD"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0599895:Protein Trafficking [Cell Function]
   767   C1159772:Protein Trafficking [Cell Function]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0599896:trafficking [Cell Function]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0972395:aicd [Medical Device]
   744   C1441547:Derived [Qualitative Concept]
   744   C1709634:Precursor [Idea or Concept]
   744   C2611803:AICD [Cell Function]
   744   C3156099:AICD [Cell Function]
   744   C3245521:derived [Idea or Concept]
   744   C3537205:AICD [Cell Function]

Phrase: "generated by -secretase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C3146294:Generated [Activity]

Phrase: "we"

Phrase: "expressed"

Phrase: "citrine-AICD fusion proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332466:Fusion [Functional Concept]
   812   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "the S3-cleaved APP C-terminus by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an ecdyson-inducible expression system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.327: Co-expression of AICD-adaptor proteins showed that Fe65 or Jip1b targeted the AICD to specific nuclear loci, whereas X11 trapped it in the cytosol. 

Phrase: "Co-expression of AICD-adaptor proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1171362:expression protein [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "or"

Phrase: "Jip1b"

Phrase: "targeted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeted [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "the AICD to specific nuclear loci,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0972395:aicd [Medical Device]
   753   C2611803:AICD [Cell Function]
   753   C3156099:AICD [Cell Function]
   753   C3537205:AICD [Cell Function]

Phrase: "whereas"

Phrase: "X11"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412456:X11 [Gene or Genome]
  1000   C3538726:X11 [Gene or Genome]

Phrase: "trapped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184047:Trapped [Medical Device]

Phrase: "it in the cytosol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1383501:Cytosol [Cell Component]
Processing 00000000.tx.328: Blocking nuclear export showed that Fe65 is actively cycled between nuclear and cytosolic compartments and can transport bound AICD. 

Phrase: "Blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "nuclear export"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0887840:Nuclear Export [Cell Function]
   861   C0699789:Export [Phenomenon or Process]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "is"

Phrase: "actively"

Phrase: "cycled between nuclear"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0521447:Nuclear [Spatial Concept]
   756   C1511572:Cycle [Temporal Concept]

Phrase: "and"

Phrase: "cytosolic compartments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1185625:Compartments [Body Space or Junction]
   861   C1382196:Compartments [Natural Phenomenon or Process]
   827 E C2986730:Compartment [Spatial Concept]

Phrase: "and"

Phrase: "can"

Phrase: "transport"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005528:Transport, NOS [Cell Function]
  1000   C1317949:Transport [Manufactured Object]
  1000   C3495449:transport [Medical Device]

Phrase: "bound AICD."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0972395:aicd [Medical Device]
   861   C2611803:AICD [Cell Function]
   861   C3156099:AICD [Cell Function]
   861   C3537205:AICD [Cell Function]
Processing 00000000.tx.329: Within nuclei Fe65 or Jip1b docked with bound AICD to the histone acetylase Tip60 and formed AICD-containing AFT- or AJT-complexes with clearly distinctive morphologies. 

Phrase: "Within nuclei Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412459:FE65 [Gene or Genome]

Phrase: "or"

Phrase: "Jip1b"

Phrase: "docked with bound AICD"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0332297:bound [Spatial Concept]
   770   C0972395:aicd [Medical Device]
   770   C1145667:Bound [Activity]
   770   C1167622:Bound [Molecular Function]
   770   C1689898:% bound [Quantitative Concept]
   770   C2349209:Bound [Conceptual Entity]
   770   C2611803:AICD [Cell Function]
   770   C3156099:AICD [Cell Function]
   770   C3537205:AICD [Cell Function]
   737   C0330386:Dock [Plant]
   737   C0442632:Dock [Manufactured Object]

Phrase: "to the histone acetylase Tip60"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1333931:TIP60 [Gene or Genome]
   827   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1705504:TIP60 [Gene or Genome]
   734   C0062773:Histone Acetylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "formed AICD-containing AFT-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1333931:TIP60 [Gene or Genome]
   799   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   799   C1705504:TIP60 [Gene or Genome]

Phrase: "or"

Phrase: "AJT-complexes with clearly distinctive morphologies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1704241:Complexes [Chemical Viewed Structurally]
   711 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.330: Nuclear AFT-complexes appeared in multiple homogenous spherical spots, whereas AJT-complexes occupied a significantly lower number of speckle-like structures. 

Phrase: "Nuclear AFT-complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C1704241:Complexes [Chemical Viewed Structurally]
   771 E C0439855:Complex [Qualitative Concept]

Phrase: "appeared in multiple homogenous spherical spots,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0015230:spots [Disease or Syndrome]
   753   C0329155:Spot [Fish]
   753   C0332501:Spherical [Spatial Concept]
   753   C0439064:Multiple [Quantitative Concept]
   753   C0848332:Spots [Sign or Symptom]
   753   C1427618:SPOT [Gene or Genome]
   753   C1705203:Spot [Conceptual Entity]
   719   C0700364:APPEAR [Qualitative Concept]

Phrase: "whereas"

Phrase: "AJT-complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1704241:Complexes [Chemical Viewed Structurally]
   779 E C0439855:Complex [Qualitative Concept]

Phrase: "occupied"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548223:Occupied [Idea or Concept]

Phrase: "a significantly lower number of speckle-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "like structures."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]
Processing 00000000.tx.331: The different morphology of the spherical spots containing AFT-complexes compared with the speckle-like structures containing the AJT-complexes suggests that they might involve the regulation of different sets of genes associated with different cellular functions. 

Phrase: "The different morphology of the spherical spots"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0332437:Morphology [Qualitative Concept]
   748   C0543482:morphology [Spatial Concept]
   748   C0700329:Morphology, NOS [Finding]
   748   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "AFT-complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1704241:Complexes [Chemical Viewed Structurally]
   779 E C0439855:Complex [Qualitative Concept]

Phrase: "compared with the speckle-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Compared [Activity]

Phrase: "like structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the AJT-complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1704241:Complexes [Chemical Viewed Structurally]
   779 E C0439855:Complex [Qualitative Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "they"

Phrase: "might"

Phrase: "involve"

Phrase: "the regulation of different sets of genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0017263:genes regulation [Genetic Function]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "associated with different cellular functions."
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0007613:Cellular Function [Cell Function]
   781   C1292719:Associated function [Functional Concept]
   760   C0007634:Cellular [Cell]
   760   C0178539:Cellular [Functional Concept]
   760   C0542341:Functions [Functional Concept]
   760   C1705242:Different [Qualitative Concept]
   726 E C0031843:function [Physiologic Function]
   726 E C0700205:FUNCTION [Classification]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1705273:Function [Intellectual Product]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.332: The precise functions of AFT- and AJT-complexes are unknown, but our measurements indicated that the nuclear structures containing these complexes are very large, consistent with the possibility that they contain additional proteins or DNA required for transcriptional activity. 

Phrase: "The precise functions of AFT-"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0542341:Functions [Functional Concept]
   714 E C0031843:function [Physiologic Function]
   714 E C0700205:FUNCTION [Classification]
   714 E C1705273:Function [Intellectual Product]

Phrase: "and"

Phrase: "AJT-complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1704241:Complexes [Chemical Viewed Structurally]
   779 E C0439855:Complex [Qualitative Concept]

Phrase: "are"

Phrase: "unknown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]

Phrase: "but"

Phrase: "our measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:measurements [Functional Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "the nuclear structures"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1518439:Nuclear Structure [Cell Component]
   861   C0521447:Nuclear [Spatial Concept]
   861   C0678594:structures [Spatial Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "these complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704241:Complexes [Chemical Viewed Structurally]
   966 E C0439855:Complex [Qualitative Concept]

Phrase: "are"

Phrase: "very large, consistent with the possibility"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that"

Phrase: "they"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "additional proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "required for transcriptional activity."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0040649:Transcriptional [Genetic Function]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1514873:Required [Functional Concept]
   770   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.333: Both FRET and IP analyses illustrated the close molecular interaction of AICD with Tip60 in the nuclear complexes. 

Phrase: "Both FRET"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0597717:Fluorescence Resonance Energy Transfer [Laboratory Procedure]
   861   C0014274:Energy Transfer [Molecular Function]
   812   C0016315:Fluorescence [Natural Phenomenon or Process]
   812   C0040671:Transfer [Mental Process]
   812   C0231881:Resonance [Finding]
   812   C0424589:Energy [Finding]
   812   C0459800:resonance [Natural Phenomenon or Process]
   812   C0542479:Energy [Natural Phenomenon or Process]
   812   C0684213:Resonance [Qualitative Concept]
   812   C1442080:Energy [Quantitative Concept]
   812   C1705822:Transfer [Activity]
   741 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   741 E C0577554:Resonant [Qualitative Concept]

Phrase: "and"

Phrase: "IP analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "illustrated"

Phrase: "the close molecular interaction of AICD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1167622:Molecular Interaction [Molecular Function]
   753   C1704675:Interaction [Functional Concept]

Phrase: "with Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "in the nuclear complexes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1704241:Complexes [Chemical Viewed Structurally]
   827 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.334: Additional studies are required to determine whether they represent sites of active transcription. 

Phrase: "Additional studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "they"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "sites of active transcription."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   819   C0205681:Sites, Active [Functional Concept]
   816   C2945843:Site of [Qualitative Concept]
   770   C0205145:Sites [Spatial Concept]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.335: The differential effects on nuclear targeting of AICD are consistent with data from yeast Gal4 transactivation experiments that showed transactivation activity for AICD together with either Fe65 or Jip1b, and inhibitory activities of X11 (Cao and Sudhof, 2001; Biederer et al., 2002; Scheinfeld et al., 2003). 

Phrase: "The differential effects on nuclear targeting of AICD"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "are"

Phrase: "consistent with data"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "from yeast Gal4 transactivation experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "that"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "transactivation activity for AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "together with either Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412459:FE65 [Gene or Genome]

Phrase: "or"

Phrase: "Jip1b,"

Phrase: "and"

Phrase: "inhibitory activities of X11"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441655:Activities [Activity]
   737 E C0205177:Activity [Functional Concept]
   737 E C0439167:% activity [Quantitative Concept]
   737 E C1561536:*Activity [Idea or Concept]

Phrase: "(Cao"

Phrase: "and"

Phrase: "Sudhof,"

Phrase: "2001"

Phrase: "; Biederer et al.,"

Phrase: "2002"

Phrase: "; Scheinfeld et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.336: The nuclear translocation of intracellular domains liberated from membranes by -secretase is an emerging concept underscored by the fact that both Notch and N-cadherin use this pathway for signaling from the cell surface to the nucleus to regulate transcription (Schroeter et al., 1998; Marambaud et al., 2003). 

Phrase: "The nuclear translocation of intracellular domains"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1518440:Nuclear Translocation [Molecular Function]
   783   C0599813:Intracellular translocation [Cell Function]
   753   C0040715:Translocation [Cell or Molecular Dysfunction]
   753   C2987521:Translocation [Activity]

Phrase: "liberated from membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0025255:Membranes [Tissue]
   756 E C0596901:Membrane [Cell Component]
   756 E C1706182:Membrane [Manufactured Object]
   706 E C0205287:Membranous [Qualitative Concept]

Phrase: "by -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "an emerging concept"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0178566:concept [Idea or Concept]

Phrase: "underscored by the fact"

Phrase: "that"

Phrase: "both Notch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1235660:Notch [Body Space or Junction]

Phrase: "and"

Phrase: "N-cadherin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0027215:N-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413277:N-CADHERIN [Gene or Genome]
   861   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1413274:cadherin [Gene or Genome]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "this pathway for signaling"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0037080:pathway signaling [Molecular Function]
   819   C0037083:signaling pathway [Cell Function]
   819   C0086982:Signaling Pathway [Molecular Function]
   770   C1704259:Pathway [Molecular Function]
   770   C1705987:Pathway [Conceptual Entity]

Phrase: "from the cell surface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0699040:Cell surface [Cell Component]
   861   C0205148:Surface [Spatial Concept]

Phrase: "to the nucleus to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0007610:Nucleus [Cell Component]

Phrase: "regulate"

Phrase: "transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]

Phrase: "(Schroeter et al.,"

Phrase: "1998"

Phrase: "; Marambaud et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.337: Full-length APP functions in nuclear signaling Our results show that the AICD generated from full-length APP by -cleavage at the plasma membrane (Cupers et al., 2001b) can be transported to the nucleus by Fe65, and docked onto Tip60 both in HEK293 and differentiated SH-SY5Y cells, suggesting the possibility that APP also functions in nuclear signaling in neuronal cells. 

Phrase: "Full-length APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "functions in nuclear signaling"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0031843:function [Physiologic Function]
   770   C0037083:Signaling [Cell Function]
   770   C0521447:Nuclear [Spatial Concept]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]
   770   C3537152:signaling [Biologic Function]

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "generated from full-length APP"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0443225:Full [Qualitative Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1444754:Length [Quantitative Concept]
   748   C1706316:LENGTH [Research Activity]
   748   C1709634:Precursor [Idea or Concept]
   748   C3146294:Generated [Activity]

Phrase: "by -cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]

Phrase: "at the plasma membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "(Cupers et al.,"

Phrase: "2001b"

Phrase: ")"

Phrase: "can"

Phrase: "be"

Phrase: "transported to the nucleus"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   816   C1550030:Transport To [Idea or Concept]
   802   C1526989:nucleus transport [Cell Function]
   770   C0007610:Nucleus [Cell Component]
   737   C0005528:Transport, NOS [Cell Function]
   737   C1317949:Transport [Manufactured Object]
   737   C3495449:transport [Medical Device]

Phrase: "by Fe65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "docked onto Tip60"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1333931:TIP60 [Gene or Genome]
   790   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1705504:TIP60 [Gene or Genome]
   756   C0330386:Dock [Plant]
   756   C0442632:Dock [Manufactured Object]

Phrase: "both in HEK293"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0238767:Both [Spatial Concept]
   790   C1706086:Both [Qualitative Concept]

Phrase: "and"

Phrase: "differentiated SH-SY5Y cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the possibility"

Phrase: "that APP also"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "functions in nuclear signaling"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0031843:function [Physiologic Function]
   770   C0037083:Signaling [Cell Function]
   770   C0521447:Nuclear [Spatial Concept]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]
   770   C3537152:signaling [Biologic Function]

Phrase: "in neuronal cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.338: Neurons express high endogenous levels of APP, Fe65 and Tip60 (Card et al., 1988; Hu et al., 1999; Ran and Pereira-Smith, 2000; Russo et al., 1998; Shivers et al., 1988), and neurons process APP to form AICD. 

Phrase: "Neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "express"

Phrase: "high endogenous levels of APP,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0428479:Protein level [Laboratory or Test Result]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "(Card et al.,"

Phrase: "1988"

Phrase: "; Hu et al.,"

Phrase: "1999"

Phrase: "; Ran"

Phrase: "and"

Phrase: "Pereira-Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0554249:Smith [Professional or Occupational Group]

Phrase: "2000"

Phrase: "; Russo et al.,"

Phrase: "1998"

Phrase: "; Shivers et al.,"

Phrase: "1988"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "neurons process APP to"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   861   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   858   C0033666:process protein [Molecular Function]
   839   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0011560:Amyloid [Pathologic Function]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1709634:Precursor [Idea or Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "AICD."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]
Processing 00000000.tx.339: It is therefore conceivable that neurons can form AFT- and AJT-complexes. 

Phrase: "It"

Phrase: "is"

Phrase: "therefore conceivable"

Phrase: "that neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "can"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "AFT-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1333931:TIP60 [Gene or Genome]
   827   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1705504:TIP60 [Gene or Genome]

Phrase: "and"

Phrase: "AJT-complexes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1704241:Complexes [Chemical Viewed Structurally]
   779 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.340: Despite the fact that recent experiments claimed the presence of intranuclear AICD in neurons (Kimberly et al., 2001), many previous attempts to localize AICD immunohistochemically in nuclei of neuronal cells or brain tissue sections failed. 

Phrase: "Despite the fact"

Phrase: "that recent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "claimed"

Phrase: "the presence of intranuclear AICD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(Kimberly et al.,"

Phrase: "2001"

Phrase: ")"

Phrase: ","

Phrase: "many previous attempts to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1516084:Attempt [Event]

Phrase: "localize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:localize [Spatial Concept]

Phrase: "AICD immunohistochemically in nuclei of neuronal cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0972395:aicd [Medical Device]
   748   C2611803:AICD [Cell Function]
   748   C3156099:AICD [Cell Function]
   748   C3537205:AICD [Cell Function]

Phrase: "or"

Phrase: "brain tissue sections"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   884   C2316368:Tissue section [Tissue]
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]
   734   C0440746:Brain tissue [Tissue]
   734   C0459385:Brain tissue [Body Part, Organ, or Organ Component]

Phrase: "failed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]
Processing 00000000.tx.341: The reasons for this absence of antibody staining could involve sensitivity issues, as well as the short half-life of free cytosolic AICD, but our results offer an alternative explanation. 

Phrase: "The reasons for this absence of antibody staining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0392360:reasons [Idea or Concept]

Phrase: "could"

Phrase: "involve"

Phrase: "sensitivity issues,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033213:Issue [Finding]
   827   C1706387:Issue [Intellectual Product]

Phrase: "as well as"

Phrase: "the short half-life of free cytosolic AICD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0018517:Half-Life [Temporal Concept]
   744   C0376558:Life [Idea or Concept]
   744   C2825407:Half [Quantitative Concept]

Phrase: "but"

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "offer"

Phrase: "an alternative explanation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0681841:Explanation [Intellectual Product]
Processing 00000000.tx.342: Our APP-derived AICD with a tandem HA-citrine tag allowed us to localize nuclear AICD via the direct citrine fluorescence, while antibodies against the HA tag at the C-terminus clearly bound to AICD in the cytoplasm, but not to the nuclear AFT-complexes. 

Phrase: "Our APP-derived AICD with a tandem HA-citrine tag"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   736   C0972395:aicd [Medical Device]
   736   C2611803:AICD [Cell Function]
   736   C3156099:AICD [Cell Function]
   736   C3537205:AICD [Cell Function]

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "localize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:localize [Spatial Concept]

Phrase: "nuclear AICD via the direct citrine fluorescence,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0972395:aicd [Medical Device]
   748   C2611803:AICD [Cell Function]
   748   C3156099:AICD [Cell Function]
   748   C3537205:AICD [Cell Function]

Phrase: "while"

Phrase: "antibodies against the HA tag"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "at the C-terminus clearly"

Phrase: "bound to AICD"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0332297:bound [Spatial Concept]
   790   C0972395:aicd [Medical Device]
   790   C1145667:Bound [Activity]
   790   C1167622:Bound [Molecular Function]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]
   790   C2611803:AICD [Cell Function]
   790   C3156099:AICD [Cell Function]
   790   C3537205:AICD [Cell Function]

Phrase: "in the cytoplasm,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010834:Cytoplasm [Cell Component]
   928 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "but"

Phrase: "not to the nuclear AFT-complexes."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   744   C0521447:Nuclear [Spatial Concept]
   744   C0972395:aicd [Medical Device]
   744   C1333931:TIP60 [Gene or Genome]
   744   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1412459:FE65 [Gene or Genome]
   744   C1518422:Not [Functional Concept]
   744   C1704241:Complexes [Chemical Viewed Structurally]
   744   C1705504:TIP60 [Gene or Genome]
   744   C2611803:AICD [Cell Function]
   744   C3156099:AICD [Cell Function]
   744   C3537205:AICD [Cell Function]
   711 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.343: These data suggest that nuclear complex formation with Tip60 and Fe65 prevents antibody access to AICD. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that nuclear complex formation with Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "antibody access to AICD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0444454:Access [Spatial Concept]
   770   C1554204:access [Idea or Concept]
Processing 00000000.tx.344: Therefore, either more elaborate protocols for tissue permeabilization or transgenic approaches with fluorescent APP fusion proteins are required to show nuclear AICD complexes in vivo. 

Phrase: "Therefore,"

Phrase: "either more"

Phrase: "elaborate"

Phrase: "protocols for tissue permeabilization"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0442711:Protocols [Intellectual Product]
   737 E C1507394:Protocol [Intellectual Product]
   737 E C1522729:Protocol [Intellectual Product]
   737 E C2348563:Protocol [Intellectual Product]

Phrase: "or"

Phrase: "transgenic approaches with fluorescent APP fusion proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0449445:Approaches [Spatial Concept]
   742   C1292724:Approaches [Functional Concept]

Phrase: "are"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "nuclear AICD complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1704241:Complexes [Chemical Viewed Structurally]
   793 E C0439855:Complex [Qualitative Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.345: AICD-dependent regulation of gene expression To test the hypothesis that AICD controls genes involved in the regulation of cellular levels of APP, we analyzed transcripts encoding APP upon induced expression of AICD. 

Phrase: "AICD-dependent regulation of gene expression To"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C0017263:Regulation of Gene Expression [Genetic Function]
           Gene Expression Regulation
           Gene Regulation
   804   C2610899:regulation of AICD [Cell Function]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "involved in the regulation of cellular levels of APP,"
Meta Candidates (Total=20; Excluded=3; Pruned=0; Remaining=17)
   775   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   775   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   756   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C0596286:Cellular Regulation [Cell Function]
   754   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   738   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0007634:Cellular [Cell]
   738   C0011560:Amyloid [Pathologic Function]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0178539:Cellular [Functional Concept]
   738   C0441889:Levels [Qualitative Concept]
   738   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0851285:Regulation [Governmental or Regulatory Activity]
   738   C1314939:Involved [Functional Concept]
   738   C1327622:Regulation [Biologic Function]
   738   C1709634:Precursor [Idea or Concept]
   737   C0428479:Protein level [Laboratory or Test Result]
   704 E C0456079:Level [Classification]
   704 E C1547707:Level [Geographic Area]
   704 E C2946261:Level [Pharmacologic Substance]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "APP upon induced expression of AICD."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1171362:expression protein [Genetic Function]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.346: By using clonal cell lines with inducible expression constructs, we generated two mRNA populations differing only in the expression of AICD and its putative downstream effector genes. 

Phrase: "By"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "clonal cell lines with inducible expression constructs,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   778   C0007600:Cell lines [Cell]
   748   C0007634:Cell [Cell]
   748   C0205132:lines [Spatial Concept]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   743   C0009013:Clone Cell [Cell]
   714 E C1550648:Line [Substance]
   714 E C1552960:Line [Quantitative Concept]

Phrase: "we"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "two mRNA populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]

Phrase: "differing"

Phrase: "only in the expression of AICD"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0205171:Only [Quantitative Concept]
   753   C0972395:aicd [Medical Device]
   753   C1720467:Only [Intellectual Product]
   753   C2611803:AICD [Cell Function]
   753   C3156099:AICD [Cell Function]
   753   C3537205:AICD [Cell Function]

Phrase: "and"

Phrase: "its putative downstream effector genes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.347: These experiments clearly showed that AICD upregulated the expression of the APP genes as part of a positive feedback mechanism, by which APP senses its own endoproteolysis and upregulates its expression to replenish full-length APP. 

Phrase: "These experiments clearly"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "upregulated"

Phrase: "the expression of the APP genes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1171362:expression protein [Genetic Function]
   750   C0017262:Gene Expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "as part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "of a positive feedback mechanism,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0015744:Feedback [Phenomenon or Process]
   827   C0439178:% Positive [Quantitative Concept]
   827   C0441712:Mechanism [Functional Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C1706376:Mechanism [Manufactured Object]
   827   C2825490:Positive [Qualitative Concept]
   827   C2911691:Feedback [Mental Process]

Phrase: "by which APP senses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0036658:senses [Organ or Tissue Function]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "its own endoproteolysis"

Phrase: "and"

Phrase: "upregulates"

Phrase: "its expression to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "replenish"

Phrase: "full-length APP."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.348: We next tested the hypothesis that AICD regulates the expression of enzymes involved in its generation and established that AICD upregulates the gene encoding the -site APP cleaving enzyme (BACE), but not the -secretase-complex protein PSEN1 or ADAM10, one of the proposed -secretases (Vassar et al., 1999; Edbauer et al., 2003; Lammich et al., 1999). 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "regulates"

Phrase: "the expression of enzymes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "involved in its generation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0079411:Generation [Temporal Concept]
   770   C1314939:Involved [Functional Concept]
   770   C3146294:Generation [Activity]

Phrase: "and"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "that AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "upregulates"

Phrase: "the gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the -site APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "cleaving"

Phrase: "enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "(BACE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412727:BACE [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the -secretase-complex protein PSEN1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1418985:PSEN1 [Gene or Genome]

Phrase: "or"

Phrase: "ADAM10,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412181:ADAM10 [Gene or Genome]
  1000   C2984597:ADAM 10 [Amino Acid, Peptide, or Protein]

Phrase: "one of the proposed -secretases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "(Vassar et al.,"

Phrase: "1999"

Phrase: "; Edbauer et al.,"

Phrase: "2003"

Phrase: "; Lammich et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.349: To be functionally meaningful for nuclear signaling, this positive feedback amplification of AICD should be associated with increased levels of the components of the nuclear AFT-complex. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "functionally meaningful for nuclear signaling,"

Phrase: "this positive feedback amplification of AICD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1517480:Amplification [Molecular Biology Research Technique]
   753   C1521871:Amplification [Phenomenon or Process]
   753   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "should"

Phrase: "be"

Phrase: "associated with increased levels of the components"
Meta Candidates (Total=12; Excluded=6; Pruned=0; Remaining=6)
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0205217:Increased [Quantitative Concept]
   748   C0441889:Levels [Qualitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C0449432:Components [Manufactured Object]
   714 E C0456079:Level [Classification]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1547707:Level [Geographic Area]
   714 E C1705248:Component [Conceptual Entity]
   714 E C1706221:Associate [Professional or Occupational Group]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "of the nuclear AFT-complex."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0439855:Complex [Qualitative Concept]
   804   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.350: Therefore, in the same cells we analyzed the expression of Tip60 and Fe65 and found that AICD also increased the expression of Tip60. 

Phrase: "Therefore,"

Phrase: "in the same cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the expression of Tip60"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that AICD also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0972395:aicd [Medical Device]
   861   C2611803:AICD [Cell Function]
   861   C3156099:AICD [Cell Function]
   861   C3537205:AICD [Cell Function]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the expression of Tip60."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.351: These data could explain the recent observation of increased Tip60 in APP transgenic mice (Baek et al., 2002). 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "could"

Phrase: "explain"

Phrase: "the recent observation of increased Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0302523:Observation [Research Activity]
   753   C0700325:observation [Health Care Activity]
   753   C1964257:Observation [Diagnostic Procedure]

Phrase: "in APP transgenic mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0025936:Mice, Transgenic [Mammal]
   804   C0003069:Transgenic [Animal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "(Baek et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.352: In the same cell lines, we were able to confirm the previously reported AICD-dependent induction of KAI-1 and GSK3 (Baek et al., 2002; Kim et al., 2003). 

Phrase: "In the same cell lines,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "we"

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the previously reported AICD-dependent induction of KAI-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205263:Induction [Functional Concept]
   742   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0244989:GSK3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Baek et al.,"

Phrase: "2002"

Phrase: "; Kim et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.353: Together, these results establish that APP not only regulates its own expression but also the expression of several genes involved in its processing and cellular function. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "that APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "regulates"

Phrase: "its own expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "but"

Phrase: "also"

Phrase: "the expression of several genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0017262:Gene Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "involved in its processing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1314939:Involved [Functional Concept]
   770   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "cellular function."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0007613:Cellular Function [Cell Function]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.354: Importantly, the NICD-effector gene Hes1 of the Notch signaling pathway, which is also regulated by -secretase, was unaffected by AICD. 

Phrase: "Importantly,"

Phrase: "the NICD-effector gene Hes1 of the Notch signaling pathway,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1415725:HES1 gene [Gene or Genome]
           HES1
   739   C1412958:HES1 [Gene or Genome]

Phrase: "which"

Phrase: "is"

Phrase: "also"

Phrase: "regulated by -secretase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "was"

Phrase: "unaffected by AICD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2986417:Unaffected [Conceptual Entity]
Processing 00000000.tx.355: From these data we cannot exclude the possibility that the effect of AICD on transcription is indirect, i.e. by influencing the nuclear signaling of other pathways controlling transcription. 

Phrase: "From these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "we"

Phrase: "cannot"

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the possibility"

Phrase: "that"

Phrase: "the effect of AICD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]

Phrase: "is"

Phrase: "indirect, i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "by influencing"

Phrase: "the nuclear signaling of other pathways"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   783   C0037080:pathways signaling [Molecular Function]
   767 E C0037083:signaling pathway [Cell Function]
           Signaling
   767 E C0086982:Signaling Pathway [Molecular Function]
   753   C3537152:signaling [Biologic Function]

Phrase: "controlling"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332298:controlling [Functional Concept]
  1000   C2587213:Controlling [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]

Phrase: "transcription."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]
Processing 00000000.tx.356: Nevertheless, Cao and Sdhof (Cao and Sdhof, 2001) have shown a transcription-activating activity for AICD bound to Fe65, and we show the colocalization of AICD together with Fe65 and Tip60 in discrete nuclear spots. 

Phrase: "Nevertheless,"

Phrase: "Cao"

Phrase: "and"

Phrase: "Sdhof"

Phrase: "(Cao"

Phrase: "and"

Phrase: "Sdhof,"

Phrase: "2001"

Phrase: ")"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a transcription-activating activity for AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "bound to Fe65,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0332297:bound [Spatial Concept]
   790   C1145667:Bound [Activity]
   790   C1167622:Bound [Molecular Function]
   790   C1412459:FE65 [Gene or Genome]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]

Phrase: "and"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the colocalization of AICD"

Phrase: "together with Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "Tip60 in discrete nuclear spots."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1333931:TIP60 [Gene or Genome]
   760   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1705504:TIP60 [Gene or Genome]
Processing 00000000.tx.357: If the average number of 32 AFT-complex-containing nuclear spots and 11 AJT-complex-containing speckles are related to the number of AICD-regulated genes, it is probable that more than the above genes are regulated by APP signaling. 

Phrase: "If"

Phrase: "the average number of 32 AFT-complex-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1880155:Complex Number [Quantitative Concept]
   742   C0237753:*Number [Quantitative Concept]
   742   C0449788:Number [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "nuclear spots"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0015230:spots [Disease or Syndrome]
   861   C0329155:Spot [Fish]
   861   C0848332:Spots [Sign or Symptom]
   861   C1427618:SPOT [Gene or Genome]
   861   C1705203:Spot [Conceptual Entity]

Phrase: "and"

Phrase: "11 AJT-complex-containing speckles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   712   C0439691:Speckled [Qualitative Concept]

Phrase: "are"

Phrase: "related to the number of AICD-regulated genes,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   744   C0017337:Genes [Gene or Genome]
   744   C0237753:*Number [Quantitative Concept]
   744   C0439849:Related [Qualitative Concept]
   744   C0445223:Related [Finding]
   744   C0449788:Number [Quantitative Concept]
   744   C0851285:Regulated [Governmental or Regulatory Activity]
   744   C0972395:aicd [Medical Device]
   744   C2611803:AICD [Cell Function]
   744   C3156099:AICD [Cell Function]
   744   C3537205:AICD [Cell Function]
   711 E C0163712:Relate [Organic Chemical]

Phrase: "it"

Phrase: "is"

Phrase: "probable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033204:Probable [Quantitative Concept]
  1000   C0332148:Probable [Qualitative Concept]

Phrase: "that more than the above genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017337:Genes [Gene or Genome]

Phrase: "are"

Phrase: "regulated by APP signaling."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1335962:Signaling Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0037083:Signaling [Cell Function]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   753   C1709634:Precursor [Idea or Concept]
   753   C3537152:signaling [Biologic Function]
Processing 00000000.tx.358: The increase in APP transcripts is accompanied by increased levels of protein. 

Phrase: "The increase in APP transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "is"

Phrase: "accompanied by increased levels of protein."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   767   C0428479:Protein level [Laboratory or Test Result]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205217:Increased [Quantitative Concept]
   753   C0441889:Levels [Qualitative Concept]
   753   C0442805:Increased [Functional Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.359: In particular, C-terminal stubs were significantly increased in parallel to the induced expression of AICD. 

Phrase: "In particular, C-terminal stubs"

Phrase: "were"

Phrase: "significantly"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "in parallel to the induced expression of AICD."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0150312:In [Quantitative Concept]
   744   C0332285:In [Spatial Concept]
   744   C2348042:Parallel [Qualitative Concept]
   744   C2826345:PARALLEL [Research Activity]
Processing 00000000.tx.360: The fact that steady-state levels of full-length APP did not increase significantly in this condition is probably related to the observed concomitant increase in BACE expression, which is expected to increase the turnover of full-length APP; 

Phrase: "The fact"

Phrase: "that steady-state levels of full-length APP"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   760   C0678587:steady state [Natural Phenomenon or Process]
   743   C0683927:state level [Spatial Concept]
   741   C0428479:Protein level [Laboratory or Test Result]
   739   C0205361:Steady [Qualitative Concept]
   739   C0441889:Levels [Qualitative Concept]
   739   C1301808:State [Geographic Area]
   739   C1442792:State [Functional Concept]
   739   C3148680:State [Geographic Area]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "significantly in this condition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0012634:condition [Disease or Syndrome]
   770   C0348080:Condition [Qualitative Concept]
   770   C1705253:Condition [Conceptual Entity]

Phrase: "is"

Phrase: "probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "related to the observed concomitant increase"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0439849:Related [Qualitative Concept]
   753   C0442805:Increase [Functional Concept]
   753   C0445223:Related [Finding]
   753   C0521115:Concomitant [Temporal Concept]
   753   C1441672:Observed [Functional Concept]
   719 E C0163712:Relate [Organic Chemical]

Phrase: "in BACE expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "which"

Phrase: "is"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the turnover of full-length APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0597297:Protein Turnover [Molecular Function]
   744   C0031227:turnover [Quantitative Concept]
   744   C0243127:turnover [Functional Concept]
   744   C0443331:Turnover [Health Care Activity]

Phrase: ";"
Processing 00000000.tx.361: a similar mechanism may be involved in the observed increased generation of -stubs. 

Phrase: "a similar mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "may"

Phrase: "be"

Phrase: "involved in the observed increased generation of -stubs."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0079411:Generation [Temporal Concept]
   744   C0205217:Increased [Quantitative Concept]
   744   C0442805:Increased [Functional Concept]
   744   C1314939:Involved [Functional Concept]
   744   C1441672:Observed [Functional Concept]
   744   C3146294:Generation [Activity]
Processing 00000000.tx.362: Together, these data are consistent with the idea that the steady-state levels of APP are maintained at constant cellular concentrations under physiological conditions. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "consistent with the idea"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that"

Phrase: "the steady-state levels of APP"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   770   C0678587:steady state [Natural Phenomenon or Process]
   754   C0683927:state level [Spatial Concept]
   750   C0428479:Protein level [Laboratory or Test Result]
   744   C0205361:Steady [Qualitative Concept]
   744   C0441889:Levels [Qualitative Concept]
   744   C1301808:State [Geographic Area]
   744   C1442792:State [Functional Concept]
   744   C3148680:State [Geographic Area]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "maintained at constant cellular concentrations"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0007634:Cellular [Cell]
   760   C0086045:Concentrations [Mental Process]
   760   C0178539:Cellular [Functional Concept]
   760   C1314677:Maintained [Functional Concept]
   760   C1547014:*Constant [Quantitative Concept]
   760   C1948059:Constant [Qualitative Concept]
   726 E C0024501:Maintain [Activity]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "under physiological conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.363: The life cycle of APP therefore encompasses a feedback mechanism of synthesis, subcellular sorting, proteolytic cleavages and finally nuclear signaling and transcriptional activation of APP by AICD. 

Phrase: "The life cycle of APP therefore"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0023675:Life Cycle [Temporal Concept]
   744   C0376558:Life [Idea or Concept]
   744   C1511572:Cycle [Temporal Concept]

Phrase: "encompasses"

Phrase: "a feedback mechanism of synthesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "subcellular sorting,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0237886:Sorting [Mental Process]
   861   C0700314:sorting [Cell Function]
   861   C1947906:Sorting [Activity]

Phrase: "proteolytic cleavages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0010813:cleavage [Cell Function]
   827   C0596311:Cleavage [Phenomenon or Process]
   827   C1330957:cleavage [Cell Function]

Phrase: "and"

Phrase: "finally nuclear signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037083:Signaling [Cell Function]
   827   C3537152:signaling [Biologic Function]

Phrase: "and"

Phrase: "transcriptional activation of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0162493:Transcriptional Activation [Genetic Function]
   783   C0599177:protein activation [Genetic Function]
   753   C1879547:Activation [Activity]

Phrase: "by AICD."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]
Processing 00000000.tx.364: The additional cellular effects of the AICD-induced increase in APP turnover remain to be determined. 

Phrase: "The additional cellular effects of the AICD-induced increase"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C1280500:effects [Qualitative Concept]
   708 E C2348382:Effect [Qualitative Concept]

Phrase: "in APP turnover"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0597297:Protein Turnover [Molecular Function]
   812   C0031227:turnover [Quantitative Concept]
   812   C0243127:turnover [Functional Concept]
   812   C0443331:Turnover [Health Care Activity]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "remain"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "determined."
Processing 00000000.tx.365: Role of -secretase processing in nuclear signaling The nuclear translocation of intracellular domains liberated from membranes by -secretase is an emerging concept for signaling from the cell surface to the nucleus, to regulate gene transcription. 

Phrase: "Role of -secretase processing in nuclear signaling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1709694:Processing [Activity]

Phrase: "The nuclear translocation of intracellular domains"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1518440:Nuclear Translocation [Molecular Function]
   783   C0599813:Intracellular translocation [Cell Function]
   753   C0040715:Translocation [Cell or Molecular Dysfunction]
   753   C2987521:Translocation [Activity]

Phrase: "liberated from membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0025255:Membranes [Tissue]
   756 E C0596901:Membrane [Cell Component]
   756 E C1706182:Membrane [Manufactured Object]
   706 E C0205287:Membranous [Qualitative Concept]

Phrase: "by -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "an emerging concept for signaling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0178566:concept [Idea or Concept]

Phrase: "from the cell surface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0699040:Cell surface [Cell Component]
   861   C0205148:Surface [Spatial Concept]

Phrase: "to the nucleus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "regulate"

Phrase: "gene transcription."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040649:Gene Transcription [Genetic Function]
           Transcription
Processing 00000000.tx.366: The intracellular domains cleaved from the membrane-bound precursors Notch, ErbB4, Neuregulin1, LRP, N-cadherin APLP1, APLP2 and APP translocate to nuclei, and transactivation activity was shown for Notch, Delta 1, Neuregulin1, N-cadherin, APLP1, APLP2 and APP (Bao et al., 2003; Ikeuchi and Sisodia, 2003; Kimberly et al., 2001; Kinoshita et al., 2002; Kinoshita et al., 2003; Marambaud et al., 2003; May et al., 2002; Ni et al., 2001; Scheinfeld et al., 2002a; Schroeter et al., 1998; Walsh et al., 2003). 

Phrase: "The intracellular domains"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0175996:intracellular [Cell Component]
   861   C0178719:Intracellular [Spatial Concept]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "cleaved from the membrane-bound precursors Notch,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   748   C0025255:Membrane [Tissue]
   748   C0205242:Cleaved [Spatial Concept]
   748   C0332297:bound [Spatial Concept]
   748   C0333853:Cleaved [Cell]
   748   C0596901:Membrane [Cell Component]
   748   C1145667:Bound [Activity]
   748   C1167622:Bound [Molecular Function]
   748   C1235660:Notch [Body Space or Junction]
   748   C1689898:% bound [Quantitative Concept]
   748   C1706182:Membrane [Manufactured Object]
   748   C2349209:Bound [Conceptual Entity]
   714   C1709634:Precursor [Idea or Concept]

Phrase: "ErbB4,"

Phrase: "Neuregulin1,"

Phrase: "LRP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "N-cadherin APLP1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1412466:APLP1 [Gene or Genome]
   734   C0027215:N-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1413277:N-CADHERIN [Gene or Genome]

Phrase: "APLP2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412467:APLP2 [Gene or Genome]

Phrase: "and"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "translocate to nuclei,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0007610:Nucleus [Cell Component]

Phrase: "and"

Phrase: "transactivation activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "shown for Notch,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1235660:Notch [Body Space or Junction]
   756   C1547282:Show [Intellectual Product]

Phrase: "Delta 1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0439097:Delta [Intellectual Product]
   861   C1705241:Delta [Quantitative Concept]
   861   C3146239:Delta [Eukaryote]
   861   C3538806:DELTA [Spatial Concept]
   861   C3540585:DELTA [Gene or Genome]

Phrase: "Neuregulin1,"

Phrase: "N-cadherin,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0027215:N-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1413277:N-CADHERIN [Gene or Genome]
   861   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1413274:cadherin [Gene or Genome]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "APLP1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412466:APLP1 [Gene or Genome]

Phrase: "APLP2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412467:APLP2 [Gene or Genome]

Phrase: "and"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "(Bao et al.,"

Phrase: "2003"

Phrase: "; Ikeuchi"

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "2003"

Phrase: "; Kimberly et al.,"

Phrase: "2001"

Phrase: "; Kinoshita et al.,"

Phrase: "2002"

Phrase: "; Kinoshita et al.,"

Phrase: "2003"

Phrase: "; Marambaud et al.,"

Phrase: "2003"

Phrase: "; May et al.,"

Phrase: "2002"

Phrase: "; Ni et al.,"

Phrase: "2001"

Phrase: "; Scheinfeld et al.,"

Phrase: "2002a"

Phrase: "; Schroeter et al.,"

Phrase: "1998"

Phrase: "; Walsh et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.367: Besides the -secretase complex similar adaptor-proteins are involved in nuclear signaling; 

Phrase: "Besides the -secretase complex similar adaptor-proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C1180347:complex protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   823   C1135629:Adaptor Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "involved in nuclear signaling"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0037083:Signaling [Cell Function]
   770   C0521447:Nuclear [Spatial Concept]
   770   C1314939:Involved [Functional Concept]
   770   C3537152:signaling [Biologic Function]

Phrase: ";"
Processing 00000000.tx.368: for example, LRP can bind Fe65 via a different phosphotyrosine-interacting domain than AICD (Kinoshita et al., 2001), and binding of numb by APP influences Notch signaling (Roncarati et al., 2002). 

Phrase: "for example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "LRP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "Fe65 via a different phosphotyrosine-interacting domain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1412459:FE65 [Gene or Genome]

Phrase: "than AICD (Kinoshita et al.,"

Phrase: "2001"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "binding of numb"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]

Phrase: "by APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "influences"

Phrase: "Notch signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "(Roncarati et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.369: Finally, in the nucleus the histone acetylase Tip60 is involved in chromatin remodeling for a variety of signals including STAT-3 (signal transducer and activator of transcription-3), CREB, c-myc, nuclear hormone receptors (Brady et al., 1999; Frank et al., 2003; Gaughan et al., 2001; Xiao et al., 2003). 

Phrase: "Finally,"

Phrase: "in the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "the histone acetylase Tip60"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1333931:TIP60 [Gene or Genome]
   827   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1705504:TIP60 [Gene or Genome]
   734   C0062773:Histone Acetylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "involved in chromatin remodeling"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1156210:chromatin remodeling [Genetic Function]
   770   C0008546:Chromatin [Amino Acid, Peptide, or Protein]
   770   C1314939:Involved [Functional Concept]
   770   C1325550:chromatin [Cell Component]

Phrase: "for a variety"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1883525:Variety [Conceptual Entity]
  1000   C2346866:Variety [Conceptual Entity]

Phrase: "of signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710082:Signal [Phenomenon or Process]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "STAT-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205548:Stat [Temporal Concept]

Phrase: "(signal transducer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040661:Transducer [Medical Device]
   861   C1705162:Transducer [Manufactured Object]
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "activator of transcription-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   819   C1336776:Transcription Activator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "CREB,"

Phrase: "c-myc,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086661:c myc [Gene or Genome]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "nuclear hormone receptors"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0887829:Nuclear Hormone Receptors [Amino Acid, Peptide, or Protein,Receptor]
   966 E C1753269:nuclear hormone receptor [Molecular Function]
   913   C0206588:Receptors, Nuclear [Amino Acid, Peptide, or Protein,Receptor]
   901   C0019929:hormone receptors [Amino Acid, Peptide, or Protein,Receptor]
   867 E C1367453:HORMONE RECEPTOR [Gene or Genome]
   827   C0019932:Hormone [Hormone]
   827   C0521447:Nuclear [Spatial Concept]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   755 E C0458083:Hormonal [Qualitative Concept]

Phrase: "(Brady et al.,"

Phrase: "1999"

Phrase: "; Frank et al.,"

Phrase: "2003"

Phrase: "; Gaughan et al.,"

Phrase: "2001"

Phrase: "; Xiao et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.370: The LRP-ICD generated by -secretase cleavage was recently shown to also localize with Tip60 in nuclear speckles (Kinoshita et al., 2003). 

Phrase: "The LRP-ICD"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   850   C0162808:Protein Domain [Spatial Concept]
   850   C1514562:Protein Domain [Amino Acid Sequence]
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]

Phrase: "generated by -secretase cleavage"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0010813:cleavage [Cell Function]
   770   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]
   770   C3146294:Generated [Activity]

Phrase: "was"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "localize with Tip60"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0392752:localize [Spatial Concept]
   790   C1333931:TIP60 [Gene or Genome]
   790   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1705504:TIP60 [Gene or Genome]

Phrase: "in nuclear speckles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1750270:nuclear speckles [Cell Component]
   777   C0439691:Speckled [Qualitative Concept]

Phrase: "(Kinoshita et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.371: Together, these findings suggest that -secretase processing of membrane proteins is involved in multiple signaling pathways, and that cross-talk of these pathways by means of the common interaction partners could affect APP-dependent nuclear signaling. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that -secretase processing of membrane proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0033666:protein processing [Molecular Function]
   753   C1709694:Processing [Activity]

Phrase: "is"

Phrase: "involved in multiple signaling pathways,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   797   C0037080:pathways signaling [Molecular Function]
   790 E C0037083:signaling pathway [Cell Function]
           Signaling
   790 E C0086982:Signaling Pathway [Molecular Function]
   760   C0439064:Multiple [Quantitative Concept]
   760   C1314939:Involved [Functional Concept]
   760   C1704259:Pathways [Molecular Function]
   760   C1705987:Pathways [Conceptual Entity]
   760   C3537152:signaling [Biologic Function]
   726 E C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "that cross-talk of these pathways"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0010357:Crosstalk [Molecular Function]
   790   C2986468:Cross-talk [Cell Function]
   753   C0037817:Talk [Organism Function]
   753   C0234856:talk [Daily or Recreational Activity]
   753   C0600118:talk [Finding]
   753   C2828360:Cross [Conceptual Entity]

Phrase: "by means of the common interaction partners"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0682323:partners [Family Group]

Phrase: "could"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "APP-dependent nuclear signaling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0037083:Signaling [Cell Function]
   799   C3537152:signaling [Biologic Function]
Processing 00000000.tx.372: In addition, these observations suggest that AICD-regulated genes are a subset of a much larger group of genes controlled by -secretase processing. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "these observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that AICD-regulated genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "are"

Phrase: "a subset of a much larger group of genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1515021:Subset [Classification]

Phrase: "controlled by -secretase processing."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   833   C0332298:Controlled by [Functional Concept]
   770   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1709694:Processing [Activity]
   770   C2587213:Controlled [Functional Concept]
   737 E C0243148:control [Qualitative Concept]
   737 E C1550141:Control [Substance]
   737 E C1882979:Control [Conceptual Entity]
   737 E C3274648:Control [Qualitative Concept]
Processing 00000000.tx.373: In summary, our data provide strong evidence in favor of nuclear signaling functions of AICD and they show that these functions are regulated by the APP-adaptor proteins Fe65, Jip1b and X11, as well as the nuclear docking protein Tip60. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "strong evidence in favor of nuclear signaling functions of AICD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "and"

Phrase: "they"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "these functions"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0542341:Functions [Functional Concept]
   966 E C0031843:function [Physiologic Function]
   966 E C0700205:FUNCTION [Classification]
   966 E C1705273:Function [Intellectual Product]
   916 E C0205245:Functional [Functional Concept]
   916 E C2700217:Functional [Conceptual Entity]

Phrase: "are"

Phrase: "regulated by the APP-adaptor proteins Fe65,"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C1621969:protein-protein adaptor [Molecular Function]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1135629:Adaptor Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1456454:Amyloid Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
           Amyloid protein
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Proteins
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0851285:Regulated [Governmental or Regulatory Activity]
   742   C1412459:FE65 [Gene or Genome]
   742   C1706710:Adaptor [Manufactured Object]
   742   C1709634:Precursor [Idea or Concept]

Phrase: "Jip1b"

Phrase: "and"

Phrase: "X11,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412456:X11 [Gene or Genome]
  1000   C3538726:X11 [Gene or Genome]

Phrase: "as well as"

Phrase: "the nuclear docking protein Tip60."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C1333931:TIP60 [Gene or Genome]
   812   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1705504:TIP60 [Gene or Genome]
   708   C0028589:Nuclear Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0949374:Nuclear Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.374: AICD regulates the expression of its precursor APP and therefore acts as a signal of APP cleavage, leading to the replenishment of full-length APP levels. 

Phrase: "AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "regulates"

Phrase: "the expression of its precursor APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "therefore"

Phrase: "acts as a signal of APP cleavage,"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   781   C0002722:Amyloid A Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   781   C0002723:Amyloid A Precursor [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Amyloid A
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0597304:Protein Cleavage [Molecular Function]
   762   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0010813:cleavage [Cell Function]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0079613:ACT [Therapeutic or Preventive Procedure]
   742   C0596311:Cleavage [Phenomenon or Process]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1330957:cleavage [Cell Function]
   742   C1709634:Precursor [Idea or Concept]
   742   C1710082:Signal [Phenomenon or Process]

Phrase: "leading to the replenishment of full-length APP levels."
Meta Candidates (Total=25; Excluded=8; Pruned=0; Remaining=17)
   775   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   775   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   756   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   738   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0011560:Amyloid [Pathologic Function]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0332152:Leading [Temporal Concept]
   738   C0441889:Levels [Qualitative Concept]
   738   C0443225:Full [Qualitative Concept]
   738   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C1444754:Length [Quantitative Concept]
   738   C1522538:Leading [Functional Concept]
   738   C1706316:LENGTH [Research Activity]
   738   C1709634:Precursor [Idea or Concept]
   737   C0428255:lead levels [Laboratory or Test Result]
   722   C0428479:Protein level [Laboratory or Test Result]
   721 E C0524167:Lead level [Laboratory Procedure]
   704 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   704 E C0456079:Level [Classification]
   704 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   704 E C1547707:Level [Geographic Area]
   704 E C2348269:Lead [Element, Ion, or Isotope]
   704 E C2946261:Level [Pharmacologic Substance]
   704 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.375: In the light of these functions of AICD, and the growing list of -secretase-substrates that signal to the nucleus, the therapeutic use of -secretase inhibitors needs to be carefully evaluated.  

Phrase: "In the light"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023693:Light [Natural Phenomenon or Process]
  1000   C1306462:Light [Functional Concept]
  1000   C1881376:Light [Qualitative Concept]

Phrase: "of these functions"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0542341:Functions [Functional Concept]
   966 E C0031843:function [Physiologic Function]
   966 E C0700205:FUNCTION [Classification]
   966 E C1705273:Function [Intellectual Product]
   916 E C0205245:Functional [Functional Concept]
   916 E C2700217:Functional [Conceptual Entity]

Phrase: "of AICD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "and"

Phrase: "the growing list of -secretase-substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1710236:Substrate [Manufactured Object]

Phrase: "that signal to the nucleus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1710082:Signal [Phenomenon or Process]

Phrase: "the therapeutic use of -secretase inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0243077:inhibitors [Chemical Viewed Functionally]
   771 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "needs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "carefully"

Phrase: "evaluated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]
Processing 00000000.tx.376: Acknowledgments  We are grateful to Boris Zarda and Andreas Luethi from Leica for ongoing support with the confocal microscope. 

Phrase: "Acknowledgments"

Phrase: "We"

Phrase: "are"

Phrase: "grateful to Boris Zarda"

Phrase: "and"

Phrase: "Andreas Luethi from Leica"

Phrase: "for ongoing support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0183683:Support [Medical Device]
   861   C1521721:Support [Conceptual Entity]

Phrase: "with the confocal microscope."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1626420:Confocal microscope [Medical Device]
   861   C0181839:Microscope [Medical Device]
   861   C1706379:Microscope [Medical Device]
Processing 00000000.tx.377: Special thanks to Jay Tracy for comments on the manuscript. 

Phrase: "Special"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205555:Special [Qualitative Concept]

Phrase: "thanks to Jay Tracy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0326402:Jay [Bird]
   770   C2986676:THANK [Gene or Genome]

Phrase: "for comments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0282411:Comments [Intellectual Product]
  1000   C0947611:comments [Intellectual Product]
  1000   C1705247:Comments [Conceptual Entity]

Phrase: "on the manuscript."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600659:Manuscript [Intellectual Product,Manufactured Object]
Processing 00000000.tx.378: The following people kindly supplied us with cDNA constructs: Steve Suhr (Bombyx mori expression system), Stefan Kins, Beyreuther lab (Fe65), Zoltan Ivics (sleeping beauty), Maria Alexander (GAPDH promotor), R.Y. 

Phrase: "The following people kindly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0027361:People [Population Group]

Phrase: "supplied"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1999230:Supplied [Activity]
   966 E C0243163:supply [Idea or Concept]
   966 E C0699914:supply [Quantitative Concept]
   966 E C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   966 E C1561604:supply [Functional Concept]
   966 E C1875802:SUPPLY [Medical Device]

Phrase: "us with cDNA constructs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   737   C2827421:Construct [Classification]

Phrase: ":"

Phrase: "Steve Suhr"

Phrase: "(Bombyx mori expression system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "Stefan Kins,"

Phrase: "Beyreuther lab (Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1412459:FE65 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "Zoltan Ivics"

Phrase: "(sleeping beauty"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0004898:Beauty [Qualitative Concept]
   805 E C0014901:aesthetic [Occupation or Discipline]
   777 E C0036658:Sensation [Organ or Tissue Function]
   777 E C0542538:Sensation, NOS [Finding]
   777 E C1455667:Sensation [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Maria Alexander"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1551702:Alexander [Population Group]

Phrase: "(GAPDH promotor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:promotor [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: ","

Phrase: "R.Y."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.379: Tsien (citrine) and Craig Robson (Tip60). 

Phrase: "Tsien"

Phrase: "(citrine"

Phrase: ")"

Phrase: "and"

Phrase: "Craig Robson"

Phrase: "(Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.380: This work was supported in parts by the SFB (6027) on Structure and Function of Membrane Proteins, a career development grant from the University of Zurich to U.K., the NCCR on Neural Plasticity and Regeneration and the EU DIADEM program.  

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in parts"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:parts [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:PARTS [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by the SFB (6027"

Phrase: ")"

Phrase: "on Structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "Function of Membrane Proteins,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   819   C0682568:membrane function [Body Part, Organ, or Organ Component]
   819   C0815043:function proteins [Amino Acid, Peptide, or Protein]
   802 E C1527118:Protein Function [Molecular Function]
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "a career development grant from the University of Zurich"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0018173:Grant [Quantitative Concept]
   742   C1548284:Grant [Idea or Concept]

Phrase: "to U.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "the NCCR on Neural Plasticity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1513892:NCCR [Health Care Related Organization]

Phrase: "and"

Phrase: "Regeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034963:Regeneration [Organ or Tissue Function]

Phrase: "and"

Phrase: "the EU DIADEM program."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1709697:Program [Conceptual Entity]
   827   C2728259:Program [Pharmacologic Substance]
   827   C3484370:Program [Functional Concept]
Processing 00000000.tx.381: References Top Summary Introduction Materials and Methods Results Discussion References  Alexander, M. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alexander,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551702:Alexander [Population Group]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.382: C., Lomanto, M., Nasrin, N. and Ramaika, C. 

Phrase: "C., Lomanto,"

Phrase: "M."

Phrase: ","

Phrase: "Nasrin,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Ramaika,"

Phrase: "C."
Processing 00000000.tx.383: (1988). 

Phrase: "(1988"

Phrase: ")."
Processing 00000000.tx.384: Insulin stimulates glyceraldehyde-3-phosphate dehydrogenase gene expression through cis-acting DNA sequences. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "stimulates"

Phrase: "glyceraldehyde-3-phosphate dehydrogenase gene expression"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   947   C1414968:Glyceraldehyde-3-Phosphate Dehydrogenase Gene [Gene or Genome]
           GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE
   827   C0017262:Gene Expression [Genetic Function]
   799   C0017337:Gene [Gene or Genome]
   799   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C3536868:Glyceraldehyde-3-phosphate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   700   C2260086:dehydrogenase, glyceraldehyde phosphate [Molecular Function]

Phrase: "through cis-acting DNA sequences."
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   912   C1516561:Cis-Acting Sequence [Nucleotide Sequence]
   861   C0162326:DNA Sequences [Nucleotide Sequence]
           Sequences
   779 E C0004793:Sequence [Nucleotide Sequence]
   779 E C0162327:Sequence [Nucleotide Sequence]
   779 E C1519249:Sequence [Functional Concept]
   729 E C1548958:Sequential [Idea or Concept]
   729 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.385: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.386: Natl. 

Phrase: "Natl."
Processing 00000000.tx.387: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.388: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.389: USA 85, 5092-5096.[Abstract] Baek, S. 

Phrase: "USA 85,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: "5092-5096."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Baek,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.390: H., Ohgi, K. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ohgi,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.391: A., Rose, D. 

Phrase: "A.,"

Phrase: "Rose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035853:Rose [Plant]
  1000   C0995005:ROSE [Pharmacologic Substance]

Phrase: "D."
Processing 00000000.tx.392: W., Koo, E. 

Phrase: "W., Koo,"

Phrase: "E."
Processing 00000000.tx.393: H., Glass, C. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Glass,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017596:Glass [Manufactured Object]
  1000   C1947936:Glass [Medical Device]
   928 E C0074759:Glassy [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   928 E C0522500:Glassy [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.394: K. and Rosenfeld, M. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Rosenfeld,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.395: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.396: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.397: Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein. 

Phrase: "Exchange of N-CoR corepressor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0678640:exchange [Social Behavior]

Phrase: "and"

Phrase: "Tip60 coactivator complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1704241:Complexes [Chemical Viewed Structurally]
   793 E C0439855:Complex [Qualitative Concept]

Phrase: "links"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "gene expression by NF-kappaB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0017262:Gene Expression [Genetic Function]
   760   C0017337:Gene [Gene or Genome]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "beta-amyloid precursor protein."
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0085151:beta amyloid precursor protein [Amino Acid, Peptide, or Protein]
           amyloid precursor protein
   923   C0078939:beta-Amyloid Protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C1750295:beta protein [Genetic Function]
   902   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2825879:Amyloid, Beta [Laboratory Procedure]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   812   C2004068:Beta [Qualitative Concept]
Processing 00000000.tx.398: Cell 110, 55-67.[Medline] Bao, J., Wolpowitz, D., Role, L. 

Phrase: "Cell 110,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "55-67."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450382:55 [Intellectual Product]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bao,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0428597:BAO [Finding]

Phrase: "J.,"

Phrase: "Wolpowitz,"

Phrase: "D."

Phrase: ","

Phrase: "Role,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035820:Role [Social Behavior]
  1000   C1705810:Role [Conceptual Entity]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.399: W. and Talmage, D. 

Phrase: "W."

Phrase: "and"

Phrase: "Talmage,"

Phrase: "D."
Processing 00000000.tx.400: A. 

Phrase: "A."
Processing 00000000.tx.401: (2003). 

Phrase: "(2003"

Phrase: ")."
Processing 00000000.tx.402: Back signaling by the Nrg-1 intracellular domain. 

Phrase: "Back signaling by the Nrg-1 intracellular domain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0037083:Signaling [Cell Function]
   744   C3537152:signaling [Biologic Function]
Processing 00000000.tx.403: J. 

Phrase: "J."
Processing 00000000.tx.404: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.405: 161, 1133-1141.[Abstract/Free FullText] Biederer, T., Cao, X., Sudhof, T. 

Phrase: "161,"

Phrase: "1133-1141."

Phrase: "[Abstract/Free FullText"

Phrase: "] Biederer,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Cao,"

Phrase: "X.,"

Phrase: "Sudhof,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.406: C. and Liu, X. 

Phrase: "C."

Phrase: "and"

Phrase: "Liu,"

Phrase: "X."
Processing 00000000.tx.407: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.408: Regulation of APP-dependent transcription complexes by Mint/X11s: differential functions of Mint isoforms. 

Phrase: "Regulation of APP-dependent transcription complexes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1158770:Transcription Regulation [Genetic Function]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]

Phrase: "by Mint/X11s"

Phrase: ":"

Phrase: "differential functions of Mint isoforms."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0542341:Functions [Functional Concept]
   726 E C0031843:function [Physiologic Function]
   726 E C0700205:FUNCTION [Classification]
   726 E C1705273:Function [Intellectual Product]
Processing 00000000.tx.409: J. 

Phrase: "J."
Processing 00000000.tx.410: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.411: 22, 7340-7351.[Abstract/Free FullText] Borg, J. 

Phrase: "22,"

Phrase: "7340-7351."

Phrase: "[Abstract/Free FullText"

Phrase: "] Borg,"

Phrase: "J."
Processing 00000000.tx.412: P., Ooi, J., Levy, E. and Margolis, B. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ooi,"

Phrase: "J.,"

Phrase: "Levy,"

Phrase: "E."

Phrase: "and"

Phrase: "Margolis,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.413: (1996). 

Phrase: "(1996"

Phrase: ")."
Processing 00000000.tx.414: The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. 

Phrase: "The phosphotyrosine interaction domains of X11"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   822   C1518827:Phosphotyrosine Interaction Domain [Amino Acid Sequence]
   719   C1880389:Domain [Functional Concept]
   719   C1883221:Domain [Conceptual Entity]
   719   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "FE65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "bind to distinct sites"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0205145:Sites [Spatial Concept]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]

Phrase: "on the YENPTY motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514562:Motif [Amino Acid Sequence]

Phrase: "of amyloid precursor protein."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.415: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.416: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.417: Biol. 

Phrase: "Biol."
Processing 00000000.tx.418: 16, 6229-6241.[Abstract] Brady, M. 

Phrase: "16,"

Phrase: "6229-6241."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Brady,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.419: E., Ozanne, D. 

Phrase: "E.,"

Phrase: "Ozanne,"

Phrase: "D."
Processing 00000000.tx.420: M., Gaughan, L., Waite, I., Cook, S., Neal, D. 

Phrase: "M."

Phrase: ","

Phrase: "Gaughan,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Waite,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Cook,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0335326:Cook [Daily or Recreational Activity]
  1000   C1306756:Cook [Professional or Occupational Group]

Phrase: "S."

Phrase: ","

Phrase: "Neal,"

Phrase: "D."
Processing 00000000.tx.421: E. and Robson, C. 

Phrase: "E."

Phrase: "and"

Phrase: "Robson,"

Phrase: "C."
Processing 00000000.tx.422: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.423: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.424: Tip60 is a nuclear hormone receptor coactivator. 

Phrase: "Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "is"

Phrase: "a nuclear hormone receptor coactivator."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0887829:Nuclear Hormone Receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C1753269:nuclear hormone receptor [Molecular Function]
   708   C0206588:Nuclear Receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.425: J. 

Phrase: "J."
Processing 00000000.tx.426: Biol. 

Phrase: "Biol."
Processing 00000000.tx.427: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.428: 274, 17599-17604.[Abstract/Free FullText] Cao, X. and Sudhof, T. 

Phrase: "274,"

Phrase: "17599-17604."

Phrase: "[Abstract/Free FullText"

Phrase: "] Cao,"

Phrase: "X."

Phrase: "and"

Phrase: "Sudhof,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.429: C. 

Phrase: "C."
Processing 00000000.tx.430: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.431: A transcriptionally active complex of APP with Fe65 and histone acetyltransferase Tip60. 

Phrase: "A transcriptionally active complex of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1523872:protein complex [Cell Component]
   744   C0439855:Complex [Qualitative Concept]
   744   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "with Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "histone acetyltransferase Tip60."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1333931:TIP60 [Gene or Genome]
   827   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1705504:TIP60 [Gene or Genome]
   734   C0062773:histone acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.432: Science 293, 115-120.[Abstract/Free FullText] Card, J. 

Phrase: "Science 293,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "115-120."

Phrase: "[Abstract/Free FullText"

Phrase: "] Card,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3275277:Card [Intellectual Product]

Phrase: "J."
Processing 00000000.tx.433: P., Meade, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Meade,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.434: P. and Davis, L. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Davis,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.435: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.436: (1988). 

Phrase: "(1988"

Phrase: ")."
Processing 00000000.tx.437: Immunocytochemical localization of the precursor protein for beta-amyloid in the rat central nervous system. 

Phrase: "Immunocytochemical localization of the precursor protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0597704:protein localisation [Cell Function]
   783   C1159772:Protein Localization [Cell Function]
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "for beta-amyloid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2825879:Amyloid, Beta [Laboratory Procedure]
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in the rat central nervous system."
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
   923   C0927232:Central Nervous System [Body System]
   923   C1269563:Central nervous system [Body System]
   923   C1882791:Rat Nervous System [Body Part, Organ, or Organ Component]
   861   C0027763:Nervous System [Body System]
   861   C0422837:NERVOUS SYSTEM [Finding]
   861   C1269560:Nervous system [Body System]
   812   C0027769:Nervous [Sign or Symptom]
   812   C0205099:Central [Spatial Concept]
   812   C0449913:System [Functional Concept]
   812   C0599851:Nervous [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   812   C1879652:Central - [Laboratory Procedure]
   805 E C0205494:Neurologic [Qualitative Concept]
   768 E C0027855:Neurology [Biomedical Occupation or Discipline]
   750 E C2707261:Neurological [Clinical Attribute]
   741 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.438: Neuron 1, 835-846.[Medline] Cupers, P., Orlans, I., Craessaerts, K., Annaert, W. and de Strooper, B. 

Phrase: "Neuron 1,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "835-846."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cupers,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Orlans,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Craessaerts,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Annaert,"

Phrase: "W."

Phrase: "and"

Phrase: "de Strooper,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.439: (2001a). 

Phrase: "(2001a"

Phrase: ")."
Processing 00000000.tx.440: The amyloid precursor protein (APP)-cytoplasmic fragment generated by gamma-secretase is rapidly degraded but distributes partially in a nuclear fraction of neurones in culture. 

Phrase: "The amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "(APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ")-"

Phrase: "cytoplasmic fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "generated by gamma-secretase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0379528:gamma-Secretase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0017011:Gamma [Natural Phenomenon or Process]
   770   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1552644:Gamma [Intellectual Product]
   770   C2349976:Gamma [Quantitative Concept]
   770   C3146294:Generated [Activity]

Phrase: "is"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "but"

Phrase: "distributes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704711:Distribute [Functional Concept]

Phrase: "partially in a nuclear fraction of neurones"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C1264633:Fraction of [Quantitative Concept]
           Fraction
   748   C0521447:Nuclear [Spatial Concept]
   748   C1554103:Fraction [Idea or Concept]
   732   C1441012:Neuronal nuclear [Immunologic Factor]
   714   C0027882:Neurone [Cell]

Phrase: "in culture."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.441: J. 

Phrase: "J."
Processing 00000000.tx.442: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.443: 78, 1168-1178.[CrossRef][Medline] Cupers, P., Bentahir, M., Craessaerts, K., Orlans, I., Vanderstichele, H., Saftig, P., de Strooper, B. and Annaert, W. 

Phrase: "78,"

Phrase: "1168-1178."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cupers,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bentahir,"

Phrase: "M."

Phrase: ","

Phrase: "Craessaerts,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Orlans,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Vanderstichele,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Saftig,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "de Strooper,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Annaert,"

Phrase: "W."
Processing 00000000.tx.444: (2001b). 

Phrase: "(2001b"

Phrase: ")."
Processing 00000000.tx.445: The discrepancy between presenilin subcellular localization and gamma-secretase processing of amyloid precursor protein. 

Phrase: "The discrepancy between presenilin subcellular localization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1290905:Discrepancy [Finding]

Phrase: "and"

Phrase: "gamma-secretase processing of amyloid precursor protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0033666:protein processing [Molecular Function]
   748   C1709694:Processing [Activity]
Processing 00000000.tx.446: J. 

Phrase: "J."
Processing 00000000.tx.447: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.448: 154, 731-740.[Abstract/Free FullText] De Strooper, B. 

Phrase: "154,"

Phrase: "731-740."

Phrase: "[Abstract/Free FullText"

Phrase: "] De Strooper,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.449: (2003). 

Phrase: "(2003"

Phrase: ")."
Processing 00000000.tx.450: Aph-1, Pen-2, and nicastrin with presenilin generate an active gamma-secretase complex. 

Phrase: "Aph-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1332101:APH [Gene or Genome]
   861   C1705550:APH [Gene or Genome]

Phrase: "Pen-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3541303:PEN-2 [Gene or Genome]
   861   C3273588:Pen [Manufactured Object]

Phrase: "and"

Phrase: "nicastrin with presenilin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1538050:NICASTRIN [Gene or Genome]

Phrase: "generate"

Phrase: "an active gamma-secretase complex."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C2753842:gamma-secretase complex [Cell Component]
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.451: Neuron 38, 9-12.[Medline] De Strooper, B., Annaert, W., Cupers, P., Saftig, P., Craessaerts, K., Mumm, J. 

Phrase: "Neuron 38,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "9-12."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] De Strooper,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Annaert,"

Phrase: "W.,"

Phrase: "Cupers,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Saftig,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Craessaerts,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Mumm,"

Phrase: "J."
Processing 00000000.tx.452: S., Schroeter, E. 

Phrase: "S."

Phrase: ","

Phrase: "Schroeter,"

Phrase: "E."
Processing 00000000.tx.453: H., Schrijvers, V., Wolfe, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Schrijvers,"

Phrase: "V.,"

Phrase: "Wolfe,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.454: S., Ray, W. 

Phrase: "S."

Phrase: ","

Phrase: "Ray,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086894:ray [Fish]
  1000   C0851346:ray [Natural Phenomenon or Process]
  1000   C2314876:ray [Fish]

Phrase: "W."
Processing 00000000.tx.455: J. et al. 

Phrase: "J. et al."
Processing 00000000.tx.456: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.457: A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. 

Phrase: "A presenilin-1-dependent gamma-secretase-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0379528:gamma-Secretase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "like protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Protease [Enzyme]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "release of Notch intracellular domain."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.458: Nature 398, 518-522.[CrossRef][Medline] Duilio, A., Zambrano, N., Mogavero, A. 

Phrase: "Nature 398,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "518-522."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Duilio,"

Phrase: "A.,"

Phrase: "Zambrano,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Mogavero,"

Phrase: "A."
Processing 00000000.tx.459: R., Ammendola, R., Cimino, F. and Russo, T. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Ammendola,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Cimino,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Russo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.460: (1991). 

Phrase: "(1991"

Phrase: ")."
Processing 00000000.tx.461: A rat brain mRNA encoding a transcriptional activator homologous to the DNA binding domain of retroviral integrases. 

Phrase: "A rat brain mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "a transcriptional activator"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1336776:Transcriptional Activator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "homologous to the DNA binding domain of retroviral integrases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1334043:Homologous [Gene or Genome]
Processing 00000000.tx.462: Nucleic Acids Res. 

Phrase: "Nucleic Acids Res."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.463: 19, 5269-5274.[Abstract] Edbauer, D., Willem, M., Lammich, S., Steiner, H. and Haass, C. 

Phrase: "19,"

Phrase: "5269-5274."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Edbauer,"

Phrase: "D."

Phrase: ","

Phrase: "Willem,"

Phrase: "M."

Phrase: ","

Phrase: "Lammich,"

Phrase: "S."

Phrase: ","

Phrase: "Steiner,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.464: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.465: Insulin-degrading enzyme rapidly removes the beta-amyloid precursor protein intracellular domain (AICD). 

Phrase: "Insulin-degrading enzyme rapidly"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "removes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "the beta-amyloid precursor protein intracellular domain"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   839   C0162808:Protein Domain [Spatial Concept]
   839   C1514562:Protein Domain [Amino Acid Sequence]
   799   C0175996:intracellular [Cell Component]
   799   C0178719:Intracellular [Spatial Concept]
   799   C1880389:Domain [Functional Concept]
   799   C1883221:Domain [Conceptual Entity]
   799   C3541951:Domain [Intellectual Product]
   734   C0085151:beta amyloid precursor protein [Amino Acid, Peptide, or Protein]
   700   C0078939:beta-Amyloid Protein [Amino Acid, Peptide, or Protein]

Phrase: "(AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: ")."
Processing 00000000.tx.466: J. 

Phrase: "J."
Processing 00000000.tx.467: Biol. 

Phrase: "Biol."
Processing 00000000.tx.468: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.469: 277, 13389-13393.[Abstract/Free FullText] Edbauer, D., Winkler, E., Regula, J. 

Phrase: "277,"

Phrase: "13389-13393."

Phrase: "[Abstract/Free FullText"

Phrase: "] Edbauer,"

Phrase: "D."

Phrase: ","

Phrase: "Winkler,"

Phrase: "E.,"

Phrase: "Regula,"

Phrase: "J."
Processing 00000000.tx.470: T., Pesold, B., Steiner, H. and Haass, C. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Pesold,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Steiner,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.471: (2003). 

Phrase: "(2003"

Phrase: ")."
Processing 00000000.tx.472: Reconstitution of gamma-secretase activity. 

Phrase: "Reconstitution of gamma-secretase activity."
Processing 00000000.tx.473: Nat. 

Phrase: "Nat."
Processing 00000000.tx.474: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.475: 5, 486-488.[CrossRef][Medline] Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "486-488."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Farris,"

Phrase: "W.,"

Phrase: "Mansourian,"

Phrase: "S."

Phrase: ","

Phrase: "Chang,"

Phrase: "Y.,"

Phrase: "Lindsley,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Eckman,"

Phrase: "E."
Processing 00000000.tx.476: A., Frosch, M. 

Phrase: "A.,"

Phrase: "Frosch,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.477: P., Eckman, C. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Eckman,"

Phrase: "C."
Processing 00000000.tx.478: B., Tanzi, R. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.479: E., Selkoe, D. 

Phrase: "E.,"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.480: J. and Guenette, S. 

Phrase: "J."

Phrase: "and"

Phrase: "Guenette,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.481: (2003). 

Phrase: "(2003"

Phrase: ")."
Processing 00000000.tx.482: Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. 

Phrase: "Insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "regulates"

Phrase: "the levels of insulin,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   819   C0202098:insulin levels [Laboratory Procedure]
   819   C0428405:insulin levels [Laboratory or Test Result]
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "amyloid beta-protein,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0078939:Amyloid beta-Protein [Amino Acid, Peptide, or Protein]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C1750295:beta protein [Genetic Function]
   901   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   901   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "and"

Phrase: "the beta-amyloid precursor protein intracellular domain"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   839   C0162808:Protein Domain [Spatial Concept]
   839   C1514562:Protein Domain [Amino Acid Sequence]
   799   C0175996:intracellular [Cell Component]
   799   C0178719:Intracellular [Spatial Concept]
   799   C1880389:Domain [Functional Concept]
   799   C1883221:Domain [Conceptual Entity]
   799   C3541951:Domain [Intellectual Product]
   734   C0085151:beta amyloid precursor protein [Amino Acid, Peptide, or Protein]
   700   C0078939:beta-Amyloid Protein [Amino Acid, Peptide, or Protein]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.483: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.484: Natl. 

Phrase: "Natl."
Processing 00000000.tx.485: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.486: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.487: USA 100, 4162-4167.[Abstract/Free FullText] Frank, S. 

Phrase: "USA 100,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: "4162-4167."

Phrase: "[Abstract/Free FullText"

Phrase: "] Frank,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.488: R., Parisi, T., Taubert, S., Fernandez, P., Fuchs, M., Chan, H. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Parisi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Taubert,"

Phrase: "S."

Phrase: ","

Phrase: "Fernandez,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Fuchs,"

Phrase: "M."

Phrase: ","

Phrase: "Chan,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.489: M., Livingston, D. 

Phrase: "M."

Phrase: ","

Phrase: "Livingston,"

Phrase: "D."
Processing 00000000.tx.490: M. and Amati, B. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Amati,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.491: (2003). 

Phrase: "(2003"

Phrase: ")."
Processing 00000000.tx.492: MYC recruits the TIP60 histone acetyltransferase complex to chromatin. 

Phrase: "MYC"

Phrase: "recruits"

Phrase: "the TIP60 histone acetyltransferase complex to chromatin."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   814   C1167136:histone acetyltransferase complex [Cell Component]
   748   C0439855:Complex [Qualitative Concept]
   748   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.493: EMBO Rep. 

Phrase: "EMBO Rep."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1744664:REP [Molecular Function]
Processing 00000000.tx.494: 4, 575-580.[Abstract/Free FullText] Gaughan, L., Brady, M. 

Phrase: "4,"

Phrase: "575-580."

Phrase: "[Abstract/Free FullText"

Phrase: "] Gaughan,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Brady,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.495: E., Cook, S., Neal, D. 

Phrase: "E.,"

Phrase: "Cook,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0335326:Cook [Daily or Recreational Activity]
  1000   C1306756:Cook [Professional or Occupational Group]

Phrase: "S."

Phrase: ","

Phrase: "Neal,"

Phrase: "D."
Processing 00000000.tx.496: E. and Robson, C. 

Phrase: "E."

Phrase: "and"

Phrase: "Robson,"

Phrase: "C."
Processing 00000000.tx.497: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.498: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.499: Tip60 is a co-activator specific for class I nuclear hormone receptors. 

Phrase: "Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "is"

Phrase: "a co-activator"

Phrase: "specific for class I nuclear hormone receptors."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205369:Specific [Qualitative Concept]
   748   C1552740:specific [Intellectual Product]
Processing 00000000.tx.500: J. 

Phrase: "J."
Processing 00000000.tx.501: Biol. 

Phrase: "Biol."
Processing 00000000.tx.502: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.503: 276, 46841-46848.[Abstract/Free FullText] Geling, A., Steiner, H., Willem, M., Bally-Cuif, L. and Haass, C. 

Phrase: "276,"

Phrase: "46841-46848."

Phrase: "[Abstract/Free FullText"

Phrase: "] Geling,"

Phrase: "A.,"

Phrase: "Steiner,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Willem,"

Phrase: "M."

Phrase: ","

Phrase: "Bally-Cuif,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.504: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.505: A gamma-secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish. 

Phrase: "A gamma-secretase inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1999216:Inhibitor [Qualitative Concept]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "Notch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1235660:Notch [Body Space or Junction]

Phrase: "signaling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a severe neurogenic phenotype in zebrafish."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1836408:Severe phenotype [Finding]
   753   C0031437:Phenotype [Organism Attribute]
   753   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.506: EMBO Rep. 

Phrase: "EMBO Rep."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1744664:REP [Molecular Function]
Processing 00000000.tx.507: 3, 688-694.[Abstract/Free FullText] Gordon, G. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "688-694."

Phrase: "[Abstract/Free FullText"

Phrase: "] Gordon,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.508: W., Berry, G., Liang, X. 

Phrase: "W., Berry,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005135:Berry [Food]
   861   C0982158:BERRY [Food]
   861   C3495134:BERRY [Organic Chemical,Pharmacologic Substance]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Liang,"

Phrase: "X."
Processing 00000000.tx.509: H., Levine, B. and Herman, B. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Levine,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Herman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.510: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.511: Quantitative fluorescence resonance energy transfer measurements using fluorescence microscopy. 

Phrase: "Quantitative fluorescence resonance energy transfer measurements"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0242485:measurements [Functional Concept]
   734   C0597717:Fluorescence Resonance Energy Transfer [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "fluorescence microscopy."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0026022:Microscopy, Fluorescence [Laboratory Procedure]
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   861   C0026018:Microscopy [Laboratory Procedure]
   789 E C0205288:Microscopic [Qualitative Concept]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.512: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.513: J. 

Phrase: "J."
Processing 00000000.tx.514: 74, 2702-2713.[Abstract/Free FullText] Gotz, J., Chen, F., van Dorpe, J. and Nitsch, R. 

Phrase: "74,"

Phrase: "2702-2713."

Phrase: "[Abstract/Free FullText"

Phrase: "] Gotz,"

Phrase: "J.,"

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "van Dorpe,"

Phrase: "J."

Phrase: "and"

Phrase: "Nitsch,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.515: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.516: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.517: Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. 

Phrase: "Formation of neurofibrillary tangles"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "in P301l tau transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0025936:Mice, Transgenic [Mammal]
   812   C0003069:Transgenic [Animal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "induced by Abeta 42 fibrils."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0205263:Induced [Functional Concept]
   760   C0225328:fibrils [Cell Component]
   760   C1420510:A-BETA [Gene or Genome]
   760   C1705543:ABETA [Gene or Genome]
   726 E C1948066:Fibril [Physical Object]
Processing 00000000.tx.518: Science 293, 1491-1495.[Abstract/Free FullText] Griesbeck, O., Baird, G. 

Phrase: "Science 293,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1491-1495."

Phrase: "[Abstract/Free FullText"

Phrase: "] Griesbeck,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Baird,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.519: S., Campbell, R. 

Phrase: "S."

Phrase: ","

Phrase: "Campbell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331936:Campbell [Health Care Related Organization]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.520: E., Zacharias, D. 

Phrase: "E.,"

Phrase: "Zacharias,"

Phrase: "D."
Processing 00000000.tx.521: A. and Tsien, R. 

Phrase: "A."

Phrase: "and"

Phrase: "Tsien,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.522: Y. 

Phrase: "Y."
Processing 00000000.tx.523: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.524: Reducing the environmental sensitivity of yellow fluorescent protein. 

Phrase: "Reducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reducing [Qualitative Concept]

Phrase: "the environmental sensitivity of yellow fluorescent protein."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0036667:Sensitivity [Quantitative Concept]
   748   C0312418:Sensitivity [Mental Process]
   748   C0427965:Sensitivity [Finding]
   748   C1511883:Sensitivity [Quantitative Concept]
   748   C1522640:Sensitivity [Qualitative Concept]
   748   C2346484:SENSITIVITY [Phenomenon or Process]
   748   C2349185:Sensitivity [Qualitative Concept]
Processing 00000000.tx.525: Mechanism and applications. 

Phrase: "Mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "applications."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0185125:applications [Health Care Activity]
   966 E C1947919:Application [Intellectual Product]
   966 E C2347934:Application [Intellectual Product]
   966 E C3539080:APPLICATION [Quantitative Concept]
Processing 00000000.tx.526: J. 

Phrase: "J."
Processing 00000000.tx.527: Biol. 

Phrase: "Biol."
Processing 00000000.tx.528: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.529: 276, 29188-29194.[Abstract/Free FullText] Hock, C., Konietzko, U., Papassotiropoulos, A., Wollmer, A., Streffer, J., von Rotz, R. 

Phrase: "276,"

Phrase: "29188-29194."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hock,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003086:Hock [Body Location or Region]
  1000   C1522382:Hock [Body Location or Region]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Konietzko,"

Phrase: "U.,"

Phrase: "Papassotiropoulos,"

Phrase: "A.,"

Phrase: "Wollmer,"

Phrase: "A.,"

Phrase: "Streffer,"

Phrase: "J.,"

Phrase: "von Rotz,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.530: C., Davey, G., Moritz, E. and Nitsch, R. 

Phrase: "C., Davey,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Moritz,"

Phrase: "E."

Phrase: "and"

Phrase: "Nitsch,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.531: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.532: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.533: Generation of antibodies specific for beta-amyloid by vaccination of patients with Alzheimer disease. 

Phrase: "Generation of antibodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0079411:Generation [Temporal Concept]
   790   C3146294:Generation [Activity]

Phrase: "specific for beta-amyloid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205369:Specific [Qualitative Concept]
   770   C1552740:specific [Intellectual Product]

Phrase: "by vaccination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042196:Vaccination [Therapeutic or Preventive Procedure]

Phrase: "of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.534: Nat. 

Phrase: "Nat."
Processing 00000000.tx.535: Med. 

Phrase: "Med."
Processing 00000000.tx.536: 8, 1270-1275.[CrossRef][Medline] Hock, C., Konietzko, U., Streffer, J. 

Phrase: "8,"

Phrase: "1270-1275."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hock,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003086:Hock [Body Location or Region]
  1000   C1522382:Hock [Body Location or Region]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Konietzko,"

Phrase: "U.,"

Phrase: "Streffer,"

Phrase: "J."
Processing 00000000.tx.537: R., Tracy, J., Signorell, A., Muller-Tillmanns, B., Lemke, U., Henke, K., Moritz, E., Garcia, E. et al. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Tracy,"

Phrase: "J.,"

Phrase: "Signorell,"

Phrase: "A.,"

Phrase: "Muller-Tillmanns,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Lemke,"

Phrase: "U.,"

Phrase: "Henke,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Moritz,"

Phrase: "E.,"

Phrase: "Garcia,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442999:Garcia [Intellectual Product]
  1000   C1621797:Garcia [Plant]

Phrase: "E. et al."
Processing 00000000.tx.538: (2003). 

Phrase: "(2003"

Phrase: ")."
Processing 00000000.tx.539: Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease. 

Phrase: "Antibodies against beta-amyloid slow cognitive decline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   714 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.540: Neuron 38, 547-554.[Medline] Hu, Q., Hearn, M. 

Phrase: "Neuron 38,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "547-554."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hu,"

Phrase: "Q.,"

Phrase: "Hearn,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.541: G., Jin, L. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Jin,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.542: W., Bressler, S. 

Phrase: "W., Bressler,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.543: L. and Martin, G. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Martin,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.544: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.545: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.546: Alternatively spliced isoforms of FE65 serve as neuron-specific and non-neuronal markers. 

Phrase: "Alternatively spliced isoforms of FE65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "serve as neuron-specific"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0027882:Neuron [Cell]
   770   C0205369:Specific [Qualitative Concept]
   770   C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "non-neuronal markers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0005516:Marker [Clinical Attribute]
Processing 00000000.tx.547: J. 

Phrase: "J."
Processing 00000000.tx.548: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.549: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.550: 58, 632-640.[CrossRef][Medline] Ikeuchi, T. and Sisodia, S. 

Phrase: "58,"

Phrase: "632-640."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ikeuchi,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.551: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.552: (2003). 

Phrase: "(2003"

Phrase: ")."
Processing 00000000.tx.553: The Notch ligands, Delta1 and Jagged2, are substrates for presenilin-dependent "gamma-secretase" cleavage. 

Phrase: "The Notch ligands,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1749388:Notch ligand [Molecular Function]
   861   C0023688:Ligands [Chemical]

Phrase: "Delta1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1414069:Delta1 [Gene or Genome]
  1000   C1414070:DELTA1 [Gene or Genome]
  1000   C3274855:Delta1 [Gene or Genome]

Phrase: "and"

Phrase: "Jagged2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827380:Jagged2 [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "substrates for presenilin-dependent ""gamma-secretase"" cleavage."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.554: J. 

Phrase: "J."
Processing 00000000.tx.555: Biol. 

Phrase: "Biol."
Processing 00000000.tx.556: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.557: 278, 7751-7754.[Abstract/Free FullText] Ivics, Z., Hackett, P. 

Phrase: "278,"

Phrase: "7751-7754."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ivics,"

Phrase: "Z.,"

Phrase: "Hackett,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.558: B., Plasterk, R. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Plasterk,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.559: H. and Izsvak, Z. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Izsvak,"

Phrase: "Z."
Processing 00000000.tx.560: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.561: Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. 

Phrase: "Molecular reconstruction of Sleeping Beauty,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020912:Reconstruction [Machine Activity]
   760   C0524865:Reconstruction [Therapeutic or Preventive Procedure]

Phrase: "a Tc1-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1413028:TC1 [Gene or Genome]
  1000   C1420652:TC1 [Gene or Genome]
  1000   C1455542:TC1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "like transposon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1257902:Transposon [Gene or Genome]

Phrase: "from fish,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016163:Fish [Fish]
  1000   C2349190:Fish [Food]
  1000   C2700184:FISH [Qualitative Concept]

Phrase: "and"

Phrase: "its transposition in human cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0040674:Transposition [Therapeutic or Preventive Procedure]
   760   C0040759:Transposition [Congenital Abnormality]
   760   C1820371:transposition [Genetic Function]
Processing 00000000.tx.562: Cell 91, 501-510.[Medline] Kim, H. 

Phrase: "Cell 91,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "501-510."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kim,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.563: S., Kim, E. 

Phrase: "S."

Phrase: ","

Phrase: "Kim,"

Phrase: "E."
Processing 00000000.tx.564: M., Lee, J. 

Phrase: "M."

Phrase: ","

Phrase: "Lee,"

Phrase: "J."
Processing 00000000.tx.565: P., Park, C. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "C."
Processing 00000000.tx.566: H., Kim, S., Seo, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kim,"

Phrase: "S."

Phrase: ","

Phrase: "Seo,"

Phrase: "J."
Processing 00000000.tx.567: H., Chang, K. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Chang,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.568: A., Yu, E., Jeong, S. 

Phrase: "A.,"

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "E.,"

Phrase: "Jeong,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.569: J., Chong, Y. 

Phrase: "J.,"

Phrase: "Chong,"

Phrase: "Y."
Processing 00000000.tx.570: H. et al. 

Phrase: "H. et al."
Processing 00000000.tx.571: (2003). 

Phrase: "(2003"

Phrase: ")."
Processing 00000000.tx.572: C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3beta expression. 

Phrase: "C-terminal fragments of amyloid precursor protein"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   778   C1707271:C-Terminal [Amino Acid Sequence]
   774   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   774   C1168438:Protein C [Laboratory Procedure]
   774   C1418943:PROTEIN C [Gene or Genome]
   774   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   757   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   748   C0205088:Terminal [Temporal Concept]
   748   C0332255:fragments [Functional Concept]
   748   C0486805:Fragments [Body Substance]
   748   C1705314:Terminal [Manufactured Object]
   748   C1705315:Terminal [Spatial Concept]
   714 E C1708096:Fragment [Qualitative Concept]

Phrase: "exert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "neurotoxicity by inducing glycogen synthase kinase-3beta expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0235032:Neurotoxicity [Injury or Poisoning]
Processing 00000000.tx.573: FASEB J. 

Phrase: "FASEB J."
Processing 00000000.tx.574: 17, 1951-1953.[Abstract/Free FullText] Kimberly, W. 

Phrase: "17,"

Phrase: "1951-1953."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kimberly,"

Phrase: "W."
Processing 00000000.tx.575: T., Zheng, J. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Zheng,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986502:Zheng [Therapeutic or Preventive Procedure]

Phrase: "J."
Processing 00000000.tx.576: B., Guenette, S. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Guenette,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.577: Y. and Selkoe, D. 

Phrase: "Y."

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.578: J. 

Phrase: "J."
Processing 00000000.tx.579: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.580: The intracellular domain of the beta-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notch-like manner. 

Phrase: "The intracellular domain of the beta-amyloid precursor protein"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   762   C0162808:Protein Domain [Spatial Concept]
   762   C1514562:Protein Domain [Amino Acid Sequence]
   742   C0175996:intracellular [Cell Component]
   742   C0178719:Intracellular [Spatial Concept]
   742   C1880389:Domain [Functional Concept]
   742   C1883221:Domain [Conceptual Entity]
   742   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "stabilized by Fe65"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0184512:Stabilized [Qualitative Concept]
   790   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "translocates to the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0007610:Nucleus [Cell Component]

Phrase: "in a notch-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1235660:Notch [Body Space or Junction]

Phrase: "like manner."
Processing 00000000.tx.581: J. 

Phrase: "J."
Processing 00000000.tx.582: Biol. 

Phrase: "Biol."
Processing 00000000.tx.583: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.584: 276, 40288-40292.[Abstract/Free FullText] Kinoshita, A., Whelan, C. 

Phrase: "276,"

Phrase: "40288-40292."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kinoshita,"

Phrase: "A.,"

Phrase: "Whelan,"

Phrase: "C."
Processing 00000000.tx.585: M., Smith, C. 

Phrase: "M."

Phrase: ","

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.586: J., Mikhailenko, I., Rebeck, G. 

Phrase: "J.,"

Phrase: "Mikhailenko,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Rebeck,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.587: W., Strickland, D. 

Phrase: "W., Strickland,"

Phrase: "D."
Processing 00000000.tx.588: K. and Hyman, B. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.589: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.590: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.591: Demonstration by fluorescence resonance energy transfer of two sites of interaction between the low-density lipoprotein receptor-related protein and the amyloid precursor protein: role of the intracellular adapter protein Fe65. 

Phrase: "Demonstration by fluorescence resonance energy transfer of two sites of interaction"

Phrase: "between the low-density lipoprotein receptor-related protein"
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
   901   C0034821:Low Density Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1366529:LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   901   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   895   C0242972:low protein [Therapeutic or Preventive Procedure]
   895   C0748025:low protein [Finding]
   861   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   839   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   827   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0178587:density [Quantitative Concept]
   799   C0205251:low [Qualitative Concept]
   799   C0439849:Related [Qualitative Concept]
   799   C0445223:Related [Finding]
   799   C1299352:Low [Qualitative Concept]
   799   C1550472:low [Idea or Concept]
   766 E C0163712:Relate [Organic Chemical]
   727 E C0080103:Relation [Family Group]
   727 E C0439794:Dense [Qualitative Concept]
   727 E C0869014:Relations [Social Behavior]

Phrase: "and"

Phrase: "the amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ":"

Phrase: "role of the intracellular adapter protein Fe65."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.592: J. 

Phrase: "J."
Processing 00000000.tx.593: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.594: 21, 8354-8361.[Abstract/Free FullText] Kinoshita, A., Whelan, C. 

Phrase: "21,"

Phrase: "8354-8361."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kinoshita,"

Phrase: "A.,"

Phrase: "Whelan,"

Phrase: "C."
Processing 00000000.tx.595: M., Smith, C. 

Phrase: "M."

Phrase: ","

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.596: J., Berezovska, O. and Hyman, B. 

Phrase: "J.,"

Phrase: "Berezovska,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "and"

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.597: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.598: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.599: Direct visualization of the gamma secretase-generated carboxyl-terminal domain of the amyloid precursor protein: association with Fe65 and translocation to the nucleus. 

Phrase: "Direct visualization of the gamma secretase-generated carboxyl-terminal domain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0175631:Visualization [Mental Process]
   739   C2827662:Visualization [Occupation or Discipline]

Phrase: "of the amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ":"

Phrase: "association with Fe65"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0004083:Association [Mental Process]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "translocation to the nucleus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040715:Translocation [Cell or Molecular Dysfunction]
   770   C2987521:Translocation [Activity]
Processing 00000000.tx.600: J. 

Phrase: "J."
Processing 00000000.tx.601: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.602: 82, 839-847.[CrossRef][Medline] Kinoshita, A., Shah, T., Tangredi, M. 

Phrase: "82,"

Phrase: "839-847."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kinoshita,"

Phrase: "A.,"

Phrase: "Shah,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tangredi,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.603: T., Strickland, D. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Strickland,"

Phrase: "D."
Processing 00000000.tx.604: K. and Hyman, B. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.605: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.606: (2003). 

Phrase: "(2003"

Phrase: ")."
Processing 00000000.tx.607: The intracellular domain of the low density lipoprotein receptor-related protein (LRP) modulates transactivation mediated by APP and Fe65. 

Phrase: "The intracellular domain of the low density lipoprotein receptor-related protein (LRP)"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   754   C0162808:Protein Domain [Spatial Concept]
   754   C1514562:Protein Domain [Amino Acid Sequence]
   738   C0175996:intracellular [Cell Component]
   738   C0178719:Intracellular [Spatial Concept]
   738   C1880389:Domain [Functional Concept]
   738   C1883221:Domain [Conceptual Entity]
   738   C3541951:Domain [Intellectual Product]

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "transactivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040624:Transactivation [Genetic Function]

Phrase: "mediated by APP"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "Fe65."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]
Processing 00000000.tx.608: J. 

Phrase: "J."
Processing 00000000.tx.609: Biol. 

Phrase: "Biol."
Processing 00000000.tx.610: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.611: 278, 41182-41188.[Abstract/Free FullText] Lammich, S., Kojro, E., Postina, R., Gilbert, S., Pfeiffer, R., Jasionowski, M., Haass, C. and Fahrenholz, F. 

Phrase: "278,"

Phrase: "41182-41188."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lammich,"

Phrase: "S."

Phrase: ","

Phrase: "Kojro,"

Phrase: "E.,"

Phrase: "Postina,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gilbert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551090:Gilbert [Quantitative Concept]

Phrase: "S."

Phrase: ","

Phrase: "Pfeiffer,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Jasionowski,"

Phrase: "M."

Phrase: ","

Phrase: "Haass,"

Phrase: "C."

Phrase: "and"

Phrase: "Fahrenholz,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.612: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.613: Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. 

Phrase: "Constitutive"

Phrase: "and"

Phrase: "regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0597304:Protein Cleavage [Molecular Function]
   742   C0010813:cleavage [Cell Function]
   742   C0596311:Cleavage [Phenomenon or Process]
   742   C1330957:cleavage [Cell Function]

Phrase: "by a disintegrin metalloprotease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025543:METALLOPROTEASE [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.614: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.615: Natl. 

Phrase: "Natl."
Processing 00000000.tx.616: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.617: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.618: USA 96, 3922-3927.[Abstract/Free FullText] Lewis, J., Dickson, D. 

Phrase: "USA 96,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: "3922-3927."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lewis,"

Phrase: "J.,"

Phrase: "Dickson,"

Phrase: "D."
Processing 00000000.tx.619: W., Lin, W. 

Phrase: "W., Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0861352:LIN [Neoplastic Process]

Phrase: "W."
Processing 00000000.tx.620: L., Chisholm, L., Corral, A., Jones, G., Yen, S. 

Phrase: "L., Chisholm,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Corral,"

Phrase: "A.,"

Phrase: "Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443013:Jones [Intellectual Product]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Yen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555429:Yen [Quantitative Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.621: H., Sahara, N., Skipper, L., Yager, D. et al. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sahara,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205654:Sahara [Geographic Area]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Skipper,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Yager,"

Phrase: "D. et al."
Processing 00000000.tx.622: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.623: Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. 

Phrase: "Enhanced neurofibrillary degeneration in transgenic mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0085400:Neurofibrillary degeneration [Acquired Abnormality]
   753   C0011164:Degeneration [Pathologic Function]
   753   C1880269:Degeneration [Functional Concept]

Phrase: "expressing"

Phrase: "mutant tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "APP."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.624: Science 293, 1487-1491.[Abstract/Free FullText] Marambaud, P., Wen, P. 

Phrase: "Science 293,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1487-1491."

Phrase: "[Abstract/Free FullText"

Phrase: "] Marambaud,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014511:Wen [Anatomical Abnormality]
  1000   C0086809:Wen [Anatomical Abnormality]
  1000   C1547963:Wen [Intellectual Product]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.625: H., Dutt, A., Shioi, J., Takashima, A., Siman, R. and Robakis, N. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Dutt,"

Phrase: "A.,"

Phrase: "Shioi,"

Phrase: "J.,"

Phrase: "Takashima,"

Phrase: "A.,"

Phrase: "Siman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Robakis,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.626: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.627: (2003). 

Phrase: "(2003"

Phrase: ")."
Processing 00000000.tx.628: A CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS1 FAD mutations. 

Phrase: "A CBP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539643:CBP [Gene or Genome]

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "transcriptional repressor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1336789:Transcriptional Repressor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Repressor

Phrase: "produced by the PS1/epsilon-cleavage of N-cadherin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   742   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0010813:cleavage [Cell Function]
   742   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0439098:Epsilon [Intellectual Product]
   742   C0596311:Cleavage [Phenomenon or Process]
   742   C1330957:cleavage [Cell Function]
   742   C1413274:cadherin [Gene or Genome]
   742   C1418985:PS1 [Gene or Genome]
   742   C2986918:PS1 [Gene or Genome]

Phrase: "is"

Phrase: "inhibited by PS1 FAD mutations."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0026882:Mutations [Genetic Function]
   760   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0311403:Inhibited [Qualitative Concept]
   760   C1418985:PS1 [Gene or Genome]
   760   C2986918:PS1 [Gene or Genome]
   760   C3247466:FAD [Pharmacologic Substance]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.629: Cell 114, 635-645. 

Phrase: "Cell 114,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "635-645."
Processing 00000000.tx.630: Matsuda, S., Yasukawa, T., Homma, Y., Ito, Y., Niikura, T., Hiraki, T., Hirai, S., Ohno, S., Kita, Y., Kawasumi, M. et al. 

Phrase: "Matsuda,"

Phrase: "S."

Phrase: ","

Phrase: "Yasukawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Homma,"

Phrase: "Y.,"

Phrase: "Ito,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415618:ITO [Gene or Genome]

Phrase: "Y.,"

Phrase: "Niikura,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hiraki,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hirai,"

Phrase: "S."

Phrase: ","

Phrase: "Ohno,"

Phrase: "S."

Phrase: ","

Phrase: "Kita,"

Phrase: "Y.,"

Phrase: "Kawasumi,"

Phrase: "M. et al."
Processing 00000000.tx.631: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.632: c-Jun N-terminal kinase (JNK)-interacting protein-1b/islet-brain-1 scaffolds Alzheimer's amyloid precursor protein with JNK. 

Phrase: "c-Jun N-terminal kinase"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
  1000   C0248813:c-jun N-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0380051:c-JUN N-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   937   C1367731:JUN N-terminal kinase [Gene or Genome]
   911   C0872123:c JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0872053:JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C1334482:Jun kinase [Gene or Genome]
   875   C1367019:Jun Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C1707271:C-Terminal [Amino Acid Sequence]
   840   C0162508:c-Jun [Gene or Genome]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0205088:Terminal [Temporal Concept]
   804   C1553033:[c] [Quantitative Concept]
   804   C1705314:Terminal [Manufactured Object]
   804   C1705315:Terminal [Spatial Concept]
   804   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(JNK)-interacting protein-1b/islet-brain-1 scaffolds Alzheimer's amyloid precursor protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   812   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   787   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   787   C0011560:Amyloid [Pathologic Function]
   787   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   787   C1709634:Precursor [Idea or Concept]

Phrase: "with JNK."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]
Processing 00000000.tx.633: J. 

Phrase: "J."
Processing 00000000.tx.634: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.635: 21, 6597-6607.[Abstract/Free FullText] May, P., Reddy, Y. 

Phrase: "21,"

Phrase: "6597-6607."

Phrase: "[Abstract/Free FullText"

Phrase: "] May,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Reddy,"

Phrase: "Y."
Processing 00000000.tx.636: K. and Herz, J. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Herz,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439482:Herz [Quantitative Concept]

Phrase: "J."
Processing 00000000.tx.637: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.638: Proteolytic processing of low density lipoprotein receptor-related protein mediates regulated release of its intracellular domain. 

Phrase: "Proteolytic processing of low density lipoprotein receptor-related protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1514570:Proteolytic Processing [Molecular Function]
   762   C0033666:protein processing [Molecular Function]
   742   C1709694:Processing [Activity]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "regulated release of its intracellular domain."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.639: J. 

Phrase: "J."
Processing 00000000.tx.640: Biol. 

Phrase: "Biol."
Processing 00000000.tx.641: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.642: 277, 18736-18743.[Abstract/Free FullText] Minopoli, G., de Candia, P., Bonetti, A., Faraonio, R., Zambrano, N. and Russo, T. 

Phrase: "277,"

Phrase: "18736-18743."

Phrase: "[Abstract/Free FullText"

Phrase: "] Minopoli,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "de Candia,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bonetti,"

Phrase: "A.,"

Phrase: "Faraonio,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Zambrano,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Russo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.643: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.644: The beta-amyloid precursor protein functions as a cytosolic anchoring site that prevents Fe65 nuclear translocation. 

Phrase: "The beta-amyloid precursor protein"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0085151:beta amyloid precursor protein [Amino Acid, Peptide, or Protein]
           amyloid precursor protein
   923   C0078939:beta-Amyloid Protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C1750295:beta protein [Genetic Function]
   902   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2825879:Amyloid, Beta [Laboratory Procedure]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]
   812   C2004068:Beta [Qualitative Concept]

Phrase: "functions as a cytosolic anchoring site"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0031843:function [Physiologic Function]
   753   C0205145:Site [Spatial Concept]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1293132:Anchoring [Therapeutic or Preventive Procedure]
   753   C1383501:Cytosolic [Cell Component]
   753   C1515974:Site [Body Location or Region]
   753   C1624581:anchoring [Molecular Function]
   753   C1705273:Function [Intellectual Product]
   753   C2825164:Site [Spatial Concept]

Phrase: "that"

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "Fe65 nuclear translocation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1518440:Nuclear Translocation [Molecular Function]
   827   C0040715:Translocation [Cell or Molecular Dysfunction]
   827   C2987521:Translocation [Activity]
Processing 00000000.tx.645: J. 

Phrase: "J."
Processing 00000000.tx.646: Biol. 

Phrase: "Biol."
Processing 00000000.tx.647: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.648: 276, 6545-6550.[Abstract/Free FullText] Ni, C. 

Phrase: "276,"

Phrase: "6545-6550."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ni,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348274:Ni [Element, Ion, or Isotope]

Phrase: "C."
Processing 00000000.tx.649: Y., Murphy, M. 

Phrase: "Y.,"

Phrase: "Murphy,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.650: P., Golde, T. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.651: E. and Carpenter, G. 

Phrase: "E."

Phrase: "and"

Phrase: "Carpenter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336362:Carpenter [Professional or Occupational Group]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.652: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.653: gamma-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. 

Phrase: "gamma-Secretase cleavage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0010813:cleavage [Cell Function]
   827   C0596311:Cleavage [Phenomenon or Process]
   827   C1330957:cleavage [Cell Function]
   734   C0379528:gamma-Secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "nuclear localization of ErbB-4 receptor tyrosine kinase."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0475264:Localisation [Functional Concept]
   744   C1744691:localisation [Biologic Function]
Processing 00000000.tx.654: Science 294, 2179-2181.[Abstract/Free FullText] Ohtsuka, T., Ishibashi, M., Gradwohl, G., Nakanishi, S., Guillemot, F. and Kageyama, R. 

Phrase: "Science 294,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "2179-2181."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ohtsuka,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ishibashi,"

Phrase: "M."

Phrase: ","

Phrase: "Gradwohl,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Nakanishi,"

Phrase: "S."

Phrase: ","

Phrase: "Guillemot,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1000873:Guillemot [Bird]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Kageyama,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.655: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.656: Hes1 and Hes5 as notch effectors in mammalian neuronal differentiation. 

Phrase: "Hes1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412958:HES1 [Gene or Genome]
  1000   C1415725:HES1 [Gene or Genome]

Phrase: "and"

Phrase: "Hes5 as notch effectors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1426393:HES5 [Gene or Genome]

Phrase: "in mammalian neuronal differentiation."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C1518294:Neuronal Differentiation [Finding]
   865 E C1159970:neuron differentiation [Cell Function]
   827   C0007589:Differentiation [Cell Function]
   827   C1511938:Differentiation [Clinical Attribute]
   827   C2945687:Differentiation [Functional Concept]
   755 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.657: EMBO J. 

Phrase: "EMBO J."
Processing 00000000.tx.658: 18, 2196-2207.[Abstract/Free FullText] Passer, B., Pellegrini, L., Russo, C., Siegel, R. 

Phrase: "18,"

Phrase: "2196-2207."

Phrase: "[Abstract/Free FullText"

Phrase: "] Passer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0491928:PASSER [Medical Device]
  1000   C0999347:Passer [Bird]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Pellegrini,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Russo,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Siegel,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.659: M., Lenardo, M. 

Phrase: "M."

Phrase: ","

Phrase: "Lenardo,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.660: J., Schettini, G., Bachmann, M., Tabaton, M. and D'Adamio, L. 

Phrase: "J.,"

Phrase: "Schettini,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bachmann,"

Phrase: "M."

Phrase: ","

Phrase: "Tabaton,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "D'"

Phrase: "Adamio,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.661: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.662: Generation of an apoptotic intracellular peptide by gamma-secretase cleavage of alzheimer's amyloid beta protein precursor. 

Phrase: "Generation of an apoptotic intracellular peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079411:Generation [Temporal Concept]
   753   C3146294:Generation [Activity]

Phrase: "by gamma-secretase cleavage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0010813:cleavage [Cell Function]
   827   C0596311:Cleavage [Phenomenon or Process]
   827   C1330957:cleavage [Cell Function]
   734   C0379528:gamma-Secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "of alzheimer's amyloid beta protein precursor."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C0085151:Amyloid beta-Protein Precursor [Amino Acid, Peptide, or Protein]
           Amyloid Protein Precursor
   888   C3538722:Amyloid Beta Precursor [Laboratory Procedure]
   804   C1709634:Precursor [Idea or Concept]
   722   C0078939:Alzheimer beta-Protein [Amino Acid, Peptide, or Protein]
           Amyloid beta-Protein
Processing 00000000.tx.663: J. 

Phrase: "J."
Processing 00000000.tx.664: Alzheimers Dis. 

Phrase: "Alzheimers Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0451119:DIS [Intellectual Product]
   861   C1444662:DIS [Finding]
Processing 00000000.tx.665: 2, 289-301.[Medline] Ran, Q. and Pereira-Smith, O. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "289-301."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ran,"

Phrase: "Q."

Phrase: "and"

Phrase: "Pereira-Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0554249:Smith [Professional or Occupational Group]

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.666: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.667: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.668: Identification of an alternatively spliced form of the Tat interactive protein (Tip60), Tip60(beta). 

Phrase: "Identification of an alternatively spliced form of the Tat interactive protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0020792:Identification [Mental Process]
   738   C0205396:Identification [Qualitative Concept]

Phrase: "(Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "(beta"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0330390:Beta [Plant]
  1000   C0439096:Beta [Intellectual Product]
  1000   C2004068:Beta [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.669: Gene 258, 141-146.[CrossRef][Medline] Roncarati, R., Sestan, N., Scheinfeld, M. 

Phrase: "Gene 258,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "141-146."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Roncarati,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Sestan,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Scheinfeld,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.670: H., Berechid, B. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Berechid,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.671: E., Lopez, P. 

Phrase: "E.,"

Phrase: "Lopez,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.672: A., Meucci, O., McGlade, J. 

Phrase: "A.,"

Phrase: "Meucci,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "McGlade,"

Phrase: "J."
Processing 00000000.tx.673: C., Rakic, P. and D'Adamio, L. 

Phrase: "C., Rakic,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "D'"

Phrase: "Adamio,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.674: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.675: The gamma-secretase-generated intracellular domain of beta-amyloid precursor protein binds Numb and inhibits Notch signaling. 

Phrase: "The gamma-secretase-generated intracellular domain of beta-amyloid precursor protein"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   754   C0162808:Protein Domain [Spatial Concept]
   754   C1514562:Protein Domain [Amino Acid Sequence]
   738   C0175996:intracellular [Cell Component]
   738   C0178719:Intracellular [Spatial Concept]
   738   C1880389:Domain [Functional Concept]
   738   C1883221:Domain [Conceptual Entity]
   738   C3541951:Domain [Intellectual Product]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "Numb"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417890:NUMB [Gene or Genome]
  1000   C1709287:Numb [Individual Behavior]

Phrase: "and"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "Notch signaling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]
Processing 00000000.tx.676: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.677: Natl. 

Phrase: "Natl."
Processing 00000000.tx.678: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.679: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.680: USA 99, 7102-7107.[Abstract/Free FullText] Russo, T., Faraonio, R., Minopoli, G., de Candia, P., de Renzis, S. and Zambrano, N. 

Phrase: "USA 99,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: "7102-7107."

Phrase: "[Abstract/Free FullText"

Phrase: "] Russo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Faraonio,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Minopoli,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "de Candia,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "de Renzis,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Zambrano,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.681: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.682: Fe65 and the protein network centered around the cytosolic domain of the Alzheimer's beta-amyloid precursor protein. 

Phrase: "Fe65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "the protein network"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1513822:Network [Professional or Occupational Group]
   861   C1705739:Network [Manufactured Object]
   861   C1882071:Network [Conceptual Entity]

Phrase: "centered around the cytosolic domain of the Alzheimer's beta-amyloid precursor protein."
Meta Candidates (Total=30; Excluded=2; Pruned=0; Remaining=28)
   790   C0085151:beta amyloid precursor protein [Amino Acid, Peptide, or Protein]
           amyloid precursor protein
   782 E C3538722:Amyloid Beta Precursor Protein [Laboratory Procedure]
           Amyloid Precursor Protein
           Amyloid Precursor Beta
   767   C0078939:Alzheimer beta-Protein [Amino Acid, Peptide, or Protein]
           beta-Amyloid Protein
   767   C1955168:Alzheimer precursor protein [Amino Acid, Peptide, or Protein]
   753   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1511625:Cytosolic Domain [Cell Component]
   753   C2825879:Amyloid, Beta [Laboratory Procedure]
   751   C0162808:Protein Domain [Spatial Concept]
   751   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   751   C1514562:Protein Domain [Amino Acid Sequence]
   751   C1750295:beta protein [Genetic Function]
   751   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   751 E C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   736   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0011560:Amyloid [Pathologic Function]
   736   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0205099:centered [Spatial Concept]
   736   C0330390:Beta [Plant]
   736   C0439096:Beta [Intellectual Product]
   736   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C1383501:Cytosolic [Cell Component]
   736   C1709634:Precursor [Idea or Concept]
   736   C1880389:Domain [Functional Concept]
   736   C1883221:Domain [Conceptual Entity]
   736   C2004068:Beta [Qualitative Concept]
   736   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.683: FEBS Lett. 

Phrase: "FEBS Lett."
Processing 00000000.tx.684: 434, 1-7.[CrossRef][Medline] Sastre, M., Steiner, H., Fuchs, K., Capell, A., Multhaup, G., Condron, M. 

Phrase: "434,"

Phrase: "1-7."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3541329:1-7 [Gene or Genome]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sastre,"

Phrase: "M."

Phrase: ","

Phrase: "Steiner,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Fuchs,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Capell,"

Phrase: "A.,"

Phrase: "Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Condron,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.685: M., Teplow, D. 

Phrase: "M."

Phrase: ","

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.686: B. and Haass, C. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.687: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.688: Presenilin-dependent gamma-secretase processing of beta-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch. 

Phrase: "Presenilin-dependent gamma-secretase processing of beta-amyloid precursor protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0033666:protein processing [Molecular Function]
   739   C1709694:Processing [Activity]

Phrase: "at a site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205145:Site [Spatial Concept]
  1000   C1515974:Site [Body Location or Region]
  1000   C2825164:Site [Spatial Concept]

Phrase: "corresponding to the S3 cleavage of Notch."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C2752250:Notch S3 cleavage [Molecular Function]
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1179706:S3 [Body Location or Region]
   748   C1235660:Notch [Body Space or Junction]
   748   C1330957:cleavage [Cell Function]
   748   C1335643:S3 [Gene or Genome]
   748   C1419033:S3 [Gene or Genome]
Processing 00000000.tx.689: EMBO Rep. 

Phrase: "EMBO Rep."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1744664:REP [Molecular Function]
Processing 00000000.tx.690: 2, 835-841.[Abstract/Free FullText] Scheinfeld, M. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "835-841."

Phrase: "[Abstract/Free FullText"

Phrase: "] Scheinfeld,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.691: H., Ghersi, E., Laky, K., Fowlkes, B. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ghersi,"

Phrase: "E.,"

Phrase: "Laky,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Fowlkes,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.692: J. and D'Adamio, L. 

Phrase: "J."

Phrase: "and"

Phrase: "D'"

Phrase: "Adamio,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.693: (2002a). 

Phrase: "(2002a"

Phrase: ")."
Processing 00000000.tx.694: Processing of beta-amyloid precursor-like protein-1 and -2 by gamma-secretase regulates transcription. 

Phrase: "Processing of beta-amyloid precursor-like protein-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0033666:protein processing [Molecular Function]
   744   C1709694:Processing [Activity]
   703   C1412466:AMYLOID PRECURSOR-LIKE PROTEIN 1 [Gene or Genome]

Phrase: "and -"

Phrase: "2 by gamma-secretase"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0379528:gamma-Secretase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0017011:Gamma [Natural Phenomenon or Process]
   770   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0740116:+2 [Quantitative Concept]
   770   C1552644:Gamma [Intellectual Product]
   770   C2349976:Gamma [Quantitative Concept]
   770   C2827735:2+ [Quantitative Concept]
   770   C2981700:2+ [Classification]

Phrase: "regulates"

Phrase: "transcription."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]
Processing 00000000.tx.695: J. 

Phrase: "J."
Processing 00000000.tx.696: Biol. 

Phrase: "Biol."
Processing 00000000.tx.697: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.698: 277, 44195-44201.[Abstract/Free FullText] Scheinfeld, M. 

Phrase: "277,"

Phrase: "44195-44201."

Phrase: "[Abstract/Free FullText"

Phrase: "] Scheinfeld,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.699: H., Roncarati, R., Vito, P., Lopez, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Roncarati,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Vito,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Lopez,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.700: A., Abdallah, M. and D'Adamio, L. 

Phrase: "A.,"

Phrase: "Abdallah,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "D'"

Phrase: "Adamio,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.701: (2002b). 

Phrase: "(2002b"

Phrase: ")."
Processing 00000000.tx.702: Jun NH2-terminal kinase (JNK) interacting protein 1 (JIP1) binds the cytoplasmic domain of the Alzheimer's beta-amyloid precursor protein (APP). 

Phrase: "Jun NH2-terminal kinase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0248813:jun-NH2-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   902   C0872053:JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   902   C1334482:Jun kinase [Gene or Genome]
   902   C1367019:Jun Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(JNK) interacting protein 1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1417024:JNK-INTERACTING PROTEIN 1 [Gene or Genome]
   923   C1422725:JNK interacting protein [Gene or Genome]
   861   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1150587:JNK [Molecular Function]
   812   C1367731:JNK [Gene or Genome]
   812   C1705632:JNK [Gene or Genome]

Phrase: "(JIP1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417024:JIP1 [Gene or Genome]

Phrase: ")"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "the cytoplasmic domain of the Alzheimer's beta-amyloid precursor protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C1511625:Cytoplasmic Domain [Cell Component]
   757   C0162808:Protein Domain [Spatial Concept]
   757   C1514562:Protein Domain [Amino Acid Sequence]
   739   C1880389:Domain [Functional Concept]
   739   C1883221:Domain [Conceptual Entity]
   739   C3541951:Domain [Intellectual Product]

Phrase: "(APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.703: J. 

Phrase: "J."
Processing 00000000.tx.704: Biol. 

Phrase: "Biol."
Processing 00000000.tx.705: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.706: 277, 3767-3775.[Abstract/Free FullText] Scheinfeld, M. 

Phrase: "277,"

Phrase: "3767-3775."

Phrase: "[Abstract/Free FullText"

Phrase: "] Scheinfeld,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.707: H., Matsuda, S. and D'Adamio, L. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Matsuda,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "D'"

Phrase: "Adamio,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.708: (2003). 

Phrase: "(2003"

Phrase: ")."
Processing 00000000.tx.709: JNK-interacting protein-1 promotes transcription of A beta protein precursor but not A beta precursor-like proteins, mechanistically different than Fe65. 

Phrase: "JNK-interacting protein-1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1417024:JNK-INTERACTING PROTEIN 1 [Gene or Genome]
   923   C1422725:JNK interacting protein [Gene or Genome]
   861   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1150587:JNK [Molecular Function]
   812   C1367731:JNK [Gene or Genome]
   812   C1705632:JNK [Gene or Genome]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "transcription of A beta protein precursor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0040649:Transcription [Genetic Function]
   716   C0085151:Amyloid beta-Protein Precursor [Amino Acid, Peptide, or Protein]

Phrase: "but"

Phrase: "not A beta precursor-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C3538722:Amyloid Beta Precursor [Laboratory Procedure]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "like proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "mechanistically different than Fe65."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.710: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.711: Natl. 

Phrase: "Natl."
Processing 00000000.tx.712: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.713: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.714: USA 100, 1729-1734.[Abstract/Free FullText] Schroeter, E. 

Phrase: "USA 100,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: "1729-1734."

Phrase: "[Abstract/Free FullText"

Phrase: "] Schroeter,"

Phrase: "E."
Processing 00000000.tx.715: H., Kisslinger, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kisslinger,"

Phrase: "J."
Processing 00000000.tx.716: A. and Kopan, R. 

Phrase: "A."

Phrase: "and"

Phrase: "Kopan,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.717: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.718: Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. 

Phrase: "Notch-1 signalling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C3537152:signalling [Biologic Function]
   793 E C1710082:Signal [Phenomenon or Process]
   734   C1334889:notch 1 [Gene or Genome]

Phrase: "requires"

Phrase: "ligand-induced proteolytic release of intracellular domain."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0030685:Release [Health Care Activity]
   748   C0391871:Release [Functional Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0680255:release [Health Care Activity]
   748   C1283071:Release [Functional Concept]
   748   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.719: Nature 393, 382-386.[CrossRef][Medline] Selkoe, D. 

Phrase: "Nature 393,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "382-386."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Selkoe,"

Phrase: "D."
Processing 00000000.tx.720: J. 

Phrase: "J."
Processing 00000000.tx.721: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.722: Translating cell biology into therapeutic advances in Alzheimer's disease. 

Phrase: "Translating cell biology into therapeutic advances"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0010819:Cell Biology [Biomedical Occupation or Discipline]
   753   C0005532:Biology [Biomedical Occupation or Discipline]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.723: Nature 399, 23-31.[CrossRef] Shearman, M. 

Phrase: "Nature 399,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "23-31."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450348:23 [Quantitative Concept]
   861   C0450355:31 [Intellectual Product]

Phrase: "[CrossRef"

Phrase: "] Shearman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.724: S., Beher, D., Clarke, E. 

Phrase: "S."

Phrase: ","

Phrase: "Beher,"

Phrase: "D."

Phrase: ","

Phrase: "Clarke,"

Phrase: "E."
Processing 00000000.tx.725: E., Lewis, H. 

Phrase: "E.,"

Phrase: "Lewis,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.726: D., Harrison, T., Hunt, P., Nadin, A., Smith, A. 

Phrase: "D."

Phrase: ","

Phrase: "Harrison,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hunt,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Nadin,"

Phrase: "A.,"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "A."
Processing 00000000.tx.727: L., Stevenson, G. and Castro, J. 

Phrase: "L., Stevenson,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Castro,"

Phrase: "J."
Processing 00000000.tx.728: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.729: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.730: L-685,458, an aspartyl protease transition state mimic, is a potent inhibitor of amyloid beta-protein precursor gamma-secretase activity. 

Phrase: "L-685,458,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0915177:L-685,458 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0439394:l's [Quantitative Concept]
   827   C1706495:L- [Intellectual Product]
   827   C3642217:/L [Quantitative Concept]

Phrase: "an aspartyl protease transition state"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   812   C0599156:Transition [Cell or Molecular Dysfunction]
   812   C1301808:State [Geographic Area]
   812   C1442792:State [Functional Concept]
   812   C2700061:Transition [Activity]
   812   C3148680:State [Geographic Area]
   741 E C1182674:Transitional [Spatial Concept]
   741 E C1548597:Transitional [Idea or Concept]

Phrase: "mimic"

Phrase: ","

Phrase: "is"

Phrase: "a potent inhibitor of amyloid beta-protein precursor gamma-secretase activity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   813   C0766890:amyloid beta-protein precursor inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.731: Biochemistry 39, 8698-8704.[CrossRef][Medline] Shivers, B. 

Phrase: "Biochemistry 39,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "8698-8704."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shivers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036973:shivers [Finding]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.732: D., Hilbich, C., Multhaup, G., Salbaum, M., Beyreuther, K. and Seeburg, P. 

Phrase: "D."

Phrase: ","

Phrase: "Hilbich,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Multhaup,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Salbaum,"

Phrase: "M."

Phrase: ","

Phrase: "Beyreuther,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Seeburg,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.733: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.734: (1988). 

Phrase: "(1988"

Phrase: ")."
Processing 00000000.tx.735: Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact. 

Phrase: "Alzheimer's disease amyloidogenic glycoprotein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017968:Glycoprotein [Amino Acid, Peptide, or Protein,Carbohydrate]

Phrase: ":"

Phrase: "expression pattern in rat brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449774:Pattern [Spatial Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a role in cell contact."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0332158:contact [Functional Concept]
   812   C0337611:Contact [Population Group]
   812   C1705415:Contact [Idea or Concept]
Processing 00000000.tx.736: EMBO J. 

Phrase: "EMBO J."
Processing 00000000.tx.737: 7, 1365-1370.[Abstract] Sisodia, S. 

Phrase: "7,"

Phrase: "1365-1370."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.738: S. and St George-Hyslop, P. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "St George-Hyslop,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1553316:St. George [Population Group]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.739: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.740: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.741: gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in? 

Phrase: "gamma-Secretase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0379528:gamma-Secretase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Notch,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1235660:Notch [Body Space or Junction]

Phrase: "Abeta"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1420510:A-BETA [Gene or Genome]
  1000   C1705543:ABETA [Gene or Genome]

Phrase: "and"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "where"

Phrase: "do"

Phrase: "the presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "fit in?"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0036572:Fit [Sign or Symptom]
   833   C0424576:Fit [Finding]
   833   C2349186:Fit [Activity]
Processing 00000000.tx.742: Nat. 

Phrase: "Nat."
Processing 00000000.tx.743: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.744: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.745: 3, 281-290.[CrossRef][Medline] Sterner, D. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "281-290."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sterner, D."
Processing 00000000.tx.746: E. and Berger, S. 

Phrase: "E."

Phrase: "and"

Phrase: "Berger,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.747: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.748: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.749: Acetylation of histones and transcription-related factors. 

Phrase: "Acetylation of histones"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   841   C1156200:Histone Acetylation [Molecular Function]
   790   C0001038:Acetylation [Molecular Function]
   790   C1521754:Acetylation [Molecular Function]

Phrase: "and"

Phrase: "transcription-related factors."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.750: Microbiol. 

Phrase: "Microbiol."
Processing 00000000.tx.751: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.752: Biol. 

Phrase: "Biol."
Processing 00000000.tx.753: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.754: 64, 435-459.[Abstract/Free FullText] Suhr, S. 

Phrase: "64,"

Phrase: "435-459."

Phrase: "[Abstract/Free FullText"

Phrase: "] Suhr,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.755: T., Gil, E. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Gil,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412493:GIL [Gene or Genome]

Phrase: "E."
Processing 00000000.tx.756: B., Senut, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Senut,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.757: C. and Gage, F. 

Phrase: "C."

Phrase: "and"

Phrase: "Gage,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456564:Gauge [Spatial Concept]
  1000   C1521879:GAGE [Immunologic Factor]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.758: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.759: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.760: High level transactivation by a modified Bombyx ecdysone receptor in mammalian cells without exogenous retinoid X receptor. 

Phrase: "High level transactivation by a modified Bombyx ecdysone receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C3158809:receptor transactivation [Physiologic Function]
   742   C0040624:Transactivation [Genetic Function]

Phrase: "in mammalian cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1512977:Mammalian Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "without exogenous retinoid X receptor."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0140283:Retinoid X Receptor [Amino Acid, Peptide, or Protein,Receptor]
   875   C0140278:Retinoid Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1421546:X RECEPTOR [Gene or Genome]
   812   C0035339:Retinoid [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C3536891:Retinoid [Pharmacologic Substance]
Processing 00000000.tx.761: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.762: Natl. 

Phrase: "Natl."
Processing 00000000.tx.763: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.764: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.765: USA 95, 7999-8004.[Abstract/Free FullText] Taru, H. and Suzuki, T. 

Phrase: "USA 95,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: "7999-8004."

Phrase: "[Abstract/Free FullText"

Phrase: "] Taru,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.766: (2004). 

Phrase: "(2004"

Phrase: ")."
Processing 00000000.tx.767: Facilitation of stress-induced phosphorylation of beta-amyloid precursor protein family members by X11-like/MINT2 protein. 

Phrase: "Facilitation of stress-induced phosphorylation of beta-amyloid precursor protein family members"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "by X11-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412456:X11 [Gene or Genome]
  1000   C3538726:X11 [Gene or Genome]

Phrase: "like/MINT2 protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.768: J. 

Phrase: "J."
Processing 00000000.tx.769: Biol. 

Phrase: "Biol."
Processing 00000000.tx.770: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.771: 279, 21628-21636.[Abstract/Free FullText] Taru, H., Iijima, K., Hase, M., Kirino, Y., Yagi, Y. and Suzuki, T. 

Phrase: "279,"

Phrase: "21628-21636."

Phrase: "[Abstract/Free FullText"

Phrase: "] Taru,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Iijima,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hase,"

Phrase: "M."

Phrase: ","

Phrase: "Kirino,"

Phrase: "Y.,"

Phrase: "Yagi,"

Phrase: "Y."

Phrase: "and"

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.772: (2002a). 

Phrase: "(2002a"

Phrase: ")."
Processing 00000000.tx.773: Interaction of Alzheimer's beta-amyloid precursor family proteins with scaffold proteins of the JNK signaling cascade. 

Phrase: "Interaction of Alzheimer's beta-amyloid precursor family proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   750   C0872079:interaction protein [Molecular Function]
   744   C1704675:Interaction [Functional Concept]

Phrase: "with scaffold proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1179132:Scaffold protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "of the JNK signaling cascade."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1155542:JNK cascade [Molecular Function]
   901   C2611812:signaling cascade [Cell Function]
   827   C1707310:Cascade [Manufactured Object]
Processing 00000000.tx.774: J. 

Phrase: "J."
Processing 00000000.tx.775: Biol. 

Phrase: "Biol."
Processing 00000000.tx.776: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.777: 277, 20070-20078.[Abstract/Free FullText] Taru, H., Kirino, Y. and Suzuki, T. 

Phrase: "277,"

Phrase: "20070-20078."

Phrase: "[Abstract/Free FullText"

Phrase: "] Taru,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kirino,"

Phrase: "Y."

Phrase: "and"

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.778: (2002b). 

Phrase: "(2002b"

Phrase: ")."
Processing 00000000.tx.779: Differential roles of JIP scaffold proteins in the modulation of amyloid precursor protein metabolism. 

Phrase: "Differential roles of JIP scaffold proteins"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0035820:Roles [Social Behavior]
   719 E C1705810:Role [Conceptual Entity]

Phrase: "in the modulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:Modulation [Spatial Concept]

Phrase: "of amyloid precursor protein metabolism."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1327340:amyloid precursor protein metabolism [Molecular Function]
   861   C0597299:Protein Metabolism [Molecular Function]
   812   C0025519:Metabolism [Organism Function]
   812   C0025520:metabolism [Functional Concept]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.780: J. 

Phrase: "J."
Processing 00000000.tx.781: Biol. 

Phrase: "Biol."
Processing 00000000.tx.782: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.783: 277, 27567-27574.[Abstract/Free FullText] Vassar, R., Bennett, B. 

Phrase: "277,"

Phrase: "27567-27574."

Phrase: "[Abstract/Free FullText"

Phrase: "] Vassar,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Bennett,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.784: D., Babu-Khan, S., Kahn, S., Mendiaz, E. 

Phrase: "D."

Phrase: ","

Phrase: "Babu-Khan,"

Phrase: "S."

Phrase: ","

Phrase: "Kahn,"

Phrase: "S."

Phrase: ","

Phrase: "Mendiaz,"

Phrase: "E."
Processing 00000000.tx.785: A., Denis, P., Teplow, D. 

Phrase: "A.,"

Phrase: "Denis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332319:denis [Qualitative Concept]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.786: B., Ross, S., Amarante, P., Loeloff, R. et al. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "S."

Phrase: ","

Phrase: "Amarante,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Loeloff,"

Phrase: "R. et al."
Processing 00000000.tx.787: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.788: Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. 

Phrase: "Beta-secretase cleavage of Alzheimer's amyloid precursor protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0597304:Protein Cleavage [Molecular Function]
   744   C0010813:cleavage [Cell Function]
   744   C0596311:Cleavage [Phenomenon or Process]
   744   C1330957:cleavage [Cell Function]

Phrase: "by the transmembrane aspartic protease BACE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1412727:BACE [Gene or Genome]
Processing 00000000.tx.789: Science 286, 735-741.[Abstract/Free FullText] Walsh, D. 

Phrase: "Science 286,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "735-741."

Phrase: "[Abstract/Free FullText"

Phrase: "] Walsh,"

Phrase: "D."
Processing 00000000.tx.790: M., Fadeeva, J. 

Phrase: "M."

Phrase: ","

Phrase: "Fadeeva,"

Phrase: "J."
Processing 00000000.tx.791: V., LaVoie, M. 

Phrase: "V., LaVoie,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.792: J., Paliga, K., Eggert, S., Kimberly, W. 

Phrase: "J.,"

Phrase: "Paliga,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3284170:Paliga [Eukaryote]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Eggert,"

Phrase: "S."

Phrase: ","

Phrase: "Kimberly,"

Phrase: "W."
Processing 00000000.tx.793: T., Wasco, W. and Selkoe, D. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Wasco,"

Phrase: "W."

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.794: J. 

Phrase: "J."
Processing 00000000.tx.795: (2003). 

Phrase: "(2003"

Phrase: ")."
Processing 00000000.tx.796: gamma-Secretase cleavage and binding to FE65 regulate the nuclear translocation of the intracellular C-terminal domain (ICD) of the APP family of proteins. 

Phrase: "gamma-Secretase cleavage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0010813:cleavage [Cell Function]
   827   C0596311:Cleavage [Phenomenon or Process]
   827   C1330957:cleavage [Cell Function]
   734   C0379528:gamma-Secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "binding to FE65"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]

Phrase: "regulate"

Phrase: "the nuclear translocation of the intracellular C-terminal domain (ICD)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C1518440:Nuclear Translocation [Molecular Function]
   762   C0599813:Intracellular translocation [Cell Function]
   742   C0040715:Translocation [Cell or Molecular Dysfunction]
   742   C2987521:Translocation [Activity]

Phrase: "of the APP family"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0015576:Family [Family Group]
   812   C1704727:Family [Conceptual Entity]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   741 E C0241888:Familial [Functional Concept]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "of proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.797: Biochemistry 42, 6664-6673.[CrossRef][Medline] Walter, J., Kaether, C., Steiner, H. and Haass, C. 

Phrase: "Biochemistry 42,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "6664-6673."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Walter,"

Phrase: "J.,"

Phrase: "Kaether,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Steiner,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.798: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.799: The cell biology of Alzheimer's disease: uncovering the secrets of secretases. 

Phrase: "The cell biology of Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0010819:Cell Biology [Biomedical Occupation or Discipline]
   753   C0005532:Biology [Biomedical Occupation or Discipline]

Phrase: ":"

Phrase: "uncovering"

Phrase: "the secrets of secretases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1424652:SECRET [Gene or Genome]
Processing 00000000.tx.800: Curr. 

Phrase: "Curr."
Processing 00000000.tx.801: Opin. 

Phrase: "Opin."
Processing 00000000.tx.802: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.803: 11, 585-590.[CrossRef][Medline] Whitmarsh, A., Cavanagh, J., Tournier, C., Yasuda, J. and Davis, R. 

Phrase: "11,"

Phrase: "585-590."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Whitmarsh,"

Phrase: "A.,"

Phrase: "Cavanagh,"

Phrase: "J.,"

Phrase: "Tournier,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Yasuda,"

Phrase: "J."

Phrase: "and"

Phrase: "Davis,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.804: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.805: A mammalian scaffold complex that selectively mediates MAP kinase activation. 

Phrase: "A mammalian scaffold complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "that selectively"

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "MAP kinase activation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1879547:Activation [Activity]
   734   C0752312:Map Kinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.806: Science 281, 1671-1674.[Abstract/Free FullText] Xia, Z. and Liu, Y. 

Phrase: "Science 281,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1671-1674."

Phrase: "[Abstract/Free FullText"

Phrase: "] Xia,"

Phrase: "Z."

Phrase: "and"

Phrase: "Liu,"

Phrase: "Y."
Processing 00000000.tx.807: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.808: Reliable and global measurement of fluorescence resonance energy transfer using fluorescence microscopes. 

Phrase: "Reliable"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C2347947:Reliability [Quantitative Concept]

Phrase: "and"

Phrase: "global measurement of fluorescence resonance energy transfer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0242485:Measurement [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "fluorescence microscopes."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   861   C0181839:Microscopes [Medical Device]
   827 E C1706379:Microscope [Medical Device]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.809: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.810: J. 

Phrase: "J."
Processing 00000000.tx.811: 81, 2395-2402.[Abstract/Free FullText] Xiao, H., Chung, J., Kao, H. 

Phrase: "81,"

Phrase: "2395-2402."

Phrase: "[Abstract/Free FullText"

Phrase: "] Xiao,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Chung,"

Phrase: "J.,"

Phrase: "Kao,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.812: Y. and Yang, Y. 

Phrase: "Y."

Phrase: "and"

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "Y."
Processing 00000000.tx.813: C. 

Phrase: "C."
Processing 00000000.tx.814: (2003). 

Phrase: "(2003"

Phrase: ")."
Processing 00000000.tx.815: Tip60 is a co-repressor for STAT3. 

Phrase: "Tip60"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]

Phrase: "is"

Phrase: "a co-repressor for STAT3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1336789:Repressor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.816: J. 

Phrase: "J."
Processing 00000000.tx.817: Biol. 

Phrase: "Biol."
Processing 00000000.tx.818: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.819: 278, 11197-11204.[Abstract/Free FullText] Related articles in JCS: Signalling by secretase JCS 2004 117: 1902. 

Phrase: "278,"

Phrase: "11197-11204."

Phrase: "[Abstract/Free FullText"

Phrase: "] Related articles in JCS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1706852:Article [Intellectual Product]

Phrase: ":"

Phrase: "Signalling by secretase JCS 2004 117"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C3537152:signalling [Biologic Function]
   719 E C1710082:Signal [Phenomenon or Process]

Phrase: ":"

Phrase: "1902."
Processing 00000000.tx.820: [Full Text]

Phrase: "[Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1527021:Text [Intellectual Product]
   861   C1554111:Text [Idea or Concept]
   861   C1705606:Text [Intellectual Product]
   861   C3541382:Text [Intellectual Product]

Phrase: "]"

